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Summary 
Integrins are heterodimeric transmembrane receptors that mediate cell adhesion through 
their interaction with the extracellular matrix (ECM). Remarkably, integrins are also 
signal transduction receptors regulating a wide range of cellular processes such as 
proliferation, survival, differentiation and migration despite lacking enzymatic activity. 
Integrins accomplish this function by recruitment of various adaptor, scaffolding and 
signaling molecules to their short cytoplasmic tails. Through extensive intracellular 
interactions integrins assemble large signaling hubs known as focal adhesions to couple to 
the cytoskeleton and to transduce signals. Integrin-linked kinase (ILK) is a central 
constituent of 1 and 3 integrin adhesions. ILK is composed of three structurally distinct 
domains: five ankyrin repeats, a pleckstrin homology (PH) domain and kinase-like 
domain, and it forms an obligatory trimeric protein complex with two other focal 
adhesion proteins, PINCH and parvin (IPP complex). ILK functions as an adaptor protein 
downstream of integrins, but in addition it was proposed to possess kinase activity 
(Hannigan, Leung-Hagesteijn et al. 1996). However, recent structural and genetic studies 
clearly demonstrate that ILK, despite its homology to serine/threonine kinases, does not 
possess catalytic activity (Lange, Wickstrom et al. 2009; Fukuda, Knight et al. 2011). In 
vivo studies have shown that the adaptor function of ILK is essential for normal 
development in the worm, fly and mouse (Zervas, Gregory et al. 2001; Mackinnon, 
Qadota et al. 2002; Sakai, Li et al. 2003).On the cellular level ILK is required for cell 
spreading, focal adhesion formation and migration (Grashoff, Aszodi et al. 2003; Sakai, 
Li et al. 2003). Interaction of ILK and -parvin is essential for maturation of focal 
adhesions into fibrillar adhesions and subsequent fibronectin matrix deposition in 
fibroblasts (Stanchi, Grashoff et al. 2009).  In addition, altered ILK protein levels have 
been shown to play a role in the pathophysiology of several cancers, heart disease, and 
fibrosis (Li, Yang et al. 2003; Zhang, Ikegami et al. 2006; Hannigan, Coles et al. 2007; 
Schmidmaier and Baumann 2008; Kavvadas, Kypreou et al. 2010). 
C-terminal of Hsp70 interacting protein (CHIP) is an Ubox E3/E4 ubiquitin ligase 
(Ballinger, Connell et al. 1999; Nyamsuren, Faggionato et al. 2007) consisting of a N-
terminal tetratricopeptide domain (TRP) and C-terminal U-box domain (Schulman and 
Chen 2005). While the TPR domain mediates interaction of CHIP with chaperones such 
Summary 
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as hsp70 and hsp90, the U box domain executes ubiquitin ligase activity (Schulman and 
Chen 2005). These two features present in one protein make CHIP an important player in 
protein quality control by integrating the ubiquitin proteasome system (UPS) with the 
chaperone machinery. CHIP is also involved in the cellular stress response by controlling 
the transcription of heat shock factor 1 (HSF-1) as well as by regulating hsp70 levels via 
ubiquitination and proteasomal degradation (Min, Whaley et al. 2008). As an important 
regulator of cellular proteostasis CHIP plays a role in many neurodegenerative diseases 
that arise as a consequence of accumulation of abnormal proteins, such as Alzheimer´s, 
Parkinson´s, Huntington`s disease as well as several spinocerebellar ataxias and spinal 
and bulbar muscular atrophy (Dickey, Patterson et al. 2007).  
In this study we have analyzed the molecular mechanisms by which ILK levels are 
adjusted in the cell. We demonstrate that CHIP is capable of regulating ILK levels 
through ubiquitination and proteasomal degradation. Furthermore we show that under 
basal conditions, ILK is protected from CHIP-mediated ubiquitination and proteasomal 
degradation through its interaction with the chaperone Hsp90. As a consequence, 
blocking the chaperone activity of Hsp90 by the inhibitor 17AAG leads to rapid 
degradation of ILK and concomitant inhibition of cell migration. As ILK is upregulated in 
various cancer cells that show cell adhesion-mediated drug resistance (CAM-DR), 
17AAG-induced degradation of ILK represents a potential approach for the treatment of 
different drug resistant tumors (Schmidmaier and Baumann 2008). In addition, 17AAG 
could potentially have anti-fibrotic activity through its effect on ILK protein levels, as 
ILK has been implicated in fibrosis development in kidney, liver and lung (Li, Yang et al. 
2003; Zhang, Ikegami et al. 2006; Kavvadas, Kypreou et al. 2010). 
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Aim of the Thesis 
ILK is an essential scaffold linking integrins and the actin cytoskeleton in 1 and 3 
integrin-containing adhesions. It has essential cellular functions in focal adhesion 
formation, cell spreading and migration. This study was directed to understand how ILK 
is regulated on the molecular level and how this regulation impacts the role of ILK as an 
essential downstream target of integrins. Therefore we were prompted to:  
1. Identify posttranslational modifications of ILK and find novel interacting partners 
responsible for these modifications. 
2. Investigate how these posttranslational modifications regulate the turnover and 
function of ILK. 
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1. Introduction 
1.1. The integrin receptor family 
Tissue integrity in all multicellular organisms depends on intercellular cohesion as well as 
communication. While cadherins and immunoglobulin superfamily proteins are the two 
largest groups of proteins involved in cell-cell interaction, integrins are the largest family 
of proteins involved in cell-matrix as well as cell-cell adhesion (Hynes and Zhao 2000). 
Integrins are heterodimeric type I transmembrane receptors consisting of non-covalently 
linked  and  subunits (Hynes 2002). They are expressed in all metazoans from sponges 
and coelenterates to insects, nematodes and vertebrates (Hynes and Zhao 2000). While C. 
elegans expresses 1  and 2  subunits, D. melanogaster has 2  and 5  subunits 
(Johnson, Lu et al. 2009). In mammals there are 8 and 18  subunits that can combine 
to form a total of 24 heterodimers (Hynes 2002). Different integrin heterodimers are 
expressed in different tissues, during different developmental stages and have different 
ligand binding properties (Bokel and Brown 2002; Humphries, Byron et al. 2006). 
Integrins mediate bidirectional mechanical and chemical signaling and by this regulate 
various cellular processes such as cell adhesion, proliferation, survival, differentiation and 
cell shape (Giancotti and Ruoslahti 1999) in physiological as well as in pathological 
conditions (Margadant, Monsuur et al. 2011). Remarkably, integrins do not posses 
intrinsic enzymatic activity and do not connect directly to cytoskeleton, but accomplish 
their function through recruiting intracellular adaptor proteins.  
   1.1.1.      Integrins and their ligands 
In mammals 24 integrin heterodimers can be detected at the protein level (Hynes 2002). 
The dimerization of integrin subunits occurs intracellularly prior to their transport to the 
cell surface (Humphries 2000) (Fig.1.1.1.). subunits are present in excess, and so the 
amount of the  subunit expressed in the cell determines which heterodimers are present 
at the cell surface (Santala and Heino 1991). Integrins can be categorized according to the 
subunit composition and ligand binding properties. 1 (12), 2 and V (5) containing 
integrin heterodimers are the three most represented groups of integrins (Barczyk, 
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Carracedo et al. 2010). Integrin receptors bind a wide range of extracellular ligands and 
many of these ligands can bind different integrin heterodimers. This promiscuity occurs 
due to the mechanism of interaction, which is similar between different integrins and their 
ligands (Humphries, Byron et al. 2006).  
                        
Figure 1.1.1. The integrin family: The integrin family in vertebrates contains 24 
heterodimers. Some isolated species that went through genome duplication (e.g., Danio 
rerio) have more integrin family members. (Barczyk, Carracedo et al. 2010). 
All five V subunit-containing integrins, 5 1 and 8 1 as well as IIb 3 integrins 
recognize ligands that contain a RGD (arginine, glycine, aspartate) tripeptide motif. The 
RGD tripeptide is a minimal recognition sequence found in fibronectin, vitronectin, 
tenascin, osteopontin and fibrinogen. It is important to note that large macromolecules 
can contain other integrin binding sites besides the RGD sequence. One such example is 
the fibronectin synergy site that can bind to the 5 subunit. α4β1, α4β7 and α9β1 bind to 
the LDV (lysine, aspartate, valine) motif that is functionally related to RGD. Fibronectin 
contains the prototype LDV motif in its type III connecting segment region. Other ligands 
such as VCAM-1 and MadCAM-1 contain sequences related to LDV.  The mode of 
interaction of the LDV sequence with integrin heterodimers is most probably similar to 
the one of RGD, at the interface of the  and  subunits. 2 integrins interact with their 
ligands in a similar mode, but involving an I domain inserted into the  subunit as a 
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major interaction interface. However, the ligand sequence that is recognized by 2 
containing integrins is structurally similar to the LDV motif. Four α-subunits that contain 
an α-I-domain (α1, α2, α10, α11) combined with β1, form a distinct laminin/collagen-
binding subfamily. Finally, three 1 containing integrins (α3β1, α6β1 and α7β1) as well 
as α6β4 present the group of integrins that are highly selective laminin receptors that lack 
an α-I-domain. However, they most probably bind to a different region of laminin 
(Campbell and Humphries 2011). In addition to these major ligand groups integrins can 
bind to other ligands such as milk fat globule-EGF factor 8 (MFGE8) and complement 
factor iC3b, which facilitate phagocytosis of apoptotic cells and pathogens, respectively; 
the latency-associated peptide of transforming growth factor β (TGFβ) that regulates the 
activation of TGFβ as well as some of the ADAM (a disintegrin and metalloproteinase) 
family members as well as matrix metalloproteinase-2 (MMP-2) which participate in 
ECM remodeling during cell adhesion and migration (Humphries, Byron et al. 2006; 
Legate and Fassler 2009). Some integrin ligands are generated by proteolysis, the best 
known examples being endostatin (derived from collagen XVIII), endorepellin (derived 
from perlecan) and tumstatin (derived from collagen α3) (Bix and Iozzo 2005). In 
addition, integrins can bind snake toxins as well as certain pathogens like viruses and 
bacteria. Some of these interactions occur outside the regular ligand-binding sites in the 
integrins and display distinct binding characteristics when compared to the binding of 
physiological ligands (Barczyk, Carracedo et al. 2010).  
Additional complexity to the integrin receptor family comes from existence of 
alternatively spliced isoforms. Different variants of both the extracellular and cytoplasmic 
domains have been reported. Alternative extracellular domains and cytoplasmic domains 
may account for different ligand-binding affinities or variations in the state of activation 
as well as variation in downstream integrin activity, cytoskeletal associations and/or 
signaling events respectively (van der Flier and Sonnenberg 2001). The best known 
example is the β1 subunit with four known cytoplasmic variants (β1A, β1B, β1C and 
β1D). These variants have tissue-specific expression patterns. For example the β1A 
subunit is present in all tissues except mature cardiac and skeletal muscle; these tissues 
instead express the highly homologous β1D variant. These two variants of β1 subunit are 
not functionally equivalent in embryonic development. The replacement of β1A by β1D 
results in embryonic lethality in mice, whereas replacement of β1D with β1A does not 
lead to severe abnormalities in striated muscles in vivo (Baudoin, Goumans et al. 1998). 
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Genetic studies employing single integrin subunit-deficient mice have demonstrated that 
all 24 vertebrate integrins are not redundant and have a specific function. The phenotypes 
of these mice range from a complete block of embryo implantation (β1) through major 
developmental defects (α4, α5, αV, β8) to perinatal lethality (α3, α6, α8, αV, β4, β8) and 
defects in leukocyte function (αL, αM, αE, β2, β7), inflammation (β6), haemostasis (αIIb, 
β3, α2), bone remodeling (β3), and angiogenesis (α1, β3), reflecting the different 
functions of individual integrins (Bouvard, Brakebusch et al. 2001). Further insights to 
function of the integrins that give rise to severe phenotypes during embryonic 
development have been accomplished by generating tissue-specific integrin knockout 
mice. 
   1.1.2.      Structural features of integrins 
Integrin  and  subunits have a large extracellular domain (approximately 800 amino 
acids), a single transmembrane domain of around 20 amino acids and a short cytoplasmic 
tail (10-70 amino acids). The exception here is 4 integrin that has an unusually long 
cytoplasmic tail of approximately 1000 amino acids (Hynes 2002).  
 
Figure 1.1.2. Schematic representation of integrin domain structure and integrin 
activation. Integrin is kept in a bent inactive conformation via a specific interaction 
between the ectodomains, the transmembrane domain, and the cytoplasmic domains. 
During integrin activation the separation of integrin legs, transmembrane domain and 
cytoplasmic domains occurs leading to the extended integrin conformation  The α subunit 
is shown in green and the β subunit in purple (Moser, Legate et al. 2009). 
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The extracellular, N-terminal domains of  and  subunits within a heterodimer adopt a 
head on stalks conformation. Most of our knowledge about the structure of integrins 
comes from the crystal structure of the αvβ3 and more recently the αIIbβ3 (Xiong, Stehle 
et al. 2001; Zhu, Luo et al. 2008). We cannot, however, be certain if these concepts can 
be applied to all other integrin heterodimers. The extracellular domain of the α subunit 
contains a β propeller domain followed by an Ig-like (thigh) and two β sandwich domains 
(calf1 and calf2) (Fig. 1.1.2.). Half of the known α subunits (the collagen-binding and 
leukocytes-specific integrins) contain an I/A domain inserted into the larger β propeller 
domain. When present, the I/A domain participates in ligand binding (Hynes 2002). The 
extracellular domain of the β subunit consists of a βI/A domain, which is inserted into an 
immunoglobulin (Ig)-like “hybrid” domain preceded by an N-terminal 54-residue PSI 
(plexin, semaphorins, and integrins) domain, four tandem cysteine-rich EGF-like repeats 
and a β-tail domain. The PSI domain forms a disulfide bond with the distal I-EGF domain 
(Hynes 2002; Arnaout, Mahalingam et al. 2005). The head domain of the integrin 
heterodimer comprises of the β propeller of the α subunit and the βΙ/A and the “hybrid” 
domains of the β subunit. The ligand-binding pocket is formed by the interface between 
the  propeller and the βI/A domain. Integrin ligand binding depends on divalent cations. 
There are three metal binding sites essential for ligand binding in the βI/A domain: a 
central Mg²+ binding site called MIDAS (metal-ion-dependent adhesion site) flanked by 
two Ca²+ sites, the SyMBS (synergistic metal ion binding site) and the AdMIDAS 
(adjacent to MIDAS)  (Zhu, Luo et al. 2008). 
The best characterized structures of transmembrane domains of integrins are the ones of 
IIb and 3 subunits. The 3 transmembrane domain has 30 amino acids that form an  
helix. The length of this structure is longer than an average thickness of a lipid bilayer, 
suggesting that it is probably tilted within the membrane (Lau, Partridge et al. 2008). The 
IIb transmembrane domain has only 24 amino acid residues forming an helix 
followed by a backbone reversal and therefore does not display the tilt within the 
membrane (Lau, Dua et al. 2008). 
The cytoplasmic tails of  and  subunits contain several well conserved features: the 
GFKKR motif in the  subunit has been proposed to be important for interaction with the 
 tail HDRRE motif (Vinogradova, Haas et al. 2000; Vinogradova, Velyvis et al. 2002). 
This data is, however, still controversial (Wegener and Campbell 2008). Moreover, the  
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tail contains two NPXY motifs, a membrane proximal and a membrane distal one, that are 
a part of a canonical recognition sequence for phosphotyrosine-binding (PTB) domains. 
The phosphotyrosine-binding (PTB) domains are present in a large number of proteins, 
enabling them to interact with  tail of integrins (Calderwood, Fujioka et al. 2003). 
   1.1.3.      Integrin signaling 
Integrins are remarkable in their ability to transduce signals across the plasma membrane 
in a bidirectional manner. Upon ligand binding, integrins cluster and various adaptor and 
signaling molecules are recruited to integrin tails. As many of these adaptors are actin-
binding proteins, this leads to the establishment of a connection to the actin cytoskeleton. 
In addition, recruitment of signaling proteins leads to activation of various signal 
transduction pathways important for cellular processes such as spreading, migration, and 
proliferation. Collectively this process is referred to as “outside-in” signaling. On the 
other hand, non-integrin mediated signaling pathways can lead to binding of regulatory 
proteins to integrin cytoplasmic tails inducing changes in integrin activity and ligand 
binding affinity. This is referred to as “inside-out” signaling. 
      1.1.3.1. Inside-out signaling 
The first studies on the regulation of integrin activation were done in platelets that express 
IIb 3 integrin. After vascular injury, presence of insoluble proteins such as collagen and 
von Willebrand factor as well as soluble agonists like ADP, thrombin and thromboxane 
A2, can activate platelets (Li, Delaney et al. 2010). These signals act through receptors 
coupled to heterotrimeric G proteins (GPCRs) or through receptors that are not directly 
coupled to G proteins such as the collagen receptor GPVI. These initial signaling events 
will almost always lead to activation of phospholipase C (PLC). Consequently, PLC will 
hydrolyse phosphatidylinositol to produce the secondary messengers inositol 
trisphosphate (IP3) that increases cytoplasmic [Ca²+], and diacylglycerol (DAG) that 
activates protein kinase C as well as a Ca²+ and DAG-dependent guanine nucleotide 
exchange factor (Cal-DAG-GEF) for the Ras-like small GTPases Rap1 (Li, Delaney et al. 
2010). Activated Rap1 binds to its effector RIAM that in turn binds to talin (Fig. 1.1.3.). 
This interaction leads to unmasking of the integrin binding site on the adaptor protein 
talin, allowing integrin activation (Han, Lim et al. 2006). Furthermore, another central 
adaptor Kindlin-3, like talin, can bind 1 and 3 integrin tail resulting in integrin 
activation (Moser, Nieswandt et al. 2008). In lymphocytes, chemokines can trigger some 
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additional signaling pathways. These involve activation of PI3K and small GTPases 
RhoA and possibly Rac1 that in turn can trigger downstream PIP2 generating kinases like 
PIPKI , , , leading to local increase of PIP2 and activation of talin (Alon and Ley 
2008). As illustrated by the above examples, all of these pathways ultimately lead to 
activation of talin that can be considered the major activator of integrins. It has been 
proposed that binding of talin to membrane-proximal residues in the β integrin tail can 
lead to disruption of a salt bridge between an Asp residue within the β-tail HDRK motif 
and an Arg residue in the GFFKR motif within the α-tail (Wegener, Partridge et al. 2007). 
 
            
Figure 1.1.3. Connection between agonist stimulation and integrin activation. Agonist 
receptors such as G protein-coupled receptors, tyrosine-kinase-coupled receptors induce 
the formation of diacylglycerol (DAG) and increased Ca
2+
. This leads to the activation 
and/or translocation of active GTP bound Rap1 to the plasma membrane via activation of 
protein kinase C (PKC) or a Rap guanine nucleotide exchange factor (Rap-GEF). At the 
plasma membrane, activated Rap interacts with RIAM. This in turn leads to the 
recruitment of talin to form the integrin activation complex, by unmasking the integrin 
binding site in F3 domain of  talin leading to integrin activation (Han, Lim et al. 2006). 
 
However, talin alone seems not be sufficient for full activation of integrins and the 
kindlin family of proteins has been shown to play a central role in integrin activation 
(Montanez, Ussar et al. 2008; Moser, Bauer et al. 2009). Talin and kindlin binding 
induces a conformational change of integrin tails that is propagated through the 
transmembrane domains to the extracellular domains of the integrins. In inactive integrins 
the transmembrane domains of  and  subunit interact through GxxxG dimerization 
motifs and in order for integrin activation to occur, the transmembrane domains have to 
be separated. It is still unclear if these changes take place through piston-like movement 
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or tilting of the transmembrane domain (Moser, Legate et al. 2009). The integrin 
heterodimer can then switch to an active state by switching from a low affinity bent 
conformation to a high affinity extended conformation. The structural changes that occur 
in the transmembrane domain during activation of the extracellular domain are still 
controversial. Two main competing models have been proposed for integrin activation: 
The switchblade model states that the separation of the cytoplasmic tails and TM domains 
of the inactive bent integrin causes knee extension and opening of the ligand binding 
pocket. The deadbolt model does not require unbending. It proposes that a change in the 
transmembrane domains leads to a conformational change within the head domain to 
reveal the ligand binding site and extension occurs only after the ligand binding (Arnaout, 
Mahalingam et al. 2005). Upon ligand binding, integrins initiate clustering and 
recruitment and activation of other integrin binding molecules thus strengthening the 
interaction with the ECM and activating intracellular signaling pathways also known as 
outside-in signaling (Arnaout, Mahalingam et al. 2005). 
      1.1.3.2. Outside-in signaling 
As already mentioned, integrins possess no enzymatic activity. They therefore depend on 
interactions with a large group of accessory proteins to transduce signals. The most recent 
studies based mainly on large scale mass spectrometry analyses show that there are 
approximately 180 proteins associated both directly and indirectly with integrins (Zaidel-
Bar and Geiger 2010). Downstream signaling events that occur upon integrin activation 
can be divided in three temporal stages (Legate, Wickstrom et al. 2009) (Fig. 1.1.4.). One 
of the immediate effects is up-regulation of lipid kinase activity that subsequently leads to 
an increase in the local concentration of phosphoinositide second messengers PtdIns-4,5-
P2 and PtdIns-3,4,5-P3 as well as rapid phosphorylation of specific proteins. On the scale 
of several minutes these changes lead to activation of various signaling pathways. The 
central event in integrin-mediated signaling is cell adhesion-dependent phosphorylation 
of Focal Adhesion Kinase (FAK) and Src kinases. 
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Figure 1.1.4. Three temporal stages of integrin signaling. Downstream signaling events 
initiated upon integrin ligand binding can be divided into three temporal stages. The 
immediate effects: up-regulation of lipid kinase activity increases the concentrations of 
phosphoinositide second messengers PtdIns-4,5-P2 and PtdIns-3,4,5-P3, as well as the 
rapid phosphorylation of specific protein substrates. Short term effects: induction of 
signaling pathways such as activation of Rho family GTPases and other actin regulatory 
proteins. This drives the reorganization of the actin cytoskeleton. Long-term 
consequences: activation of proliferation and survival pathways as well as the induction 
of genetic programs to regulate cell fate (Legate, Wickstrom et al. 2009). 
 
Phosphorylation of FAK at the tyrosine-397 enables the interaction with Src family 
kinases by creating a docking site for the SH2 domain of Src. This interaction in turn 
releases an autoinhibitory interaction thus activating Src. The activated FAK/Src complex 
in turn phosphorylates other focal adhesion proteins such as FAK, paxillin and p130Cas. 
This results in the recruitment of intermediate signaling molecules including Grb2 as well 
as activation of downstream signaling pathways such as the Ras/MAPK signaling 
pathway. 
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Figure 1.1.5. Examples of signaling pathways downstream of integrin activation. The 
growth factor receptors (GFR) and the growth factor environment in cooperation with 
components and mechanical properties of the extracellular matrix regulate outside-in 
signaling of integrins. Integrin-mediated signaling interacts with growth factor signaling 
on multiple levels: integrin affinity for ligands (I), the activity of the integrin-associated 
signaling proteins ( FAK, Src, and PI3K) (II), and the activity of the downstream effectors 
( ERK, Akt, JNK, and the Rho GTPases) (III). The central signaling module downstream 
of integrins is the Src/FAK complex that activates ERK and JNK to regulate cell survival, 
proliferation, and differentiation. In addition to this, the Src/FAK complex regulates Rho 
GTPase activity through activation of Crk/Dock180 or PIX/GIT pathways, resulting in 
cytoskeletal reorganization and leading to regulation of migration, adhesion, and 
polarity. An additional signaling event is activation of PI3K, which in collaboration with 
mTOR and possibly ILK regulates cell survival through Akt. The alternative activation 
pathways and cross-talk between the various depicted pathways are not presented. (GFR) 
Growth factor receptor; (PI3K) PI-3-kinase; (ILK) integrin linked kinase; (TORC) 
mammalian target of rapamycin complex; (FAK) FA kinase; (ERK) extracellular signal-
regulated kinase; (Cas) Crk-associated substrate; (JNK) Janus kinase; (DOCK180) 
dedicator of cytokinesis 1; (PIX) PAK interactive exchange factor; (GIT) G protein-
coupled receptor kinase-interacting protein (Legate, Wickstrom et al. 2009). 
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Activation of Rho family GTPases and other actin regulatory proteins is another 
important event of integrin signaling. It drives the reorganization of the actin cytoskeleton 
leading to changes in cell shape and initiation of cell migration. On a long-term scale 
integrin outside-in signaling leads to activation of proliferation and survival pathways and 
to induction of genetic programs that control cell fate (Legate, Wickstrom et al. 2009).   
It is important to note that integrin signaling operates partly through extensive cross-talk 
with other signaling pathways such as the EGF, IGF, PDGF and TGF-  pathways (Fig. 
1.1.5.). This crosstalk is regulated on multiple levels and is relevant both under 
physiological and pathophysiological conditions (Schwartz and Ginsberg 2002; Cabodi, 
Moro et al. 2004; Beattie, McIntosh et al. 2010; Margadant and Sonnenberg 2010).  
   1.1.4.      Assembly of integrin dependant adhesion structures 
Upon activation integrins respond not only by increasing their affinity towards ligand but 
also by increasing their avidity by clustering. Integrin clustering is important for pulling 
together thousands of weak interactions thus establishing a strong adhesive structure with 
the ECM. The smallest integrin-containing structures that can be observed by light 
microscopy are focal complexes and nascent adhesions (Nobes and Hall 1995; Geiger, 
Bershadsky et al. 2001; Alexandrova, Arnold et al. 2008; Choi, Vicente-Manzanares et al. 
2008). These early integrin-based adhesions are approximately 100 nm in diameter, and 
they are composed of a few thousand protein molecules including integrins, talin and 
paxillin (Zaidel-Bar, Ballestrem et al. 2003; Ponti, Machacek et al. 2004; Giannone, 
Dubin-Thaler et al. 2007; Alexandrova, Arnold et al. 2008; Choi, Vicente-Manzanares et 
al. 2008). They are positioned close to the leading edge of a migrating cell, forming the 
contact between the lamellipodium, a flat and ribbon-shaped actin-based protrusion at the 
edge of the cell, and the matrix. The forces that are generated through actin flow drive 
growth of nascent adhesions to form bigger focal complexes (Alexandrova, Arnold et al. 
2008; Choi, Vicente-Manzanares et al. 2008). The link between the moving actin 
cytoskeleton and integrins is described as a molecular clutch that enables movement of 
the cell body in respect to stationary cell-matrix adhesions (Huttenlocher and Horwitz 
2011) (Fig. 1.1.6.). As the edge of the moving cell is advancing, the growing adhesions 
remain attached to the matrix and mature in a process which is characterized by changes 
in their protein composition (e.g., the recruitment of zyxin), tyrosine phosphorylation 
(e.g., of paxillin), dynamics (e.g., enhanced exchange rate) and association with actin 
stress fibers (Ballestrem, Hinz et al. 2001; Cluzel, Saltel et al. 2005; Ballestrem, Erez et 
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al. 2006; Zaidel-Bar, Milo et al. 2007; Zamir, Geiger et al. 2008). Maturation of focal 
complexes to focal adhesions is also accompanied by changes in length and size of the 
adhesions (Berrier and Yamada 2007). 
 
                                    
      
Figure 1.1.6. Adhesion assembly, turnover and maturation In the course of cell 
protrusion, adhesions initially assemble as puncta (blue circle) in the lamellipodium 
(gray band); this process is driven by or linked to actin polymerization. These nascent 
adhesions remain small and stable within the lamellipodium. The stability of these 
adhesions is linked to the integrity of the actin cytoskeleton network; the nascent 
adhesions turn over (clear circle) after the depolymerizing dendritic actin at the rear of 
the lamellipodium has passed them. Myosin II activity is not required for the formation 
and turnover of nascent adhesions. Maturing adhesions are formed as nascent adhesions 
that grow along the actin template, which elongates centripetally at the lamellipodium-
lamellum interface. For the initial elongation of adhesions both myosin II and α-actinin 
cross-linking activities, possibly in conjunction with contraction, are necessary. For the 
proper positioning of the adhesions on actin filaments α-actinin is required. Further 
development and maturation of adhesions is mediated by the cross-linking of actin by 
myosin II and α-actinin most likely working in synergy with contraction. (Choi, Vicente-
Manzanares et al. 2008). 
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In certain cell types like fibroblasts adhering to a fibronectin matrix, focal adhesions will 
mature into so called fibrillar adhesions (Hynes and Destree 1978; Chen and Singer 1982; 
Chen, Hasegawa et al. 1985; Zamir, Katz et al. 2000). Fibrillar adhesions are elongated 
adhesion structures located in the central region of the cell. Maturation of focal adhesions 
to fibrillar adhesions is followed by increased recruitment of tensin and a change in 
integrin content. While focal adhesions contain both 5 1 and V 3, fibrillar adhesions 
are rich in 5 1 integrin. Maturation of fibrillar adhesion is tightly connected to the 
formation of fibronectin fibrils (Pankov, Cukierman et al. 2000; Zamir, Katz et al. 2000; 
Baharloo, Textor et al. 2005). Certain highly migratory and invasive cell lines such as v-
Src transformed fibroblasts, osteoclasts, macrophages and dendritic cells, form special 
integrin adhesion structures called podosomes (Tarone, Cirillo et al. 1985; Linder, Nelson 
et al. 1999). Invadopodia are found in invasive cancer cells and are related protrusive 
structures. Both podosomes and invadopodia have the ability to degrade cell matrix, 
however the relation between podosomes and invadopodia is not clearly defined 
(Huttenlocher and Horwitz 2011). 
It is important to note that most of the studies on different types of adhesive integrin 
structures as well as their dynamics were done in cell culture on rigid 2D surfaces. In 
recent years there has been some controversy on the existence of such structures in vivo 
or in 3D model systems. Observing cells embedded in 3D cell-derived matrices as well as 
in collagen gels or 3D systems derived from other extracellular matrix molecules has, 
however, allowed the conclusion that most cells do form distinct adhesion structures also 
in 3D, and that these structures contain a similar set of molecules that are present in 2D 
adhesions, including integrins, vinculin and paxillin (Harunaga and Yamada 2011). It has 
been shown that 3D adhesions are similar to fibrillar adhesions in respect to their 5 1 
integrin content, but also similar to focal adhesions in regard to the presence of vinculin, 
a-actinin and phosphorylated paxillin (Zamir and Geiger 2001; Yamada, Pankov et al. 
2003; Berrier and Yamada 2007) (Fig. 1.1.7.).   
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Figure 1.1.7. Differences between focal adhesions, fibrillar adhesions, and 3D-matrix 
adhesions. The various matrix adhesion structures differ in the levels of protein tyrosine 
phosphorylation (pY )and of adaptor and signaling protein composition. In focal 
adhesions as opposed to fibrillar and 3D-matrix adhesions, levels of phosphorylated 
FAK, particularly tyrosine (Y) 397 are high. Both focal adhesions and 3D-matrix 
adhesions in contrast to fibrillar adhesions have high levels of phosphorylated paxillin 
(particularily pY 31) and FAK (pY 861). Distinct protein complexes are likely to form 
within each type of matrix adhesion leading to the activation of specific signaling 
pathways (Berrier and Yamada 2007). 
   1.1.5.      Mechanisms of cell motility 
In order for the cell to successfully migrate through a given environment, tight regulation 
of adhesion assembly and disassembly is necessary. At the leading edge of a migrating 
cell nascent adhesions are formed, and they can either mature into focal adhesions or be 
turned over. This allows the cell to generate pulling force that is necessary for motility. At 
the cell rear, disassembly of focal adhesions is necessary for detachment and retraction of 
the trailing edge. This allows net forward motion of the cell. Two major cellular processes 
are important for adhesion dynamics: actin polymerization and myosin II-generated 
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tension (Parsons, Horwitz et al. 2010). The remodeling of the actin cytoskeleton is driven 
by Rho GTPases that are in turn regulated by a complex signaling network arising from 
integrin adhesions. The best studied examples are paxillin and FAK that can either 
directly or indirectly bind various GEFs and GAPs, thus influencing the activity of Rho 
GTPases (Brown and Turner 2004; Huttenlocher and Horwitz 2011). Rho GTPases Rac 
and cdc42 drive polymerization of actin within the lamellipodium through downstream 
effectors WASP (Wiscot Aldrich syndrome protein) and WAVE (WASP-family verprolin 
homologue) that activate the Arp2/3 complex. Arp2/3 in turn induces actin 
polymerization to form a specific branched structure. The plasma membrane at the 
leading edge provides resistance to actin polymerization, resulting in retrograde flow of 
actin. 
Within the structure directly behind the lamellipodium, the lamella, actin gets organized 
in thick bundles, so called stress fibers that undergo much slower retrograde flow. Here 
the retrograde flow is mainly regulated by myosin II contraction that pulls antiparallel 
actin fibers past each other, thus creating the force that rearranges the actin cytoskeleton. 
(Parsons, Horwitz et al. 2010). Myosin II activity (ATP hydrolysis and actin filament 
formation) depends on the reversible phosphorylation of two tyrosine residues Thr18 and 
Ser19.  This phosphorylation is regulated by Rho GTPases via activation of Rho kinase 
and inhibition of myosin phosphatases (Parsons, Horwitz et al. 2010; Huttenlocher and 
Horwitz 2011). Myosin activity can also be regulated by Rac/Cdc42 via inhibition of 
myosin light chain kinase or phosphorylation of the regulatory light chain of myosin 
directly (Vicente-Manzanares, Koach et al. 2008; Huttenlocher and Horwitz 2011). 
Tension generated by myosin is essential for adhesion maturation. This might occur for 
example by inducing conformational changes in focal adhesion proteins such as talin and 
vinculin. This results in exposure of additional actin binding sites of vinculin, thereby 
strengthening the integrin-actin linkage. On the other hand it has also been shown that the 
actin bundling activity of myosin plays an important role in adhesion maturation 
(Vicente-Manzanares, Koach et al. 2008; Parsons, Horwitz et al. 2010).  
Disassembly of focal adhesion is thought to be driven by microtubule targeting of focal 
adhesions as well as by cleavage of certain adhesion components by calpain 
(Rinnerthaler, Geiger et al. 1988; Zhong, Chrzanowska-Wodnicka et al. 1998; Small and 
Kaverina 2003; Geiger and Yamada 2011). Microtubule targeting of focal adhesions 
might lead to local modulation of Rho GTPase signaling, thereby regulating adhesion 
Introduction 
16 
 
turnover (Broussard, Webb et al. 2008). On the other hand it has been reported that 
microtubules regulate disassembly of focal adhesions through the FAK/dynamin pathway 
by inducing clathrin mediated integrin endocytosis, independently of Rho and Rac 
(Ezratty, Partridge et al. 2005; Ezratty, Bertaux et al. 2009; Huttenlocher and Horwitz 
2011).  
Mechanisms of focal adhesion disassembly at the rear of a migrating cell are less well 
understood. It is, however, likely that mechanisms that destabilize focal adhesions at the 
trailing edge are similar to those that act at the cell front during focal adhesion turnover. 
A specific feature of the trailing edge is that actomyosin stress fiber contraction driven by 
Rho activity and subsequent retraction of the cell rear can lead to formation of so called 
footprints. In response to rapid detachment of the rear, molecular bonds can be broken at 
the level of the integrin-actin linkage, resulting in a large part of the adhesion, including 
the integrins and part of the membrane, being left behind in a form of a footprint 
(Broussard, Webb et al. 2008). In certain cell types such as neutrophils, 
Ca++/calmodulin-activated integrin V 3 endocytosis also plays role in rear end 
detachment (Lawson and Maxfield 1995; Huttenlocher and Horwitz 2011). In fibroblasts 
calpains, calcium-dependent proteases acting downstream of microtubules, play a role in 
destabilizing focal adhesion at the rear. The best described targets of calpains are  FAK, 
paxillin and talin (Huttenlocher, Palecek et al. 1997; Carragher, Levkau et al. 1999; 
Dourdin, Bhatt et al. 2001; Glading, Lauffenburger et al. 2002; Franco, Rodgers et al. 
2004; Huttenlocher and Horwitz 2011). 
Cell adhesion, spreading and migration in adherent cells is regulated by integrin 
trafficking. This can occur through regulation of focal adhesion disassembly, ECM 
turnover or integrin redistribution to new adhesion sites at the leading edge of migrating 
cell (Caswell, Vadrevu et al. 2009; Margadant, Monsuur et al. 2011). Integrin trafficking 
includes several aspects of targeted protein transport such as the cell surface delivery of 
newly synthesized integrins by biosynthetic-secretory pathways, integrin internalization, 
and recycling. Integrin internalization may occur both through clathrin-independent and 
clathrin-dependent pathways, and many integrins can follow more than one pathway. In 
recent years clathrin-dependent integrin endocytosis has emerged as a mechanism 
important in the process of focal adhesion disassembly during cell migration. Most 
integrins require adaptor proteins such as Disabled (Dab-2) and adaptor protein-2 (AP-2) 
to recruit them to clathrin-coated pits (Margadant, Monsuur et al. 2011). It has been 
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demonstrated that the  integrin tails can bind the adaptors such as Numb and Dab-2 
through their NPxY motifs, the canonical signal for clathrin-mediated endocytosis 
(Calderwood, Fujioka et al. 2003). Triggering focal adhesion disassembly, for example by 
inducing the microtubule-dependent FA disassembly using nocodazole, results in 
dynamin-dependent integrin internalization and transport along microtubules to Rab5-
positive endosomes  (Ezratty, Bertaux et al. 2009). Depletion of dynamin 2, clathrin or its 
adaptors Dab-2 and AP-2 leads to increased integrin surface expression and reduced cell 
migration (Chao and Kunz 2009; Ezratty, Bertaux et al. 2009). In addition, in vivo studies 
performed on D. melanogaster embryos and larvae have demonstrated the importance of 
clathrin-dependent and particularly Rab5-dependent integrin turnover for maintenance of 
the myotendinous junction (Yuan, Fairchild et al. 2010).  
Integrins can also be internalized by the clathrin-independent pathway. For example, 
integrin 5 1 has been shown to be endocytosed via a caveolin-mediated pathway and 
that this is relevant for turnover of fibronectin and collagen (Shi and Sottile 2008; Shi, 
Harman et al. 2010). The internalized integrins can be recycled back to the plasma 
membrane or degraded via the lysosome (Margadant, Monsuur et al. 2011). 
   1.1.6.      The ILK/PINCH/parvin (IPP) complex 
The molecular composition of adhesion structures creates an additional level of 
complexity to integrin signaling. Alternative components of adhesion complexes can lead 
to activation of different signaling pathways. The central constituent of at least 1 
integrin- and possibly also 3 integrin-containing adhesions is the Integrin-linked kinase 
(ILK)/PINCH/parvin (IPP) complex. This ternary complex serves as a signaling hub 
downstream of integrins but most importantly it couples integrins to actin cytoskeleton 
providing mechanical support to adhesion structures (Fig. 1.1.8.). 
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      1.1.6.1. The molecular composition of the IPP complex 
    
Figure 1.1.8. The IPP complex. The integrin-linked kinase –pinch–parvin (IPP) complex 
is formed by ILK, PINCH1/PINCH2 and α-parvin/β-parvin/γ-parvin. Depicted are the 
central interactions of the IPP complex. ILK associates with the cytoplasmic tails of β1 
integrin. Pinch isoforms can in addition bind to receptor tyrosine kinases (RTKs) through 
the NCK adaptor protein 2 (NCK2). This leads to coupling of growth factor signaling to 
integrin signaling. PINCH1 interacts with Ras suppressor protein 1 (RSU1) and 
thymosin-β4 (Tβ4) leading to the  activation of JUN N-terminal kinase (JNK) signaling 
and cell migration and survival, respectively. a-parvin and β-parvin bind to F-actin 
directly and indirectly, through the interaction with paxillin (PXN) or α-actinin. ANK, 
ankyrin repeat domain; CH, charged amino acid-rich domain; ECM, extracellular 
matrix; FBLIM1, filamin binding LIM protein 1; FERMT2, fermitin family member 2; 
ILKAP, integrin-linked kinase-associated serine/threonine phosphatase 2C; PH, 
pleckstrin homology domain (Cabodi, del Pilar Camacho-Leal et al. 2010). 
ILK is a ubiquitously expressed protein that is essential for vertebrate and invertebrate 
development (Legate, Montanez et al. 2006; Hannigan, McDonald et al. 2011). 
Structurally it consists of three different domains: five ankyrin repeats at N-terminus 
followed by a pleckstrin homology (PH)-like domain and a putative kinase domain at C-
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terminus (Hannigan, Leung-Hagesteijn et al. 1996). ILK was discovered in a yeast-two 
hybrid screen as a protein that binds 1 and 3 integrin tails (Hannigan, Leung-
Hagesteijn et al. 1996). Although the interaction of ILK with  tails has been shown in 
vitro to be direct, it is possible that recruitment of ILK may depend, at least in some cell 
types, on kindlin-2 (Montanez, Ussar et al. 2008) and/or paxillin (Nikolopoulos and 
Turner 2001; Nikolopoulos and Turner 2002). ILK is the central constituent of a ternary 
complex with the LIM only domain-containing protein PINCH and the calponin 
homology (CH) domain-containing protein parvin (Zhang, Guo et al. 2002). Formation of 
the ILK-PINCH-parvin (IPP) complex precedes cell adhesion, implying that the complex 
is preassembled in the cytoplasm. Assembly of the IPP complex is essential for the 
stability of the individual components and their recruitment to FAs, at least in mammals 
(Fukuda, Chen et al. 2003). 
In mammals there are two PINCH and three parvin isoforms. Both PINCH1 and PINCH2 
consist of five LIM domains and contain a nuclear export signal. The first LIM domain of 
PINCH binds to the groove formed between the second and fifth ankyrin repeat of ILK 
(Chiswell, Zhang et al. 2008; Yang, Wang et al. 2009). α-parvin is ubiquitously 
expressed, β-parvin is enriched in heart and skeletal muscle, and γ-parvin is only found in 
hematopoietic cells  (Nikolopoulos and Turner 2000; Olski, Noegel et al. 2001; Tu, 
Huang et al. 2001; Yamaji, Suzuki et al. 2001; Chu, Thievessen et al. 2006). Structurally 
parvins are comprised of an N-terminal polypeptide followed by two C-terminal CH 
domains, where the second CH domain binds the kinase-like domain of ILK (Tu, Huang 
et al. 2001; Fukuda, Gupta et al. 2009). 
      1.1.6.2. The biological function of the IPP complex 
Mice lacking ILK die during peri-implantation around embryonic day (E) 5.5-6.5, due to 
a failure of cells within the embryo proper to organize their F-actin cytoskeleton and to 
polarize (Sakai, Li et al. 2003). In addition, in vitro studies showed that ILK is required in 
fibroblasts and chondrocytes for cell spreading, focal adhesion formation and migration 
(Grashoff, Aszodi et al. 2003; Sakai, Li et al. 2003). ILK-deficient fibroblasts show 
defective maturation of focal adhesions into fibrillar adhesions resulting in the loss of 
their ability to deposit fibronectin matrix (Stanchi, Grashoff et al. 2009). Interestingly, 
this function requires the interaction of ILK with -parvin but not with PINCH-1 
(Stanchi, Grashoff et al. 2009). The importance of ILK as a scaffold between integrins 
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and the actin cytoskeleton has been further studied and confirmed in several cell types as 
well as different tissues (McDonald, Fielding et al. 2008). Recent studies have also 
demonstrated the involvement of ILK in the regulation of the microtubule network and 
mitotic spindle orientation (Dobreva, Fielding et al. 2008; Fielding, Dobreva et al. 2008). 
In keratinocytes, ILK acts in a complex with IQGAP-1 and mDia1, thereby stabilizing 
microtubules and their interaction with the cortical actin cytoskeleton. This function 
allows specific vesicular carriers containing the scaffold protein caveolin-1 to switch 
from microtubule-based motility to actin-based motility (Wickstrom, Lange et al. 2010). 
PINCH-1 is ubiquitously expressed throughout mammalian development and adult life, 
whereas PINCH-2 expression starts during the second half of embryonic development 
and has a slightly more restricted expression pattern (Braun, Bordoy et al. 2003). Ablation 
of PINCH-2 does not affect mouse development, but loss of PINCH-1 results in abnormal 
epiblast polarity, impaired cavitation, and detachment of endoderm and epiblast from 
basement membranes (Li, Bordoy et al. 2005). PINCH1 null mice also show an increase 
in endodermal cell apoptosis, which demonstrates that PINCH1 regulates cell survival 
(Li, Bordoy et al. 2005; Legate, Montanez et al. 2006). PINCH1 null embryos die at E6.5-
7.5. Delayed mortality compared to ILK null embryos cannot be a consequence of 
expression of the PINCH2 since this isoform is expressed later on during embryonic 
development (Braun, Bordoy et al. 2003; Legate, Montanez et al. 2006). PINCH2 null 
mice are viable probably due to compensation by PINCH1 isoform (Legate, Montanez et 
al. 2006; Stanchi, Grashoff et al. 2009). 
-Parvin null mice die around the embryonic day E11.5-E14.5 due to vascular defects, 
whereas -parvin and -parvin null mice show no obvious phenotypes. Delayed lethality 
compared to ILK and PINCH1 null mice suggests that there might be functional 
compensation between different parvin isoforms (Chu, Thievessen et al. 2006; Montanez, 
Wickstrom et al. 2009). It has been shown that parvins play a role in modulating cell 
spreading as well as actin organization; however the exact role of each of parvin isoform 
in these processes is not yet clear. All three parvin isoforms contain two CH-domains. In 
vitro studies have demonstrated that the CH-domains of parvin can bind F-actin, even 
though these domains have a significantly different sequence from typical actin-binding 
CH-domains  (Olski, Noegel et al. 2001; Yamaji, Suzuki et al. 2001; Gimona, Djinovic-
Carugo et al. 2002; Yamaji, Suzuki et al. 2002). In addition, -parvin can interact with 
paxillin. Since the CH-domains are highly conserved between all parvin isoforms it is 
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highly likely that all three isoforms can bind paxillin, as well as its homolog Hic-5 
(Nikolopoulos and Turner 2000; Lorenz, Vakonakis et al. 2008; Wang, Fukuda et al. 
2008). 
Binding of the two PINCH and three parvin isoforms to ILK gives rise to molecularly 
distinct IPP complexes with differential binding partners. One example is the interaction 
of PINCH1 with Ras suppressor protein 1 (RSU1) which is important for integrin-
mediated cell adhesion and spreading (Ito, Takahara et al. 2010)(Ito et al., 2010). While 
RSU1, a known regulator of growth factor induced Jun N-terminal kinase (JNK), binds to 
LIM 5 domain of PINCH1 it does not bind to PINCH2 (Kadrmas, Smith et al. 2004; Ito, 
Takahara et al. 2010). Through its interaction with Nck2, an adaptor protein that interacts 
with receptor tyrosine kinases (RTKs), PINCH might couple integrin signaling to the 
growth factor signaling (Vaynberg, Fukuda et al. 2005). Parvin isoforms on the other 
hand have differential effects on the actin cytoskeleton. Parvins not only passively 
crosslink integrins with actin, but also actively regulate actin remodeling through 
interaction with various actin regulatory proteins. For example α-parvin, through of its 
interaction with testis-specific kinase 1 (TESK1), promotes F-actin polymerization 
through cofilin phosphorylation (LaLonde, Brown et al. 2005). -parvin in turn interacts 
with α-Pix, a guanidine exchange factor (GEF) for Rac1 and cdc42, two major regulators 
of actin dynamics (Mishima, Suzuki et al. 2004; Legate, Wickstrom et al. 2009). α-parvin 
can also recruit CdGAP to focal adhesions, resulting in inhibition of G-proteins 
(LaLonde, Grubinger et al. 2006). Furthermore, α-Parvin functions as a negative regulator 
of RhoA/ ROCK driven contractility in vascular smooth muscle cells (Montanez, 
Wickstrom et al. 2009). 
In summary, ILK plays an important role as a scaffold protein within the IPP complex, 
providing an important link between integrin and the actin cytoskeleton. However, the 
molecular details of this regulation remain partly unclear.  
      1.1.6.3. The ILK kinase controversy 
Since its discovery as a serine (Ser)/threonine (Thr) kinase in 1996 by Hannigan and co-
workers, the potential kinase activity of ILK has been hotly debated. In this initial study it 
was shown that ILK possesses a high degree of sequence homology to Ser/Thr kinases 
(Hannigan, Leung-Hagesteijn et al. 1996). However, it was obvious that ILK lacks 
several sequence motives that are highly conserved among eukaryotic kinases, including 
Introduction 
22 
 
sequences within the active loop and the DXG motif (Hanks and Hunter 1995). Despite a 
large number of studies claiming kinase activity in vitro and in cell culture systems, a 
significant body of recent work demonstrates that ILK does not possess kinase activity. It 
has was initially shown that bacterially expressed recombinant ILK can  phosphorylate β1 
integrin as well as the model substrate myelin basic protein in an in vitro kinase assay 
(Hannigan, Leung-Hagesteijn et al. 1996). These studies were followed by identification 
of numerous ILK kinase targets including myosin light chain kinase, β-parvin, GSK3b 
and Akt/PKB (Legate, Montanez et al. 2006). These studies were convincingly disproved 
by Fukuda et al. who demonstrated that ILK kinase activity is a result of impurities of 
purified recombinant ILK and thereby a laboratory artefact (Fukuda, Knight et al. 2011).  
In vivo studies in invertebrates had already earlier substantiated the role of ILK as a 
scaffold protein with no requirement for kinase activity (Zervas, Gregory et al. 2001; 
Mackinnon, Qadota et al. 2002). Deletion of ILK in Drosophila could be completely 
rescued by re-expression of a kinase dead mutant (K220M) (Zervas, Gregory et al. 2001). 
Following studies in mouse fibroblasts showed that the same kinase dead ILK mutant 
could rescue the actin reorganization defects of ILK-deficient cells (Sakai, Li et al. 2003). 
Finally, studies using various knock-in mutants of ILK demonstrated the both kinase-dead 
and kinase-hyperactive mutations of ILK allow normal development and adult life in 
mice. Interestingly, these studies also showed that the K220M mutation thought to affect 
the kinase activity actually destabilizes the interaction between ILK and α-Parvin. This 
mutation results in a severe defect in kidney development, a phenotype also found in the 
α-parvin -/- mice (Legate, Wickstrom et al. 2009).  
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Figure 1.1.9. Schematic representation and comparison of ILK and PKA kinase 
domains. The ATP coordination in the ILK kinase-like center is defective; ILK orientates 
ATP with single Mg
2+
 or Mn
2+
; increased distance between the phosphate of the ATP 
and the catalytic loop (Widmaier, Rognoni et al. 2012). 
Resolving the crystal structure of ILK kinase domain allowed mechanistic insight into the 
function of the K220 residue. This residue plays a crucial role in stabilizing the global 
structure of ILK in the ATP unbound state. Therefore mutations in this residue lead to a 
similar effect as partial or complete loss of ILK (Fukuda, Knight et al. 2011). 
Furthermore, the crystal structure allows the conclusion that ILK is a pseudo-kinase by 
demonstrating that important regulatory structures are locked in an ``active´´ state 
(activation loop, DFG-motive and p-loop) and the kinase domain therefore lacks the 
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structural flexibility essential for kinase activity (Fukuda, Gupta et al. 2009). 
Surprisingly, the strongly degraded p-loop indeed can coordinate ATP with moderate 
affinity. The ATP γ-phosphate, however, is far away from the putative active center 
(10Å) and its access to the substrate is partially blocked by the γ-phosphate coordinating 
residue K321 (Fukuda, Gupta et al. 2009; Fukuda, Knight et al. 2011) (Fig. 1.1.9.). 
Finally, the acidic residue of the catalytic core that polarizes the substrate hydroxyl group 
is exchanged to alanine and no other residue in structural vicinity can compensate for this. 
Therefore ILK was not able to hydrolyze ATP in the crystal, allowing full resolution of 
the ATP conformation (Fukuda, Gupta et al. 2009).  
In conclusion, the in vivo studies together with the crystal structure demonstrate that ILK 
does not possess kinase activity and support previous work showing that ILK functions as 
a scaffold protein in integrin adhesions. 
1.2. Ubiquitin 
Functional diversity and dynamics of the eukaryotic proteome is accomplished by a 
variety of different posttranslational modifications; attachment of small molecule groups 
such as phosphorylation, acetylation, methylation, and glycosylation but also attachment 
of small proteins such as ubiquitin, a small 76 amino acids polypeptide chain, or ubiquitin 
like proteins such as SUMO, Nedd8, Atg8, and ISG15 (Kerscher, Felberbaum et al. 2006; 
Hochstrasser 2009). Ubiquitination, the covalent attachment of ubiquitin, of target 
proteins has been shown to be one of the most prevalent posttranslational modifications 
(Strieter and Korasick 2012). Proteins can be modified by monoubiquitin or polyubiquitin 
chains of different architecture. These various ubiquitin modifications allow differential 
recognition of the targets by regulatory proteins harboring ubiquitin binding domains 
(UBDs). In this way ubiquitination is involved in various cellular processes including 
transcription, autophagy, DNA repair, signal transduction and cell cycle control 
(Kerscher, Felberbaum et al. 2006). As ubiquitination is essential for normal cellular 
physiology it is not surprising that dysregulation of this process plays a central role in a 
number of pathological conditions such as cancer, immune disorders, neurodegenerative 
diseases, and congestive heart failure (Strieter and Korasick 2012).  
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   1.2.1.      Ubiquitination cascade 
The ubiquitination cascade is a three-step enzymatic process in which the carboxylic acid 
of the terminal glycine from the di-glycine motif in the activated ubiquitin forms an 
amide bond with the  amine of the lysine in the target protein. In the first step ubiquitin 
is activated in an ATP-dependent manner by the E1 ubiquitin activating enzyme. The E1 
enzyme uses energy from ATP hydrolysis to adenylate ubiquitin at its C-terminus in order 
to create a ubiquitin-adenylate intermediate. Subsequently the C-terminal carboxyl group 
of ubiquitin forms a high-energy thioester bond with the cysteine sulfhydryl group of the 
E1 enzyme, while releasing AMP. In the second step activated ubiquitin is passed on to 
the active site of the E2 ubiquitin conjugating enzyme by a trans(thio)esterification 
reaction. Finally, in the third step ubiquitin is conjugated to the substrate protein with the 
help of an E3 enzyme, the ubiquitin ligase. This results in the covalent isopeptide linkage 
of the C-terminus of ubiquitin with the -amino group of lysine in the substrate (Kerscher, 
Felberbaum et al. 2006) (Fig. 1.2.1). Recently it has been demonstarated that ubiquitin 
can also be attached to cysteine, serine and threonine residues in the substrate (Cadwell 
and Coscoy 2005; Ravid and Hochstrasser 2007; Wang, Herr et al. 2007; Hochstrasser 
2009). After attaching the first ubiquitin the entire process can be paused creating a 
monoubiquitin modification on the substrate. It can also proceed by attaching another 
ubiquitin molecule via its C-terminal glycine to one of the seven lysine residues (Lys6, 
Lys11,Lys27, Lys29, Lys33, Lys48, Lys63) or the N-terminal methionine (Met1) in the 
previous ubiquitin (Hochstrasser 2009; Behrends and Harper 2011).  
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Figure 1.2.1. The ubiquitin cascade and consequences of ubiquitination on protein 
function. (A) Schematic illustration of the three-step ubiquitination cascade. 
Monoubiquitination and K63 polyubiquitination generally serve non-proteolytic 
functions, while polyubiquitin chains of other linkages have a proteolytic function. (B) 
Structure of ubiquitin (PDB code: 1UBQ), the seven lysine residues in ubiquitin protein 
are indicated (Liu and Chen 2011).  
 
In this way polyubiquitine chains of different architecture are created. Substrates can also 
be decorated by several single monoubiquitins attached within close proximity thus 
creating an atypical multivalent ubiquitin signal (Ikeda and Dikic 2008). The specificity 
of the chain type depends on the E3 ligase as well as on the E2 enzyme (Ikeda and Dikic 
2008). Collectively monoubiquitination and different polyubiquitin chains are able to 
create around ten different signals.  
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Figure 1.2.2. Possible formations of ubiquitin chains on a target protein. (A) 
Homotypic typical and atypical chains include  lysine 6 (Lys 6)-, Lys 11-, Lys 27-, Lys 29-
, Lys 33-, Lys 48- and Lys 63-linked ubiquitin (Ub) chains. (B) Mixed-linkage atypical 
chains can be formed by the use of different lysines for sequential Ub conjugation. This 
leads to the formation of bifurcated chains, such as Lys 48/Lys 29 forks. (C) 
Heterologous chains can be formed between Ub and Ub-like proteinssuch as the small 
ubiquitin-like modifier (SUMO) 2. (D) Multiple multiple mono-Ub molecules attached to 
the substrate can be regarded as a subtype of multivalent chain-like Ub signals (Ikeda 
and Dikic 2008).  
 
However, taking into account the fact that the chains can be of different lengths as well as 
the posibility of heteromeric chains containing for example two different types of 
linkages such as Lys 6/11, Lys 27/29, Lys 29/48 or Lys 29/33, one can apreciate the vast 
complexitiy of ubiquitin signalling (Ikeda and Dikic 2008; Ikeda, Crosetto et al. 2010) 
(Fig. 1.2.2.).  
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   1.2.2.      Ubiquitin the modifier of many faces 
The ground breaking observations on ubiquitin and its biological role were made in the 
late 1970´s and early 1980´s and resulted in the Nobel Prize for chemistry being awarded 
to Aaron Ciechanover, Avram Hershko and Irwin Rose in 2004 for their discovery of 
ubiquitin-mediated protein degradation. Today it is textbook knowledge that covalently 
attached K48-linked polyubiquitin chains target proteins to the proteasome for 
degradation. However, in recent years it has become clear that ubiquitin has a much 
broader role in cellular physiology and pathology than just disposing of cellular ``junk´´. 
Involvement of ubiquitin in DNA repair is a good example of how different ubiquitin 
modifications can change the function of a protein. PCNA (proliferating cell nuclear 
antigen) is a DNA polymerase processivity factor that trimerizes around a DNA strand 
and serves as the platform for binding of accessory factors. In case of DNA damage, the 
DNA polymerase is unable to proceed with replication. Monoubiquitination of PCNA at 
K164 leads to error prone DNA lesion bypass by allowing a switch to a specialized 
translesion synthesis (TLS) polymerase, that is able to insert nucleotides opposite to 
damaged bases (Kannouche, Wing et al. 2004; Pickart and Fushman 2004). The extension 
of this monoubiquitin to a K63-linked polyubiquitin chain leads to an error-free mode of 
lesion bypass probably by allowing the switch to the unaffected sister chromatid DNA 
strand (Hoege, Pfander et al. 2002; Pickart and Fushman 2004). In addition to 
ubiquitination PCNA can be modified by SUMO (small ubiquitin related modifier) 
leading to inhibition of its role in DNA repair, probably allowing normal DNA replication 
(Hoege, Pfander et al. 2002; Pickart and Fushman 2004). 
Ubiquitin is involved in regulation of transcription in multiple ways. One way is through 
monoubiquitination of histones of which the best studied are histone H2B and H2A. 
Monoubiquitination of histone H2B at K123 mediates the methylation of histone H3 at 
K4 and this in turn regulates transcription. On the other hand monoubiquitination of 
histone H2A at K119 is associated with gene silencing rather than gene activation 
(Welchman, Gordon et al. 2005; Osley 2006). Another way by which ubiquitin controls 
transcription is through ubiquitin-dependent proteasomal degradation of transcription 
factors. The best example of this is the regulation of p53 by Mdm2, a RING finger E3 
ligase (Conaway, Brower et al. 2002). On the other hand the 26S proteasome can interact 
with RNA polymerase II to facilitate termination as well as with stalled elongation 
complexes to allow degradation of proteins in these stalled complexes (Welchman, 
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Gordon et al. 2005). Another example of regulation of transcription by ubiquitination is 
estrogen receptor degradation by the 26S proteasome as a part of the cyclical regulation 
of estrogen-sensitive promoters (Welchman, Gordon et al. 2005). 
Ubiquitination also regulates various signaling pathways; the best studied example is the 
NF-kB signaling pathway. On the one hand the p105 and p100 precursors of the NF-kB1 
complex are processed into the active NF-kB p52 and p50 subunits by ubiquitination and 
cleavage by the proteasome (Conaway, Brower et al. 2002). On the other hand activation 
of NF- B signaling requires degradation of I B, which is regulated by phosphorylation 
and subsequent K48-linked polyubiquitination and proteasomal degradation (Liu and 
Chen 2011). Also the phosphorylation of I B depends on ubiquitination. Upon binding of 
an immunostimulative ligand to the receptor such as TNF to TNFR  the receptor 
trimerizes and recruits the E3 ligase TRAF2 (depending on the stimulus signal it can also 
be TRAF6) that attaches a K63 polyubiquitin chain to RIP (receptor- interacting protein) 
and to itself. The recruitment of TAK1-TAB1-TAB2 complex to the membrane is 
accomplished by binding to the K63 polyubiquitin chain of RIP. Once membrane-bound, 
TAK1 is activated and phosphorylates IKK  subunit of IKK that in turn phosphorylates 
I B. Additional level of control is added by CYLD (cylindromatosis) which has the 
ability to cleave polyubiquitin chain from TRAF6,  as well as by A20 that can edit the 
K63 chain on RIP to a K48 chain, leading to its proteasomal degradation (Ravid and 
Hochstrasser 2004; Welchman, Gordon et al. 2005).  
In addition to regulation of DNA repair, transcription and signaling, ubiquitination is also 
involved in endocytosis and sorting and of course in proteasomal and lysosomal 
degradation of proteins. The role of ubiquitin in protein turnover will be discussed in 
more detail in the next chapter. 
      1.2.2.1. Ubiquitin in different degradation pathways 
The entire cellular machinery including proteins and organelles is kept in a state of self-
renewal through constant degradation and synthesis of new components. In order for cells 
to maintain their proteome, constant quality control of the individual proteins is carried 
out. This quality control results from cooperation between chaperones and the proteolytic 
systems. The task of chaperones is to assist in the folding of polypeptides into their 3-
dimensional conformations. If the chaperones fail in this process, the misfolded protein is 
recognized and sent to one of the two major degradation pathways for proteolysis. These 
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are the lysosome pathway and ubiquitin-proteasome pathway (Wong and Cuervo 2010). 
Proteins that enter the cell from the extracellular environment are generally degraded in a 
nonselective manner by the lysosome. The same is true for the proteolysis during cellular 
stress, whereas cytosolic proteins are degraded in a highly selective manner by the 26S 
proteasome. However, in recent years it has become clear that both endocytosis of 
extracellular proteins and autophagy of both large non-hydrophobic proteins and cellular 
organelles can also be performed in a very selective manner. Furthermore, the mutual 
dependence and integration of all cellular proteolytic systems has become evident 
         1.2.2.1.1.      Ubiquitin-proteasome system 
Degradation of proteins by the ubiquitin proteasome system is a two-step process. The 
first step involves covalent attachment of multiple ubiquitin molecules that are recognized 
by the proteasome that degrades the modified protein in the second step (Ciechanover 
1994). Most commonly a polyubiquitin chain of K48 linkage targets the proteins for 
proteasomal degradation. Recently it has been shown that some of the atypical chains 
such as K6, K11, K27, K29, monoubiquitin and multiple monoubiquitins can play a 
proteolytic role as well (Adhikari and Chen 2009). Studies with the K48 polyubiquitin 
chain have shown that affinity of the chain for the proteasome increases with chain length 
and that the minimal signal contains 4 ubiquitins in the chain. By increasing the number 
of ubiquitin moieties from two to four the affinity for the proteasome increases 100 fold 
(Thrower, Hoffman et al. 2000). Other atypical proteolytic signals may also involve 
heterogeneous (branched) chains of mixed linkage and heterologus chains between 
ubiquitin and other ubiquitin-like molecules such as SUMO (Kravtsova-Ivantsiv and 
Ciechanover 2012). 
The specificity for a substrate is determined by cooperation between E3 and E2 enzyme 
in the ubiquitination cascade. Typically, ubiquitination occurs on one of the lysine 
residues in the substrate protein, but in rare cases also cysteine, serine and threonine can 
serve as ubiquitin acceptors (Kravtsova-Ivantsiv and Ciechanover 2012). The 26S 
proteasome is a large multicatalytic protease composed of a 20S core particle with 
proteolytic activity and a 19S regulatory particle (Fig. 1.2.3.). The 20S core particle is 
barrel shaped and contains two outer  rings and two inner  rings. Each ring has seven 
subunits termed 1-7 and 1-7. The 19S regulatory subunit is placed on one or both ends 
of the core subunit. The 19S regulatory particle is responsible for the recognition of the 
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polyubiquitin signal and it further facilitates the entry of the substrate into the proteasome 
by opening the orifice of the  ring and unfolding the substrate. This particle is composed 
of 17 different subunits forming the so-called base and lid. Six of the subunits have 
ATPase activity allowing energy-dependent processes like  ring opening and substrate 
unfolding to take place. The end products of proteasomal degradation are short peptides 
and reusable ubiquitin that is cleaved prior to substrate degradation (Ciechanover 2005). 
 
1.2.3. Electron-microscopy image and schematic representation of a 26S proteasome. 
(a) electron-microscopy image of ubiquitin from Saccharomyces cerevisiae, (b)a 
schematic representation of the structure and function of the 26S proteasome. Ub, 
ubiquitin (Ciechanover 2005). 
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         1.2.2.1.2.      Ubiquitin in autophagy 
Besides proteasomal degradation, autophagy is one of the two cellular degradation 
pathways. The main catalytic component of the autophagic system is the lysosome, a 
single membrane organelle characterized by a very low pH and the presence of a number 
of endo- and exoproteases (Ciechanover 2005). The targets of autophagy are long lived 
proteins as well as complete organelles (Kraft, Peter et al. 2010). There are several 
different mechanisms by which autophagy can occur (Fig. 1.2.4.). The best characterized 
mechanisms in mammalian cells are macroautophagy, microautophagy, and chaperone-
mediated autophagy (CMA) (Wong and Cuervo 2010). Macroautophagy is characterized 
by de novo formation of a double membrane vesicle, known as the autophagosome that 
subsequently fuses with the late endosome or lysosome. Microautophagy, much like 
macroautophagy, sequesters large regions of cytoplasm. However, in the case of 
microautophagy, the sequestration occurs directly via the lysosome (Wong and Cuervo 
2010). Chaperone-mediated autophagy does not require vesicular transport but depends 
on the recognition of the KFERQ peptide motif within the substrate proteins by 
chaperones. The chaperone machinery, containing the constitutive form of heat shock 
protein 70 (Hsc70), heat shock protein 40 (Hsp40), heat shock protein 90 (Hsp90), the 
hsc70- interacting protein (hip), the Hsc70-Hsc90 organizing protein (hop) and Bcl2- 
associated athanogene 1 protein delivers the cargo protein to the lysosome where it 
interacts with lysosome-associated membrane protein type 2a (lamp2a). Subsequently the 
cargo is unfolded and pulled into the lysosome probably with the assistance of lysosomal 
hsp70 (Majeski and Dice 2004).  
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1.2.4. Different autophagic pathways. Three different mechanisms by which cytosolic 
proteins can reach the lumen of the lysosome in the autophagic degradation pathway. (A) 
Macroautophagy, an entire region of the cytosol is sequestered into a double membrane 
vesicle that consequently fuses with lysosomes. (B) Microautophagy, the lysosomal 
membrane invaginates to trap regions of the cytosol forming single membrane vesicles. 
(C) Chaperone-mediated autophagy, cytosolic chaperones recognize a targeting motif in 
the substrate proteins leading to its delivery to the surface of the lysosome. The substrate 
protein subsequently binds to a lysosomal receptor that forms a translocation complex. 
The translocation of the target protein is mediated by the luminal chaperones (Wong and 
Cuervo 2010). 
For a long time autophagy was regarded as a nonselective process. In recent years it has 
been proposed that ubiquitination can provide selectivity to autophagy as well. It has been 
shown that organelles like mitochondria, ribosomes, and peroxisomes, cytoplasmic 
protein aggregates as well as certain intracellular bacteria can be removed from the 
cytoplasm by autophagy in a selective manner. This mechanism requires adaptor proteins 
that are able to bind both ubiquitin and LC3/GABARAP proteins on the lysosomal 
membrane, such as p62/sequestrosome1 and neighbor of BRCA1 gene (NBR1) (Kirkin, 
Lamark et al. 2009; Clague and Urbe 2010). 
         1.2.2.1.3.      Ubiquitin in endosomal degradation 
The lysosome is a final step in degradation of plasma membrane proteins such as 
membrane receptors and ion channels. Proteins residing at the plasma membrane are 
internalized by endocytosis after which they can either be recycled back to the membrane 
or degraded in the lysosome. 
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1.2.5. Ub-dependent endosomal trafficking 
Eps15 and Epsin are early-acting clathrin associated proteins bind and concentrate 
ubiquitinated cargo in clathrin coated pits. Epsin and Eps15 both contain UIM (Ub-
interaction motifs) that allow them to associate with Ub. Other Ub-binding proteins that 
have a similar function are not depicted. Ubiquitinated cargo is recognized by the 
ESCRT-0 subunits Hrs and STAM as well other Ub-binding ESCRT components to target 
ubiquitinated cargo into intralumenal vesicles of multivesicular bodies/late endosomes. 
Ub-binding domains are in addition found within ESCRT-I and ESCRT-II proteins that 
execute the deformation and scission of the membrane. This occurs in collaboration with 
the additional ESCRT-III polymer that constrict the neck of intralumenal vesicles (Piper 
and Lehner 2011).  
 
Removal of proteins from the cell surface serves not only as a means for protein quality 
control but also as a mechanism to regulate signaling from certain receptors or transport 
of metabolites across the plasma membrane (Piper and Lehner 2011). Internalization of 
plasma membrane proteins is followed by sorting into intraluminal vesicles, either late 
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endosomes or multi-vesicular bodies (MVB). Here ubiquitin serves as a tag for 
internalization and sorting into the MVBs (Piper and Lehner 2011). Different ubiquitin 
signals from monoubiquitination to various polyubiquitin chains have been implicated in 
endocytosis, but the K63-linked polyubiquitin chain is emerging as the most common 
one. The best understood processes are the clathrin-mediated endocytosis of epidermal 
growth factor receptor (EGFR), class I major histocompatibility complex (MHC-I) and 
prolactin receptor. Epsin and Eps15 are two clathrin binding proteins that contain an 
ubiquitin interacting motif (UIM) (Fig. 1.2.5.). These proteins play important roles in the 
internalization of ubiquitinated cargo. It has been shown that Epsin plays a role in 
membrane bending and in recruiting additional adaptor proteins to clathrin coated pits. 
Furthermore ubiquitin plays a role in MVB sorting of the cargo through the interaction 
with ESCRT-0 complex that contains ubiquitin-binding domains (UBDs) in several 
components (Piper and Lehner 2011). 
Interestingly, the 5 and 1 integrin subunits and fibronectin have been shown to localize 
to multivesicular bodies/late endosomes in fibroblast. This occurs as a response to 
ubiquitination of the 5 subunit bound to fibronectin. Ubiquitination of the 5 subunit 
serves as a sorting signal for the endocytosed 5 1 integrin and fibronectin to the 
multivesicular endosomes (MEVs) and is dependent on ubiquitin binding ability of 
ESCORT (Hurley and Emr 2006; Lobert, Brech et al. 2010). This process is required for 
the proper fibroblast migration (Lobert, Brech et al. 2010).  
      1.2.2.2. Role of ubiquitination in cell motility  
In addition to the role of various E3 ligases and ubiquitination in regulation of cell 
proliferation, apoptosis, and development of neurodegenerative diseases, they also play a 
role in the regulation of cell motility. In recent years it has been demonstrated that various 
E3 ligases can regulate cell adhesion and migration on different levels by ubiquitinating 
specific substrates, such as adhesion molecules, regulators of actin polymerization, small 
GTPases, protein kinases, growth factor receptors and transcription factors (Huang 2010). 
One example for this is c-Cbl, a ubiquitously expressed E3 ligase family with three 
members in mammals (c-Cbl, c-Cbl-a, c-Cbl-b) (Keane, Rivero-Lezcano et al. 1995; Liu, 
DeYoung et al. 2003; Huang 2010). It has been demonstrated that c-Cbl can ubiquitinate 
the 5 integrin subunit leading to its degradation, which in turn results in reduced 
adhesion of osteoblasts on fibronectin (Kaabeche, Guenou et al. 2005). It has also shown 
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to influence integrin activation through ubiquitinating regulators of Rap1, thereby 
suppressing Rap1 activity (Kaabeche, Guenou et al. 2005). c-Cbl has been shown to 
negatively regulate actin polymerization, either by ubiquitination of mouse Disabled 
homologue 1 (mDab-1) or WAVE2 (Takenawa and Miki 2001; Suetsugu, Tezuka et al. 
2004). 
In recent years, two members of Nedd4 ubiquitin ligase family, Smad ubiquitin regulatory 
factor 1 and 2 (Smurf-1, Smurf-2), have been implicated in cell adhesion and migration 
(Huang 2010). An example of this is the Smurf-1-mediated ubiquitination and down 
regulation of RhoA in the lamellipodium (Wang, Zhang et al. 2003). In addition, Smurf-1 
ubiquitinates and subsequently down regulates the talin head domain, leading to focal 
adhesion disassembly. This action of Smurf-1 on talin head is opposed by Cdk5 and 
through its ability to phosphorylation the talin head domain at Ser425 (Huang, Rajfur et 
al. 2009). Smurf-1 also ubiquitinates hPEM-2, a guanidine exchange factor for Cdc42, 
thus playing a role in the spatiotemporal regulation of Cdc42 during cell migration 
(Yamaguchi, Ohara et al. 2008). 
In conclusion, ubiquitination and E3 ligases appear to be the new important regulators of 
actin polymerization, focal adhesion turnover and cell migration. 
   1.2.3.      CHIP (STUB1) 
C-terminal of Hsp70 interacting protein (CHIP) is an enzyme with E3/E4 ubiquitin ligase 
activity that is highly expressed in the nervous system and muscle tissue (Ballinger, 
Connell et al. 1999; Nyamsuren, Faggionato et al. 2007). It has two functional domains:  
the N-terminal tetratricopeptide domain (TPR) and the C-terminal U-box domain, which 
are highly conserved across species (Ballinger, Connell et al. 1999; Schulman and Chen 
2005). The TPR domain mediates its interaction with chaperones such as hsp70 and 
hsp90, while the U box domain executes ubiquitin ligase activity (Schulman and Chen 
2005). These two features allow CHIP to play an important role in protein quality control 
by integrating the UPS with the chaperone machinery. CHIP also regulates the cellular 
stress response by controlling the transcription of heat shock factor 1 (HSF-1) as well as 
down regulating the hsp70 by ubiquitination and proteasomal degradation after the stress 
stimulus has been removed (Min, Whaley et al. 2008).  
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      1.2.3.1. CHIP and Hsp70/Hsp90 chaperone machinery in protein quality 
control 
CHIP is a versatile E3 ligase with the ability to interact with various E2 ligases such as 
Ubc4, Ubc5, Ubc6 and Ubc13. Depending on the E2 ligase interaction, CHIP can form 
polyubiquitin chains of different linkage. For example, when interacting with UbcH5a, 
CHIP forms K48 polyubiquitin chains, while interaction with Ubc13/Uve1 leads to 
formation of K63 polyubiquitin chains (Zhang, Windheim et al. 2005). Additionally, K6 
and K11 chain formation by CHIP has been reported (Kundrat and Regan 2010). This 
flexibility in chain formation enables CHIP to be involved in clearance of misfolded 
proteins not only by the ubiquitin proteasome system but also via ubiquitin-mediated 
selective autophagy (Kraft, Peter et al. 2010). CHIP links the molecular chaperones, such 
as Hsc70/Hsp70 and Hsp90 to the ubiquitin proteasome system thereby assuming a 
central role in cellular triage decisions (Fig. 1.2.8.). While Hsp70 is essential in protein 
quality control as it binds all misfolded proteins, Hsp90 binds so called client proteins 
that play central regulatory roles within the cell, such as  protein kinases, transcription 
factors and receptors (Stankiewicz, Nikolay et al. 2010). Simultaneous binding of both 
Hsp70 and Hsp90 to HOP (Hsp70-Hsp90 organizing protein) allows the passage of client 
proteins from Hsp70 to Hsp90 followed by final folding and maturation (Kundrat and 
Regan 2010). Contrary to this, binding of CHIP to Hsp70 or Hsp90 is mutually exclusive. 
However, CHIP shows preference for ubiquitination of Hsp70-bound proteins. The 
misfolded proteins that cannot be refolded back to the native state spend more time in a 
complex with Hsp70 and are therefore more likely to be ubiquitinated by CHIP and 
subsequently degraded by proteasome (Stankiewicz, Nikolay et al. 2010). In addition, 
binding of the Hsp70 and Hsp90 to CHIP excludes their binding to HOP demonstrating 
mutual exclusion of cellular refolding and degradation pathways (Kundrat and Regan 
2010; Stankiewicz, Nikolay et al. 2010). Under normal conditions proteins are found in a 
Hsp70-HOP-Hsp90 complex and the balance is shifted towards the folding process. 
However, upon inhibition of Hsp90 by geldanamycine or 17AAG, completion of the 
client protein folding is not possible. These unfolded proteins spend more time in a 
complex with Hsp70 and are consequently ubiquitinated by CHIP and degraded (Kundrat 
and Regan 2010).  
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Figure 1.2.8. Role of CHIP in the triage decision.  Substrate proteins encountered by 
chaperones can be refolded (gray symbols and gray arrows) in only few cycles of 
chaperone binding, thus spending a short time in a Hsp70 chaperone-bound state. 
Protein substrates that cannot be effectively refolded (black symbols and black arrows) 
are repeatedly bound and released by the Hsp70 system (black arrows), and therefore 
spend a longer time in complex with the chaperones allowing  efficient ubiquitination by 
CHIP (Stankiewicz, Nikolay et al. 2010). 
CHIP can also interact with various co-chaperones such as BAG1 and BAG3. In young 
cells the co-chaperone BAG1 is highly expressed promoting proteasomal degradation. 
With age the expression of co-chaperone BAG3 increases leading to more autophagic 
degradation (Fig. 1.2.9.). It seems that the ratio of BAG1 to BAG3 determinates the 
decision between the two degradation pathways and the ability of CHIP to interact with 
both co-chaperones allows it to act as a dual ubiquitin ligase targeting misfolded proteins 
to either autophagy or the proteasome (Kraft, Peter et al. 2010). 
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Figure 1.2.9. Various degradation pathways of misfolded proteins. Depicted are three 
different pathways of misfolded protein degradation: 26S proteasomes, autophagy and 
chaperone-mediated autophagy (CMA). Misfolded proteins can be polyubiquitinated. 
This serves a recognition signal for proteasomal degradation. If misfolded proteins 
aggregate, they are targeted for autophagic clearance either by p62/NBR1-mediated 
autophagosomal engulfment or by aggresome formation coordinated by HDAC6. The 
decision between proteasomal and autophagic degradation is influenced by BAG1/BAG3 
and CHIP, while p97 and parkin are involved in both proteasomal degradation and 
aggresome formation. It is still unclear how these different factors are coordinated and 
how the decision between different degradation pathways is made. Depicted in red are 
components involved during different steps of the degradation routes. Cross-talk between 
the different pathways is indicated by dashed arrows. Ub, ubiquitin (Kraft, Peter et al. 
2010). 
      1.2.3.2. Biological function of CHIP 
Mice lacking CHIP expression are born in an expected Mendelian ratio, indicating that 
this protein is not essential for embryonic development. During the perinatal period 
CHIP-deficient mice show increased mortality up to 20% compared to wild type and 
heterozygous mice. The most interesting feature of those CHIP-deficient adult mice that 
fail to survive is the thymic atrophy that occurs due to hypocellularity and massive 
thymocyte apoptosis. However, the surviving CHIP-deficient mice do not display this 
phenotype (Dai, Zhang et al. 2003). Interestingly, these mice display accelerated ageing 
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with age-related changes affecting various organs and cell types leading to shortened life 
span (Min, Whaley et al. 2008). These mice also show an impaired response to 
physiological stress. The CHIP-deficient mice are unable to cope with a mild heat shock 
such as 42 
o
C administered for 10 min. While wild type mice normally survive thermal 
challenge, all knockout mice die during the heat exposure or in the recovery period, 
exhibiting lesions also common in humans suffering from a heat shock. These mice show 
characteristic stress response lesions such as edema, hyperemia and friability of the small 
intestine with blunting of the villi and thrombosis of subvillous arterioles. In addition, 
many different cell types show increased apoptosis in the gastrointestinal tract as well as 
in the spleen (Dai, Zhang et al. 2003). All this indicates that CHIP-mediated quality 
control mechanisms control cellular senescence and regulate longevity in mammals. 
As a part of the system that regulates cellular proteostasis, CHIP plays a role in many 
neurodegenerative diseases that arise as a consequence of abnormal protein accumulation. 
CHIP is involved in regulation of aggregation of tau the protein responsible for 
Alzheimer´s disease. In addition, CHIP can cause both lysosomal and proteasomal 
degradation of -synuclein thus playing a role in the progression of Parkinson´s disease. 
Furthermore, CHIP is involved in heat shock protein-mediated degradation of aggregated 
proteins such as huntingtin, ataxin and androgen receptor, making it part of the first line 
of defense in polyglutamine expansion diseases such as Huntington`s disease, several 
spinocerebellar ataxias and spinal and bulbar muscular atrophy (Dickey, Patterson et al. 
2007). A wide range of substrates such as p53, ErbB2, estrogen receptor, myocardin 
illustrate CHIP´s involvement in different cellular physiological and pathophysiological 
processes from smooth muscle cell differentiation to breast cancer (Zhou, Fernandes et al. 
2003; Tripathi, Ali et al. 2007; Patterson and Ronnebaum 2009; Xie, Fan et al. 2009). 
 
 
 
 
 
 
 
 
                                                                                                                        Materials and Methods 
41 
 
2. Materials and Methods 
2.1. Common chemicals 
All chemicals used in this study, if not further specified, were purchased from the 
following companies: Carl Roth GmbH (Karlsruhe, Germany), Merck (Darmstadt, 
Germany), and Sigma Aldrich (Munich, Germany). 
2.2. Animals 
Mouse strains were maintained and bred in the animal facility of the Max Planck Institute 
of Biochemistry, Martinsried, Germany. The mice had free access to water and to 
standard rodent diet. The light cycle in the animal facility was set for 12 h. Mice of an age 
of 8 weeks were used for breeding. Mice were weaned and separated by sex and housed 
in different cages at an age of 3-4 weeks after birth. All weaned mice were marked with 
ear tags and clipped at the tail. DNA for genotyping was immediately isolated from the 
tails. All animals were treated according to the German Animal Protection Law. 
   2.2.1.      Breeding scheme 
CHIP+/- heterozygous mice were obtained from Cam Patterson from University of North 
Carolina at Chapel Hill School of Medicine, Department of Medicine, Chapel Hill, NC, 
USA. After the quarantine period the mice were transferred to a dirty animal facility 
where they were bred with 4-6 week old C57/BL6 females. The pregnant females from 
these breeding were used for an embryo transfer.  In this way the animals were sanitized 
and introduced to the main animal facility. 
2.3. Cell culture methods 
   2.3.1.     Materials cell culture 
5 ml Pipette: Corning, Costar Stripette, 4487 
15 ml Pipette: Corning, Costar Stripette, 4488 
25 ml Pipette: Corning, Costar Stripette, 4489 
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96-well: Corning, 35 3799 
12-well: Corning, 35 3043 
6-well: Corning, 35 3046 
15 ml tube: Corning, 43 0791 
50 ml tube: Falcon BlueMax, 35 2070 
Cryogenic vial: Corning, 43 0489 
100 mm dish: Falcon, 353003 
140 mm dish: NUNC, 168381 
DMEM High Glucose GlutaMAX: Invitrogen, 31966-021 
Foetal bovine serum: Gibco, 10270-106 
Trypsin: Trypsin / EDTA (10x), Gibco, 15400-054 
P/S: Penicillin, Streptomycin (100x), PAA, P11-010 
Fibronectin: bovine plasma fibronectin, Calbiochem, 341631 
Phosphate Buffered Saline (PBS) 
   2.3.2.      Isolation of mouse kidney fibroblasts 
3 week old CHIP-/- and CHIP+/+ control mice were sacrificed and dissected as sterile as 
possible. The kidneys were collected in sterile PBS buffer. Kidneys were additionally 
rinsed in PBS and associated membranes were removed. The kidneys were dissected 
sagittally in 2 pieces each and rinsed again in PBS. Each kidney half was cut in small 
pieces and digested in 7 ml of 2 mg/ml Collagenase in DMEM + Pen/Strep for 30 min at 
37°C with mixing every 10 min. After digestion the tissue was spinned down at 500 rpm 
for 5 min. After the removal of digestion medium the tissue was washed twice in 
DMEM+10%FCS+Pen/Strep to inactivate collagenase. The pellets were resuspended in 
DMEM+10%FCS+Pen/Strep and plated in 2 10 cm cell culture Petri dishes. The tissue 
was cultured for several days until the cells migrated out and attached to the dish. The 
cells were trypsinized and replated in order to remove any remaining tissue debris. 
Subsequently the cells were immortalized with SV40 virus and cloned. The cells were 
maintained in growth medium in a humidified atmosphere (5 % CO2, 95 % H2O). 
Digestion medium 
Collagenase type II 125 U/mg.................2 mg  
Dissection medium.................................1 ml 
Collagenase type II, Worthington ( Cat.No. LS 004196) 
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Growth medium 
FBS ......................................................10 ml 
P/S..........................................................1 ml 
DMEM...............................................100 ml 
   2.3.3.      Isolation of mouse embryonic fibroblasts 
A CHIP+/- heterozygous timed mating was set up. The pregnant female was sacrificed 
and the E14 staged embryos were isolated as sterile as possible. The embryos were 
collected in sterile PBS buffer and additionally rinsed in PBS. The head and inner organs 
were removed and used for genotyping. The embryos were digested in trypsinization 
solution for 5 min. After digestion the tissue was spinned down at 500 rpm for 5 min. 
After the removal of the digestion medium the tissue was washed twice in DMEM+10 % 
FCS+Pen/Strep to inactivate the trypsin. The pellets were resuspended in DMEM+10 % 
FCS+Pen/Strep and plated in 6-well cell culture dishes. The tissue was cultured for 
several days until the cells migrated out and attached to the dish. The cells were 
trypsinized and replated in order to remove any remaining tissue debris. Subsequently the 
cells were immortalized with SV40 virus and cloned. The cells were maintained in 
growth medium in a humidified atmosphere (5 % CO2, 95 % H2O). 
Digestion medium / Trypsinization solution 
10x Trypsin /EDTA ..............................10 ml 
PBS pH 7.4 ...........................................90 ml  
Growth medium 
FBS .......................................................10 ml 
P/S............................................................1 ml 
DMEM.................................................100 ml 
   2.3.4.      Immortalization of mouse fibroblasts 
Psi684 cells producing the SV40 virus were plated into a medium or large flask in a 
medium appropriate for the downstream application. When the cells reached 80-90% 
confluence the medium was changed. After the 10-12 h the medium was harvested and 
replaced. The harvested medium was spinned down at 900 rpm for 5 min and passed 
through a 0.22 µm filter in order to remove all cells from the viral supernatant. At this 
stage the viral supernatant was used fresh since the freezing down can cause the viral titer 
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to drop to 50 %, which reduces the efficiency of immortalization. The target cells were 
cultured in parallel and when they reached 50-60 % confluence the medium was removed 
and exchanged by the viral supernatant. For a 75 cm medium flask 7 ml of viral 
supernatant was used. After 1 h incubation period, 5 ml of fresh growth medium was 
added without removing the viral supernatant. The cells were kept in this medium over 
night after which the whole process was repeated once again. The next day the cloning 
was initiated by trypsinization and plating 200 cells on a 10 cm cell culture Petri dish.   
      2.3.4.1. Cell culture and trypsinization of immortalized mouse fibroblasts 
Immortalized mouse fibroblasts were maintained in growth medium in a humidified 
atmosphere at 37 °C and 5 % CO2. In order to be passaged the cells were taken into 
suspension by trypsinization. The cells were washed in prewarmed PBS and detached 
from the substrate by incubation with trypsinization solution for approximately 2 min at 
37°C. Detached cells were resuspended in growth medium. 
Trypsinization solution 
10x Trypsin /EDTA ..............................10 ml 
PBS pH 7.4............................................40 ml  
      2.3.4.2. Cryo-preservation of immortalized mouse fibroblasts 
For long term storage frozen cultures were stored in liquid nitrogen tanks at -196 °C. The 
cells were trypsinized and resuspended in prewarmed growth medium. The cell 
suspension was centrifuged for 5 min at 900 rpm in order to remove trypsin. The cell 
pellet was resuspended in cooled freezing medium at an approximate concentration of 
1x10
6
 cells/ml. The cell suspension was distributed in 1 ml aliquots in cryogenic vials and 
frozen on dry ice. The cells were stored at -80 °C for a short period of time after which 
they were transferred into liquid nitrogen at -196 °C for long term storage.  
Freezing medium 
FBS ......................................................20 ml 
DMSO..................................................10 ml 
DMEM..................................................70 ml 
      2.3.4.3. Thawing of cryo-preserved fibroblasts 
Frozen cells were placed in a water bath at 37 °C until the freezing medium had thawn. 
After this the cells were resuspended in prewarmed growth medium in approximately 10 
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fold volume of the initial cryoculture and centrifuged for 5 min at 900 rpm. The cell pellet 
was resuspended in growth medium and seeded in a flask of appropriate size. The cells 
were subsequently maintained in growth medium in a humidified atmosphere at 37 °C 
and 5 % CO2.   
   2.3.5.      Establishment of ILK-Flag expressing stable cell lines 
Primary fibroblasts were isolated and cultured as described previously. Single cell clones 
were obtained after which the Ilk gene was deleted by adenoviral expression of Cre-
recombinase. ILK-/- fibroblast clones were retrovirally infected with Flag-tagged wild-
type ILK or K341R pCLMFG constructs. Alternatively the CHIP-/- and CHIP+/+ kidney 
fibroblasts still expressing endogenous ILK were infected with the retrovirus expressing 
Flag tagged wild-type ILK. The fibroblasts stably expressing ILK-Flag or ILK-K341R 
were cultured in DMEM supplemented with 10% FCS.  
      2.3.5.1. Preparation of retroviruses 
All retroviral preparations were done by Hildegard Reiter as previously described by 
Carsten Grashoff. Human embryonic kidney cells (HEK293T) were transiently 
transfected with pCLMFG construct packaging plasmids (encoding HIV gag, pol and rev) 
and a plasmid encoding the envelope of the vesicular stomatitis virus G by a calcium 
phosphate method in order to produce VSV-G pseudotyped retroviral vectors. The 
supernatant containing the VSV-G pseudotyped retrovirus was harvested, enriched by 
centrifugation and directly used for infection of ILK -/- , CHIP-/- or CHIP+/+ fibroblasts. 
      2.3.5.2. Calcium phosphate transfection of HEK293 cells 
HEK 293 cells were expanded in growth medium at 37 °C and 10% CO2 in a humidified 
atmosphere. Cells were grown on 140 mm plates until 60 % confluence. Cells were 
incubated over night at 37 °C in 3 % CO2 in 2.3 ml of transfection mixture. After this the 
medium was exchanged to growth medium. Cells were further cultured in growth 
medium at 3 7°C and 10 % CO2. 
2xBBS 
BES pH 6.95.......................................4.26 g  
NaCl....................................................6.54 g 
Na2HPO4..........................................0,085 g 
Filled up to 400ml with H2O 
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Transfection mix ( for 1x 140mm dish) 
DNA of pCLMFG.............................. 25 μg 
DNA of packaging plasmid................ 25 μg 
DNA of VSV-G env plasmid........... 12.5 μg 
filled up to 1.16ml with sterile H2O, then addition of 
CaCl2 (2.5M) .................................... 112 μl 
vortexed, then addition of 
2xBBS..............................................1.16 ml 
inverted, incubate 10-15 min at room temperature 
BES, Sigma (Cat.No. 9879) 
      2.3.5.3. Harvest of retroviral supernatant 
The virus was harvested from HEK293 cells twice. The first harvest was done 24 h after 
initial transfection. The supernatant was collected and replaced by 16 ml growth medium 
after which the cells were incubated for additional 24 h at 37 °C in 10% CO2. The 
collected supernatant was filtered through a 0.45 μm filter. The filtrate was centrifuged at 
50000x g for 2 h at 17 °C after which the pellets were resuspended in 50 μl HBSS, 
vortexed and stored at 4°C. The second harvest was performed 48 h after the initial 
transfection. The retroviral supernatant was collected and treated as the first harvest. For 
obtaining a higher concentration of the virus, pellets of the first and second harvest were 
combined, mixed with 2 ml of 20 % sucrose and centrifuged at 42000g for 2 h. Pellets 
were resuspended in 50-100 μl HBSS, mixed at room temperature for 45 min and pelleted 
by centrifugation. The supernatant was collected and stored at -80 °C. 
Hanks’ Balanced Salt Solution (HBSS), Gibco (Cat.No. 14175-046) 
      2.3.5.4. Infection of fibroblasts with VSV-G pseudotyped retroviral vectors 
1.5-2x 10
6
cells, approximately 50 % of confluence, were seeded on a 6-well plate and 
cultured over night in 1.5 ml of growth medium. The next day in the afternoon, 800 μl of 
growth medium containing 10-12 μl of the virus preparation was added onto the cells that 
were then incubated over night. After this the medium was changed to growth medium 
and the cells were grown until confluency. The cells were then expanded by 
trypsinization and replating onto 10 cm cell culture dishes. Finally, a subset of cells was 
frozen down for long term preservation and the remaining cells were used in experiments 
or further cloned into single cell clones. 
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   2.3.6.      Establishment of ILK-GFP expressing stable cell lines 
Primary fibroblasts were isolated and cultured as described previously.
 
 Single cell clones 
were obtained after which the Ilk gene was deleted by adenoviral expression of Cre-
recombinase. ILK-/- fibroblast clones were lentivirally infected with GFP-tagged wild-
type ILK or K341R pHAGE-CMV-eGFP-W-mU6 constructs. All lentiviruses were 
produced and lentiviral transduction of fibroblasts was performed by Hildegard Reiter. 
The fibroblasts were expanded by culturing in DMEM supplemented with 10% FCS. The 
ILK-GFP, ILK-K341R GFP and ILK-/- GFP only expressing cells were sorted for the 
comparable high GFP expression using FACS Aria I cell sorter by Raphael Ruppert. 
   2.3.7.      Establishment of clonal cell lines 
In order to isolate single cell clones from a mixed population, cells were seeded in very 
low density of 200 cells/10 cm dishes and cultured in growth medium. After 
approximately 1 week single colonies were visible. The colonies were picked under 
sterile conditions with a 200 μl pipet. Cells were transferred into 200 μl pre-warmed 2x 
Trypsin/EDTA, incubated for 2 min at 37°C and resuspended in 2 ml of growth medium. 
Cells were cultured for approximately 1 week in 12-wells until confluent. The cells were 
then expanded to 6-well culture dishes by trypsinization and replating. Finally, a subset of 
cells were cryopreserved while the rest were expanded further and used in various assays. 
   2.3.8.      3D/ collagen gel migration assay 
1x10
6
 of cells were resuspended in 1 ml of growth medium. The cells were mixed with 
type I collagen in a 1:2 ratio, avoiding air bubble formation. The gels were loaded in self-
made U-shaped invasion chambers consisting of objective slides, 18x18 mm cover slips, 
and paraffin. The gels were allowed to set at 37˚C for 30 min. DMEM supplemented with 
10 % FCS and 1 mg/ml EGF as well as additional inhibitors, when required, were then 
added on top of the gel. The chambers were then sealed using paraffin and imaged using a 
Zeiss Axiovert 40C microscope (5X objective) equipped with a CCD camera (Prosilica, 
GC2450), heated stage (37 ˚C) and supplied with 4,7 % CO2. Cell migration was tracked 
and quantified using the Chemotaxis and Migration plugin tool of ImageJ software. 
Statistical analyses on the data were performed using the GraphPad Prism software. 
Statistical significance was assessed by ANOVA followed by a Tucky post test. 
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Collagen gel 
Collagen I……………………….750 µl 
10XMEM...……………………..100 µl 
NaHCO3 pH 7.5…………….……50 µl 
Collagen 3mg/ml stock: PureCol, Advanced BioMatrix ( Cat.No. 5005-B) 
10XMEM, Invitrogen ( Cat.No. 11430-030) 
Object glass, Thermo Scientific ( Cat.No. J1800AMNZ) 
Cover Slips, Menzel Glaser ( Cat.No. BB018018A1) 
   2.3.9.      Biofunctionalized Micropatterned Substrates and 1D migration Assay 
2,5 µm-line micropatterns were generated on PEG-coated cover slips using deep UV 
lithography (adapted from (Azioune, Storch et al. 2009)) by Dr. Julien Polleux and Zhu Min. 
Cells were seeded and grown on the micropatterns functionalized with fibronectin in 1% FCS 
supplemented DMEM.  Live cell imaging was performed using a Zeiss microscope Axiovert 
40C equipped with a CCD camera (Prosilica, GC2450). The stage was supplied with 
4,7% CO2 and heated at 37˚C. FireWire software (Molecular Devices, Downingtown, 
PA) was used for image acquisition as well as the microscope control. All images were 
obtained at +37 C and 5% CO2 Cells were tracked manually using the Chemotaxis plug-in of 
ImageJ software. 
2.4. Immunological methods 
   2.4.1.      Materials immunological methods 
Antibodies:  
Primary antibodies used: anti-Ilk mouse (Transduction Laboratories), anti-ilk rabbit (Cell 
SignalingTechnology), anti-PINCH mouse (Transduction Laboratories), anti-parvin rabbit 
(Cell Signaling Technologies), anti-paxillin mouse (BD Biosciences), phalloidin 
Alexa546 (Invitrogen), anti-CHIP (Calbiochem).  
Secondary antibodies used: Alexa488-, Alexa647- (Invitrogen) or Cy3- (Jackson Immuno 
Research Laboratories), anti-pFAK (Tyr397, Biosource), anti-FAK rabbit (Upstate), anti-
GAPDH mouse (Calbiochem), anti-paxillin mouse (Transduction Laboratories), anti-
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CHIP rabbit (Calbiochem), anti-FLAG M2 mouse HRP conjugated (Sigma) and goat anti-
mouse HRP, and goat anti-rabbit HRP (Bio-Rad Laboratories). 
   2.4.2.      Immunostaining of adherent cells 
For cellular immunostaining, cells were grown on glass cover slides (Roth) coated with 5 
µg/ml
 
fibronectin or allowed to adhere and spread for 24 h. Cells were fixed in 4 % PFA, 
rinsed with PBS and permeabilized with 0.1 % Triton X-100. Nonspecific protein binding 
sites were saturated with 3 % bovine serum albumin (BSA) and 5 % goat serum in PBS, 
followed by incubation with primary antibodies over night at 4 ˚C or 1 h room 
temperature followed by incubation with secondary antibodies and DAPI (1:10 000 in 
PBS). The cover slides were washed and mounted on object glass slides with elvanol. The 
fluorescent images were collected by laser scanning confocal microscopy (DMIRE2; 
Leica) using Leica Confocal Software version 2.5 Build 1227 with ×100 oil objective.  
Glass cover slides, Roth ( Cat.No. P231.1) 
Fixation solution 
Paraformaldehyde (PFA) ....................... 4% 
dissolved in PBS (pH 7.4), boiled for 1 min and cooled on ice 
Permeabilization solution 
Triton-X-100 ....................................... 0.1% 
Dissolved in PBS (pH 7.4) 
Blocking solution 
bovine serum albumin (BSA) ................ 3% 
goat serum……………………………….5% 
Dissolved in PBS (pH 7.4) 
Elvanol 
Mowiol 4-88............................................12 g  
H2O.......................................................30 ml 
mixed for 10 min, incubated 2-3 h at RT, then addition of 
0.2 M Tris-HCl pH 8.5.............................60 ml  
87 % glycerol..........................................30 ml 
Mixed for 10min, and then kept at 4°C overnight, aliquoted and stored at -20°C 
Mowiol, Roth (Cat.No.0713) 
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2.5. Biochemical methods 
   2.5.1.      Materials biochemical methods 
Centrifuge: Beckman Coulter, GS-15R 
Ultracentrifuge (small): Beckman Coulter, TL-100 Ultracentrifuge 
Ultracentrifuge rotor: Beckman Coulter, TL-100 
Ultracentrifuge (large): Beckman Coulter, L8-60M 
Ultracentrifuge rotor: Beckman Coulter, SW41 
Protease inhibitor cocktail: complete Mini, EDTA-free, Roche, 12740900 
   2.5.2.      Preparation of total protein lysates form adherent cells 
Cells grown on polystyrene dishes at 70-80% of confluence were rinsed in ice cold PBS 
and suspended in lysis buffer. The cells were incubated for 10 min on ice to allow cell 
lysis to proceed after which the lysates were harvested with a cell scraper. Cell lysates 
were cleared by centrifugation at 15000xg for 5 min at 4°C. The protein concentration of 
the supernatant was determined using a bicinchoninic acid protein assay kit. After the 
protein concentrations were adjusted, lysates were reduced in the appropriate amount of 
4x SDS sample buffer by incubating for 5 min at 95 °C and either frozen in -80°C or 
directly subjected to SDS-PAGE. After separation of polypeptides on SDS-PAGE they 
were transferred onto PVDF membranes and subjected to western blot analyses. 
Alternatively, the lysates were used for performing immunoprecipitation assays. 
Cell lysis buffer 
Tris/HCl pH 8.0.....................................50 mM  
NaCl.....................................................150 mM 
Triton X-100 ............................................... 1 % 
EDTA…………………………..……...10 mM 
protease inhibitor cocktail......1 tablet/10ml 
Phosphatase inhibitor I and II 100µl per 10ml of lysis buffer 
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4x SDS sample buffer 
20 %SDS................................................16 ml 
1 M Tris pH 6.8........................................8 ml  
0.5 M EDTA........................................0.32 ml 
87 % glycerol..........................................16 ml 
bromphenol blue .............................. ..0.001 % 
before use, mercaptoethanol was added to a final concentration of 4 % and stored at RT 
The following volumes of cell lysis buffer were used: 
6-well plate ......................................... 250 μl 
10 cm dish.......................................... 0.5-1 ml 
   2.5.3.      Determination of protein concentration-BCA protein assay 
The BCA method is based on the reduction of Cu
2+
- to Cu
1+
-ions by proteins under 
alkaline conditions (Buiret-reaction). The detection of Cu
1+-
ions is mediated by 
bicinchoninic acid, which is chelated by cuprous cations forming a complex with a strong 
absorbance at 562 nm. The assay was performed according to the instructions of the 
manufacturer. 
BCA Protein Assay Kit, Pierce (Cat.No.23225) 
   2.5.4.      Immunoprecipitation 
Cell lysates were prepared as described above. For immunoprecipitation assays protein 
concentrations of 0.5-1.5 mg/ml in a volume of 0.5-1 ml were used. The beads were 
prepared by washing 3x in TBS with centrifugation for 5 min at 5000g between the steps. 
Usually 50-100 µl of the beads was used for incubation of 2 h with lysates. After the 
binding of the protein to the beads the beads were washed 2 times with lysis buffer and 2 
times with PBS.  
      2.5.4.1. FLAG Immunoprecipitation 
For immunoprecipitation of FLAG tagged proteins, cell lysates were incubated for 2 h at 
+4°C with anti-FLAG M2 affinity gel that had previously been washed 3 times with TBS 
to remove the methanol-containing storage buffer. 50 μl of the gel was applied to protein 
concentrations of 0.5-1.5 mg/ml in 0.5-1 ml of volume. After this the gel was washes 2 
times with lysis buffer and 2 times with PBS to remove unspecifically bound material. 
Immunoprecipitated Flag tagged proteins were eluted by incubation with FLAG-peptide 
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for 30 min on ice. The gel was then centrifuged 5 minutes at 5000g and the supernatant 
was reduced by Laemmli sample buffer and boiled at 95°C for 5 min. The reduced 
samples were further subjected to SDS-PAGE or alternatively processed for mass 
spectrometry analysis. 
Anti-FLAG M2 affinity gel, Sigma (Cat.No.A2220) 
3xFLAG peptide, Sigma (Cat.No.F4799) 
      2.5.4.2. Mass Spectrometry 
FLAG immunoprecipitation was performed as described above using lysates from 
fibroblasts stably expressing wt ILK-Flag and ILK-K341R.  The parental ILK fl/fl 
fibroblasts were used as a negative control. In solution trypsin digestion was performed 
on immunoprecipitates followed by reversed-phase liquid chromatography (Proxeon 
Biosystems) coupled online to an LTQ-Orbitrap mass spectrometer (Thermo Fisher 
Scientific). Data were acquired with Xcalibur software and analyzed with MaxQuant 
software. The mass spectrometry analysis was performed by Dr. Tami Geiger. 
 Trypsin is a serine protease cleaving the peptide bonds in which the carbonyl group is 
contributed either by an Arg or Lys residue. After the digestion by trypsin ubiquitin 
modification leaves behind only a Gly-Gly dipeptide covalently attached to the target 
protein. However, other small protein modifiers such as SUMO leave the same Gly-Gly 
dipeptide and therefore cannot be distinguished from ubiquitin only by mass 
spectrometry. 
      2.5.4.3. In Vivo Ubiquitination Assay 
In this assay covalent protein modifications are analyzed by performing an 
immunoprecipitation under reducing conditions. This allows disruption of noncovalent 
protein interactions as well as the inactivation of enzymes that catalyze removal of 
modifications. The immunoprecipitation can be performed by using an antibody against 
ubiquitin. This leads to precipitation of all ubiquitinated proteins allowing subsequent 
western blot analysis with antibodies against the target protein to confirm the 
ubiquitination. Alternatively, antibodies against target proteins can be used for 
immunoprecipitation followed by detection of ubiquitin with western blot. 
Cells grown on polystyrene dishes at 70-80% confluence were rinsed with PBS. The PBS 
was subsequently removed and the cells were harvested from the dish by scraping and 
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collected in 1.5 ml eppendorf tubes. The cells were immediately resuspended in 100 µl of 
denaturing lysis buffer, mixed by vortexing and boiled for 5 min at 95˚C. Rapid 
denaturation is essential in order to inactivate very potent deubiquitinase enzymes. The 
lysates were then diluted 1:10 in non-denaturing lysis buffer followed by incubation on 
ice for 5 min. The non-denaturing buffer contains Triton-X 100 that allows the 
sequestration of SDS in micelles. This facilitates immunoprecipitation without 
interference of SDS with the antibody-antigen interaction. The Flag immunoprecipitation 
was subsequently carried out as described above. 
Denaturing lysis buffer  
Tris/HCl pH 7.4………………….50 mM 
SDS…………………………………..1 % 
EDTA……………………………..5 mM   
Non-denaturing lysis buffer 
Triton X-100…………..……………..1% 
NaCl ……………………………300 mM 
Tris pH 7,4/HCl…………………...50 mM 
 EDTA…………………….……….5 mM 
Both denaturing and non-denaturing buffers were supplemented with a complete protease 
inhibitor cocktail, 1tablet /10 ml of lysis buffer and 25 mM N-Ethymaleimid (NEM), an 
inhibitor of deubiqutinases, freshly before use. 
      2.5.4.4. GFP Immunoprecipitation 
GFP immunoprecipitation was performed using the Miltenyi Biotec MultiMACS GFP 
Isolation Kit. Cells grown on polystyrene dishes at 70-80% of confluence were rinsed 
with ice cold PBS and harvested in lysis buffer provided by the manufacturer, collected in 
1.5 ml eppendorf tubes and incubated for additional 20 min on ice. Cell lysates were 
cleared by centrifugation at 10000g for 10 min at 4 °C. The protein concentration of the 
supernatant was determined using a bicinchoninic acid protein assay kit. After protein 
concentrations were adjusted the lysates were used for immunoprecipitation assays. 
Typically concentrations of 0.5-1.5 mg/ml in 1 ml of lysis buffer volume were used. The 
lysates were incubated with 50 µl of magnetic anti-GFP beads for 30 min on ice with 
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occasional mixing. After this the lysates were loaded on the µ columns, placed into the 
µMACS separating magnet and allowed to flow through. The proteins bound to the beads 
were washed 2 times with 1:10 dilution of the lysis buffer in de-gassed TBS and 2 times 
with wash buffer II. The bound proteins were eluted and reduced with elution buffer 
preheated at 95˚C. The eluates were additionally incubated for 5 min at 95 ˚C after which 
they were subjected to SDS-PAGE. 
GFP lysis buffer 
Tris/HCl pH 8.0…………..…..50 mM 
Triton X-100…………………….…1 % 
NaCl…………………………150 mM 
Wash buffer II 
Tris/HCl pH 7.4………….…..20 mM 
Elution buffer 
Tris/HCl pH 6.8………………..50 mM 
DTT…………………………….50 mM 
EDTA…………………………....1 mM 
Bromphenol blue……………...0,0005 % 
Glycerol…………………………....10 % 
   2.5.5.      One-dimensional SDS-polyacrylamide-gel electrophoresis (SDS-PAGE) 
Protein lysates were typically precleared by centrifugation and reduced by boiling at 95˚C 
in the presence of sodium dodecyl sulphate (SDS). 2-Mercaptoethanol or dithiothreitol 
(DTT) was added to reduce disulfide bonds. In this assay proteins are separated 
electrophoretically. Separating and stacking gels that are differentially buffered are 
poured on top of each other in order to perform discontinuous gel electrophoresis. In the 
stacking gel proteins get concentrated at the stacking/separating gel interface. In the 
separating gel the proteins are separated according to molecular size in a denaturing gel 
(containing SDS). Here proteins were separated in the Mini gel format (7.3 mm x 8.3 mm 
x 1.5 mm) using the Mini Protean III System (BioRad). After polymerization of the 
polyacrylamide gel and assembly of the electrophoresis apparatus the gel running 
chamber was filled with SDS-PAGE running buffer. The protein samples were reduced in 
4x SDS sample buffer and boiled for 5 min at 95 °C. Samples were loaded on the 
stacking gel. The electrophoresis was performed at 100V at room temperature. 
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Separating gel (10ml) 8 %................10 %............... 12 % ...............15 % 
H2O.......................... 4.6 ml............. 4.0 ml .............3.3 ml .............. 2.3 ml 
30 % ProtoGel........... 2.7 ,ml............. 3.3 ml .............4.0 ml ............ 5.9 ml 
1.5 M Tris pH 8.8 .…. 2.5 ml............. 2.5 ml ..............2.5 ml ........... 2.5 ml 
10 % SDS................... 0.1 ml...............0.1 ml .............0.1 ml............. 0.1 ml 
10 %  APS.................. 0.1 ml.............. 0.1 ml .............0.1 ml............. 0.1 ml 
TEMED.................. 0.006 ml.......... 0.006 ml ........0.006 ml ..........0.006 ml 
 
Stacking gel (5 ml)...... 5 % 
H2O................................................... 3.4 ml 
3 0% ProtoGel................................... 0.83 ml 
1 M Tris pH 6.8………………......... 0.63 ml  
10 % SDS........................................... 0.04 ml 
10 % APS...........................………....0.04 ml 
TEMED.......................................... 0.004 ml 
10x SDS-PAGE running buffer (1l) 
Glycine.................................................144 g 
Tris-HCl...............................................30.3 g 
SDS .......................................................10 g 
N,N,N',N'-Tetramethylethylenediamine (TEMED), Serva (Cat.No.35925) 
ProtoGel (Ultra Pure), National Diagnostics (Cat.No.EC-890) 
   2.5.6.      Western blotting and Immunoblotting 
Western blotting is used to identify specific proteins by polyclonal or monoclonal 
antibodies. After the proteins are separated by SDS-PAGE they are electrically 
transferred onto an activated PVDF membrane. Subsequently, proteins bound to the 
surface of this membrane can be visualized by immunodetection reagents. 
After separation of proteins by SDS-PAGE, the stacking gel was removed while the 
separating gel was placed in Western blotting transfer buffer. The PVDF membrane was 
activated by incubation in methanol and then washed in blotting buffer. Typically the 
semi-dry method of transfer was used in which a gel is placed on top of the PVDF 
membrane in between two layers of Whatman paper soaked with transfer buffer. Proteins 
were then electrically transferred 1.5 h with 100 mA at room temperature. After 
disassembly of the transfer sandwich, membranes were stained for 1 min with Ponceau S 
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solution and rinsed in H2O in order to visualize proteins bands on the membrane and to 
confirm the success of transfer. Membranes were subsequently washed in TBS-T and 
blocked for 1 h at room temperature in blocking buffer. Next, the primary antibody was 
incubated on the membrane either over night at 4 °C or for 1 h at room temperature 
(depending on the instructions of the antibody manufacturer or personal experience), 
membranes were washed 3 times 10 min with TBS-T and the appropriate secondary 
antibody was incubated with the membrane for 30 min at room temperature. After 6 
washes for 10 min in TBS-T and an additional wash for 10 min in TBS only, membranes 
bound HRP was detected using a chemiluminescence-based detection kit. 
Western Blotting transfer buffer (1l) 
Tris-HCl...................................................6 g 
Glycine................................................28.8 g 
Methanol.............................................200 ml 
10x TBS (1000 ml) 
Tris-HCl................................................24.3 g 
NaCl.........................................................80 g 
TBS-T (1000 ml) 
Tween-20 ................................................1 ml 
10x TBS...............................................100 ml in H2O 
Blocking buffer 
Skim milk powder .............................. 5 % in TBS-T 
Ponceau S solution, Sigma (Cat.No. P3504) 
Chemiluminescence Reagent Plus, Western Lightning (Cat.No.NEL104) 
   2.5.7.      In Vitro Ubiquitination Assay 
For many known ubiquitin targets modification by ubiquitin (Ub) has been reconstituted 
in vitro. This assay typically involves incubation of recombinant target protein with 
recombinant or purified enzymes, Ub and ATP. Ub modification results in mobility shift 
of the target of approximately 8 kDa, and it can be detected by anti-Ub immunoblot. In 
vitro ubiquitination assay was performed by incubating recombinant ILK and CHIP with 
E1 (Calbiochem), UbcH5a (Sigma), 5 mM ATP, 2.5 mg/ml Ub (Sigma) in total of 20 μl 
of reaction buffer for 2-4 h at 30 °C. Reactions were stopped by adding Laemmli buffer, 
boiling at 95 ˚C and running the samples on a 4-12 % gradient gel Tris/HCl gel 
(BIORAD). 
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In vitro ubiquitination reaction: 
ILK……………………….....….0.36 µg 
E1……………….…………..……1 µM 
UbcH5a………….……………..…1 µM 
Hsp70….......................................1 µM 
Hsp40……………………….….0.1 µM 
CHIP…………….…………...…1-3 µM 
Ub……………….…………….2.5 µg/µl 
ATP……………….…………....100 mM 
All the assays were performed in total of 20 µl of reaction volume. 
In vitro ubiquitination reaction buffer 
MOPS pH 7.2………….…...20 mM      
KCl………………………...100 mM    
MgC………………………..l25 mM         
DTT…………………………10 mM      
PMSF……………………...…1 mM        
E1 enzyme, Calbiochem (Cat.No.662070) 
UbcH5a enzyme, Sigma (Cat.No. SRP6026) 
Ubiquitin, Boston Biochem (Cat.No.U-100) 
2.6. Molecular Biological methods 
   2.6.1.      Materials Molecular Biological methods 
Autoclave: KSG, KSG-112 
Centrifuge: Eppendorf, 5417C 
Centrifuge: Beckman Coulter, Avanti J-25 
Centrifuge rotor: Beckman Coulter J 14 / J 25.50 
Microwave: Daewoo, KOR 63D7 
Thermocycler: Biometra T3 
Thermomixer: Eppendorf 5350 
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   2.6.2.      Isopropanol extraction of tail DNA 
For genotyping of mice, a small part of the mouse tail was amputated and digested with 
500 μl DNA lysis buffer in an eppendorf tube over night. The next day the lysate was 
precleared by centrifugation 5 min 15000g at room temperature. 500μl Isopropanol (1:1) 
was added to the DNA solution and inverted several times until precipitated DNA flakes 
appeared in the solution. The DNA was centrifuged for 5 min at 15000xg. The 
supernatant was decanted and the DNA pellet was washed by 500 μl of 70% Ethanol. 
After washing, the DNA was centrifuged again for 5 min at 15000g. Pellets were air-dried 
for 1-2 min and subsequently resuspended in 250-300 µl H2O. 
DNA lysis buffer 
NaCl...................................................20 mM 
Tris/HCl pH 7.6................................100 mM  
EDTA ..................................................5 mM 
SDS ...................................................... 0.2 % 
proteinase K..................................... 100 μg/m 
   2.6.3.      Bacteriological tools 
Escherichia coli (E.coli) cultures were cultured in lysogeny broth (LB) rich medium. 
Media were prepared and autoclaved for 20 min at 120 °C. Antibiotics were added after 
the solutions were cooled below 50 °C. LB plates were poured into 100 mm Petri dishes 
and stored at 4°C. 
LB medium 
NaCl.........................................................10 g 
Trypton.....................................................10 g 
Yeast extract .............................................5 g 
filled up to 1000 ml with H2O, autoclaved and stored at 4°C 
LB plates 
LB medium........................................1000 ml 
Agar-Agar................................................15 g 
autoclaved, poured into 100 mm Petri dishes, stored at 4 °C 
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Additives 
Ampicillin........................................... 50 μg/ml 
Kanamycin.......................................... 25 μg/ml 
Tetracycline ..................................... 12.5 μg/ml 
      2.6.3.1. Preparation of competent bacteria 
An XL-1 blue E.coli bacterial culture was grown o/n in 10 ml LB +Tetracycline at 37 °C 
on constant shaking at 180 rpm. The next morning, 100 ml of LB+Tetracycline was 
inoculated with 2 ml overnight culture and grown until an optical density at 550 nm 
(OD550) of 0.5 was reached. The bacterial culture was placed on ice for 10 min and then 
centrifuged for 15 min at 4 °C with 1000g. The pellet was resuspended in 10 ml TSS and 
2.9 ml glycerol (87%) was added. The bacterial suspension was distributed in 200 μl 
aliquots and immediately snap frozen in liquid nitrogen. Competent cells were stored at -
80°C. 
TSS (500ml) 
polyethylenglycol ....................................50 g 
Tryptone.....................................................5 g 
Yeast extract ..........................................2.5 g 
NaCl........................................................2.5 g 
DMSO....................................................25 ml 
1 M MgCl2 .............................................25 ml 
Filtrated and stored at 4°C 
      2.6.3.2. Cryo-preservation of competent bacteria 
The bacterial cultures were frozen by adding 250 μl glycerol (87 %) to 750 μl bacterial 
over night culture. Cryocultures were stored at -80 °C. 
      2.6.3.3. Transformation of competent bacteria 
100 μl of competent bacteria were thawn on ice for 15 min. For simple retransformation 
of a plasmid, 1 µg of DNA was added and incubated on ice for 30 min. Alternatively, 1 µl 
of cloning reaction for newly cloned vectors was added to bacteria. Cells were then 
placed on 42 °C for 45 sec (heat shock) and subsequently placed on ice for 2 min. 
Bacteria were spread on LB plates with appropriate antibiotics. Plates were incubated 
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over night at 37 °C. Colonies appeared within 8-12 h depending on the transformed DNA 
construct. 
      2.6.3.4. Preparation of plasmid DNA from bacterial cultures 
Bacterial colonies were inoculated in 5 ml LB medium containing appropriate antibiotics 
over night at 37 °C. 750 μl of this bacterial culture was frozen down as described above. 3 
ml of bacterial culture was used for DNA isolation that was performed using the Qiagen 
Plasmid Mini Kit. This is a method based on an alkaline bacterial lysis, followed by 
binding of DNA to an anion-exchange resin under low salt and low pH conditions. 
Impurities such as proteins or RNA are removed by medium salt washing steps. DNA is 
eluted from the resin under neutral or alkaline pH conditions. Large amounts of DNA 
were prepared by the same method using larger volumes (ProOmega Midi Kit). DNA 
concentration was determined by photometric measurement at 260 nm. DNA was stored 
at -20°C. 
Qiagen Plasmid Mini Kit, Qiagen (Cat.No. 12125) 
PureYeald Midiprep Kit, ProOmega (Cat.No. A2492) 
   2.6.4.      Recombinant protein purification 
STUB-1 (CHIP) cDNA was subcloned in the pET-16b vector for the expression of a His 
tagged CHIP protein. E.Coli BL-21 strain was transformed as described above. The 
bacteria were grown in LB medium containing ampicillin. The 50 ml preculture was 
grown at 37˚C while shaking at 180 rpm over night. Next day a larger culture (3 l) was 
inoculated and grown until an optical density of 0.8 at 550 nm (OD550) was reached. At 
this point 0.5 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to the 
culture in order to induce the synthesis of the recombinant protein. The bacterial culture 
was incubated over night at 37 ˚C while shaking at 180 rpm. Next day the bacteria were 
pelleted by centrifugation for 15 min at 6000g at 4 ˚C. After removal of the supernatant 
the bacterial pellet was resuspended in lysis buffer, 10 ml/3.9 g of bacterial pellet. The 
bacteria were lysed on ice for 30 min and sonicated on ice until the lysate had lost its 
viscosity. The lysates were precleared by centrifugation for 30 min at 20000g. NaCl was 
added into the supernatant to a final concentration of 150 mM and MgCl2 to a final 
concentration of 2 mM. 
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A His pull down was performed to purify the His-tagged CHIP from the lysate. The Talon 
slurry was equilibrated in the His wash buffer containing 10 mM imidazole. 2 ml of the 
Talon slurry was then incubated with 20 ml of lysate for 20 min at room temperature 
while rocking. The Talon slurry with bound protein was washed 2 times in 20 ml of His 
wash buffer after which it was packed into a 2 ml disposable BioRad column. The elution 
was performed with 5 ml of His elution buffer while collecting 500 µl elution fractions. 
The protein concentration was determined by the BCA method. Fractions 1 and 2 had a 
protein concentration of 1.2 µg/µl while fraction 3 had 12 µg/µl of protein. The purity and 
the concentration of protein was also confirmed by SDS-PAGE followed by Coomassie 
staining. The fraction 3 as well as fractions 1 and 2 were pooled and dialyzed against 20 
mM Tris pH 8.0, 150 mM NaCl. The dialysis was performed in 5 l volume of dialysis 
buffer for 2 h followed by and exchange of dialysis buffer and subsequent over night 
dialysis. 
His wash buffer  
Tris pH 8.0……………………... 20 mM 
NaCl…………………...…….…150 mM 
Imidazole…………………….….10 mM   
His elution buffer  
Tris pH 8.0………………….…...20 mM 
NaCl……………….....….……..150 mM 
Imidazole……………………….200 mM 
Dialysis buffer 
Tris/HCl pH 8.0……………..……20 mM 
NaCl…………………………….150 mM 
Isopropyl β-D-1-thiogalactopyranoside, Sigma (Cat.No. I6758) 
TALON His Tag Purification resin, Clontech (Cat.No. 635501) 
Disposable columns, BioRad (Cat.No. 731-1550) 
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   2.6.5.      Molecular cloning 
In molecular biology restriction enzymes are commonly used to cleave DNA at specific 
sites. There are three subgroups of restriction enzymes. The type I restriction enzymes cut 
the DNA random far from their recognition sequence. They are complex multi-subunit 
enzymes. The type II enzymes cut the DNA within or close to the binding motif within 
the DNA molecule. They recognize and bind a specific DNA sequences. The type III 
restriction enzymes cleave the DNA outside of their recognition sequence and are 
complex molecules. The most widely used tool in molecular biological are type II 
restriction enzymes. 
      2.6.5.1. Digestion of DNA with restriction enzymes 
All digestions were performed according to the manufacturer´s instructions. In general, 
reactions were performed using the following conditions and appropriate NEB buffer 
with or without BSA: 
DNA digestion 
DNA ................................................ 3-5 μg 
NEB buffer ……… ............................. 3 μl 
BSA(+/-)……………..…..…………....0.1 µl 
Restriction enzyme..................................5 U 
filled up to 30 μl with H2O, incubated for 2 h at 37°C 
All restriction enzymes were purchased from New England Biolabs (NEB). 
      2.6.5.2. Dephosphorylation of plasmid DNA 
After the digestion of DNA with restriction enzymes reactive 5’-phosphate and a 3’- 
hydroxyl groups are generated. This leaves the possibility for self-ligation which can 
decrease the success of the cloning. In order to prevent this, the 5’-phosphate group was 
typically removed using shrimp alkaline phosphatase (SAP). Digestion enzymes were 
heat inactivated according to the manufacturer´s instructions. Subsequently the digestion 
reaction was incubated at high pH conditions for 30 min with SAP. 
Dephosphorylation of DNA 
DNA ............................................... 3-5 μg 
SAP buffer .......................................... 3 μl 
SAP.......................................................5 U 
In a total reaction volume of 30 μl filled in with H2O and incubated for 30 min at 37°C 
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      2.6.5.3. Ligation of DNA fragments 
In general the ligation of DNA occurs through the formation of a phosphodiester bond 
between a 3’-hydroxyl group and a 5’-phosphate group. In this study the DNA back bone 
was typically dephosphorylated after the digestion with restriction enzymes before 
proceeding to the ligation reaction. DNA inserts were generated by restriction enzymes or 
by PCR and subsequent restriction in order to create the ``sticky ends´´. The reactions 
were performed using 200 ng of total DNA. The ratios between the amounts of backbone 
and insert were typically 1:3, 2:5 or 1:5 depending on the sizes of the insert and the 
backbone DNA. In order to perform DNA ligation the following protocol was used. 
DNA ligation 
DNA backbone (vector) .................. 0.5-1 μl  
DNA insert............................................. 5 μl  
ATP (10mM)........................................1.5 μl 
Fast link ligase buffer.......................... 1.5 μl 
Fast link ligase........................................ 1 μl 
In total reaction volume of 15 μl filled in with H2O and incubated for 45 min at room 
temperature. After this heat-inactivation was preformed for 10 min at 70°C. Typically 1 
µl of the ligation reaction was used for transformation of bacteria as described above. 
Several colonies were picked and after DNA purification succesful cloning was 
confirmed by sequencing. 
   2.6.6.      Polymerase chain reaction (PCR) 
PCR is a method of enzymatic DNA amplification (Saiki et al. 1988). The reaction 
requires the presence of a DNA template as well as two primers. In addition, DNA 
polymerase and dNTPs are necessary to carry out the reaction. Typically Taq polymerase 
is used or alternatively a high fidelity polymerase. The amplification occurs in three 
different steps. The denaturation step requires a high temperature of 95 °C. The next step 
is annealing of the primers to the DNA template and it requires lower temperatures, 
usually 58-68 °C depending on the primer melting temperature. Finally the DNA 
synthesis occurs at typically at 72 °C but can also vary depending on the DNA 
polymerase used in the reaction. 
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      2.6.6.1. PCR primers 
All oligonucleotides were purchased from Metabion International, Martinsried, Germany. 
Oligonucleotides used for site directed mutagenesis were HPLC purified. 
      2.6.6.2. PCR reactions 
Genotyping PCR reaction was performed using tail DNA and self-made recombinant Taq 
polymerase. The cloning PCR was performed using purified plasmid DNA or cDNA 
obtained by reverse transcription PCR from total cellular RNA and high fidelity 
polymerase such as PFU Ultra with an additional proof reading activity. Use of the 
different PCR buffers depended on the DNA polymerase in the reaction. 
 
Genotyping PCR 
DNA ……………................................... 1 μl 
primer1 (10 pmol)................................... 1 μl 
primer2 (10 pmol)................................... 1 μl 
dNTP (10 mM)........................................ 1 μl 
DMSO................................................. 0.5 μl 
10x PCR buffer ..................................... 5 μl 
Taq polymerase................................... 0.5 μl 
filled up to 50 μl with H2O, subjected to PCR  
Different cloning PCR reactions and programs were used in order to generate various 
constructs used in this study. These will be discussed in chapters describing the cloning 
steps of particular construct in more detail.  
The following PCR program was used to genotype the CHIP +/+ and -/- mice: 
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Genotyping PCR  for CHIP +/+ and -/- mice      
                                                             
Step Time (s) Temp.(˚C) 
1 300 95 
2 30 95 
3 30 65 
4 60 72 
5 30 95 
6 30 55 
7 60 72 
8 600 72 
9 ∞ 4 
 
PCR’s were performed as touch down from 65 -55 °C for 10 cycles by sequential 
reduction of the annealing temperature for -1°C per cycle (steps 2-4), followed by 
additional 35 cycles at 55 °C (steps 5-7). 
   2.6.7.      Site directed mutagenesis 
In vitro site-directed mutagenesis is a PCR-based method to generate mutations in DNA. 
The principle is based on two oligonucleotides carrying the desired mutation. The 
oligonucleotide primers are extended during temperature cycling by proof-reading DNA 
polymerase generating a mutant plasmid using the parental plasmid as a template. The 
parental plasmid that does not carry the mutation is digested with an endonuclease that 
only targets methylated DNA, typically DpnI. DNA from most of the E. coli strains is 
dam methylated so only the parental plasmid that has been purified from bacteria is 
susceptible to DpnI digestion. The newly synthesized plasmid generated in an in vitro 
PCR reaction is not susceptible to this digestion. 
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Site directed mutagenesis is a very powerfully tool in study of protein function since it 
allows for amino acids in the protein of interest exchanged inserted or deleted by means 
of mutation of expression plasmid DNA.  
      2.6.7.1. Design of mutagenesis primers 
All oligonucleotides were ordered from Metabion with additional HPLC purification step 
to insure the exact sequence of the oligonucleotides. The oligonucleotides were designed 
according to following rules. The desired mutation was inserted approximately in the 
middle of the primer that was flanked by 10-15 bases of correct sequence on both sides. 
The melting temperature (Tm) of the primer was higher than 78°C so the length of the 
primer was adjusted accordingly. Primers can be longer than 45 base pairs with minimum 
of 40 % GC content. The Tm was calculated according to the following formula: 
Tm= 81.5 + 0.41 (x %GC content) - 675/N - % mismatch 
N is primer length in bases. 
      2.6.7.2. Mutagenesis 
After the mutagenesis PCR was performed the reaction was subjected to digestion by 
adding 1µl of DpnI enzyme. This lead to the digestion of the parental DNA.  
 
Mutagenesis PCR reaction 
parental plasmid DNA.............................100 ng 
primer1....................................................125 ng 
primer2....................................................125 ng 
dNTPs (10mM) .......................................... 1 μl 
10x reaction buffer ..................................... 5 μl 
PfuUltra Polymerase...................... 1 μl 2.5 U/μl 
filled up to 50 μl with H2O, subjected to mutagenesis PCR program 
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Mutagenesis PCR 
 
Step Time (s) Temp.(˚C) 
1 30 95 
2 30 95 
3 60 55 
4 300 68 
5 ∞ 4 
 
PCR was performed for 18 cycles. 
The mutagenesis PCR reaction was subjected to digestion by adding 1 μl of Dpn I 
restriction enzyme (10 U/μl) and incubation for 1 h at 37 °C. The DpnI enzyme was heat 
inactivated by incubation at 80°C for 20 minutes. After this, 1 μl of this reaction was used 
for DNA transformation as described above. 
   2.6.8.      Agarose gel electrophoresis 
Agarose gel electrophoresis is a method used for separating, identifying or purifying 
DNA fragments. Typically the gels were prepared by dissolving a desired amount of 
agarose in 1xTAE buffer by boiling in a microwave for 3 minutes. Usually gels between 1 
%-2 % were used, depending on the size of the DNA fragment analyzed. For 250 ml 
agarose solution 13 μl ethidium bromide was used in order to visualize DNA. The melted 
agarose was poured into casting platform. After allowing the gel to harden at room 
temperature it was placed into an electrophoresis chamber containing 1xTAE buffer. 
DNA was prepared by mixing with 6x loading buffer and loaded on the agarose gel. 
Electrophoresis was carried out at 150 V at room temperature. DNA bands were 
visualized under a UV light transilluminator at 366 nm. 
TAE buffer (50x) 
Tris-base ..............................................242 g 
EDTA ..................................................37.2 g 
glacial acetic acid...............................57.1 ml 
filled up to 1000ml with H2O 
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Agarose, Invitrogen (Cat.No. 15510-027) 
Ethidiumbromid, Roth (Cat.No. 2218.1) 
      2.6.8.1. Extraction of DNA from agarose gels 
DNA extraction from agarose gels was performed by using QIAEX Gel Extraction Kit 
(Qiagen) according to the manufacturer´s instructions. 
QIAEX Gel Extraction Kit, Qiagen (Cat. No. 20021) 
   2.6.9.      Expression vectors 
All expression vectors in this study were generated by cloning using PCR, restriction 
enzymes or by performing site directed mutagenesis. 
Additional ubiquitin and ubiquitin mutant expressing vectors were purchased from 
Addgene. 
pRK5-HA-Ubiquitin-WT (Plasmid #17608) 
pRK5-HA-Ubiquitin-K48 (Plasmid #17605) 
pRK5-HA-Ubiquitin-K63 (Plasmid #17606) 
      2.6.9.1. RNA extraction and generation of cDNA 
Mouse fibroblasts were plated and grown to the confluence of 70-80%. The lysis and 
extraction of RNA was performed using the RNAEasy Mini Kit according to the 
manufacturer´s instructions. RNA was stored at -80˚C. 
Reverse transcription PCR was performed to obtain total cellular cDNA by using iScript 
Select cDNA Synthesis Kit according to the manufacturer´s instructions. The cDNA was 
stored at -20˚C and subsequently used for specific cDNA cloning such as cloning of the 
STUB1 (CHIP) cDNA. 
RNAEasy Mini Kit (50), Qiagen (Cat.No. 74104) 
iScript Select cDNA Synthesis Kit, BioRad (Cat.No.170-8890) 
      2.6.9.2. TOPO TA cloning 
TOPO cloning system uses the DNA topoisomerase I that functions both as the 
endonuclease and polymerase. The topoisomerase is in this case bound by a covalent 
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bond to the 3´phosphate in the pentameric sequence 5´-(C/T)CCTT-3´of the vector 
backbone. The enzyme is therefore able to ligate any DNA sequence with the vector back 
bone. At the same time the enzyme releases itself from the backbone. In this study the 
TOPO cloning was performed at room temperature for 30 min, otherwise the reaction was 
preformed according to the manufacturer’s instructions. This part of the work was carried 
out by a practical student Dennis Zimmermann. 
TOPO cloning reaction 
PCR producte………….………1 µl 
TOPO…………………………..1 µl 
salt solution……………….……1 µl 
H2O……………………….....…3 µl 
CHIP cDNA was initially amplified from the total cellular cDNA generated by reverse 
transcription PCR from fibroblast RNA using following primers:  
PCR primers 
CHIP Fwd  5'CGCCATGAAGGGCAAGGAGGAAAAG3' 
CHIP Rev  5'GGCCTCAATAGTCCTCTACCCAG3' 
Subsequently the PCR product was cloned into the TOPO TA vector backbone as 
described above. 
      2.6.9.3. CHIP-WT-pEGFP-C1 
CHIP was subcloned by excising the fragment using EcoRI enzyme and subsequently 
ligating it into the pEGFP-C1 vector. Digestion of CHIP-TOPO and pEGFP-C1 desired 
vector backbone was done for 2 h at 37°C. The vector backbone was additionally 
subjected to dephosphorylation for 30 min as described before. After the gel purification 
and extraction of linearized vector and insert of appropriate size form the agarose gel the 
ligation reaction was performed by using the Fast Link Ligation Kit as described above. 
In the reaction the ratio of insert to vector 3:1 (150 ng : 50 ng) was used. 
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      2.6.9.4. CHIP-H260Q-pEGFP-C1 
CHIP H260Q point mutation was generated by site directed mutagenesis as described 
above. The CHIP-WT-pEGFP-C1 was used as a template together with the following 
primers. 
CHIP H260Q mut Fwd 5'GGACATTGAGGAGCAACTGCAGCGTGTGGGC3' 
CHIP H260Q mut Rev 5'GCCCACACGCTGCAGTTGCTCCTCAATGTCC3' 
      2.6.9.5. CHIP-K30A-pEGFP-C1 
CHIP K30A point mutation was generated by site directed mutagenesis as described 
above. The CHIP-WT-pEGFP-C1 was used as a template together with the following 
primers. 
CHIP K30A mut Fwd5'CGAGTGCGCAAGAGCTCGCGGAGCAGGGAAACCGGC3' 
CHIP K30A mut Rev 5'GCCGGTTTCCCTGCTCCGCGAGCTCTTGCGCACTCG3' 
      2.6.9.6. CHIP-Ubox-pEGFP-C1 
The U-box domain of CHIP was subcloned by using CHIP Ubox EcoRI Fw and CHIP 
Ubox BamHI Rev primers. The CHIP-TOPO was used as a template and Herculase II 
high fidelity polymerase was used for amplification. The primers were designed so that 
they create EcoRI and BamHI restriction sites. After the PCR the reaction was ran on an 
agarose gel and PCR a product of the right size was extracted from the agarose gel as 
described above. Subsequently the extracted PCR product was subjected to digestion by 
these two enzymes allowing the formation of ``sticky ends´´ on the PCR product 
PCR primers 
CHIP Ubox EcoRI Fw 5´TGAATTCGAAGAAGCGCTGGAACAGTATCG3´ 
CHIP Ubox BamHI Rev 5´TGGATCCTCAATAGTCCTCTACCCAG3´ 
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Cloning PCR reaction 
CHIP-TOPO…………………1 µl (100µg) 
CHIP U-box EcoRI Fw….………...1.25 µl 
CHIP U-box BamHI Rev…………1.25 µl 
dNTPs…………………………....…0.5 µl 
5X buffer……………………………10 µl 
HerculaseII…………………………0. 5µl 
The reaction was performed in total volume of 50 µl by adding the H2O. Following PCR 
was performed: 
Cloning PCR 
 
 
 
 
 
 
 
 
Digestion of PCR product and 1 µl pEGFP-C1 desired vector backbone was done for 2 h 
at 37 °C. The vector backbone was additionally subjected to dephosphorylation for 30 
min as described before. After gel purification and extraction of the linearized vector 
form the agarose gel, a ligation reaction was performed by using the Fast Link Ligation 
Kit as described above. In the reaction a ratio of insert to vector 3:1 (150 ng : 50 ng) was 
used. 
      2.6.9.7. CHIP-TPR-pEGFP-C1 
TPR domain of STUB-1 was subcloned in pEGFP-C1 using CHIP TPR EcoRI Fw and 
CHIP TPR BamHI Rev primers and CHIP-WT-TOPO vector as a template. The high 
Step Time (s) Temp.(˚C) 
1 120 95 
2 30 95 
3 30 55 
4 60 72 
5 600 72 
6 ∞ 4 
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fidelity polymerase Herculase II was used in the cloning PCR reaction. The primers were 
designed so that they create EcoRI and BamHI restriction sites. After PCR the reaction 
was ran on an agarose gel and a product of the right size was extracted from the agarose 
gel as described above. Subsequently the extracted PCR product was subjected to 
digestion by these two enzymes allowing the formation of ``sticky ends´´ on the PCR 
product. 
PCR primers 
CHIP TPR EcoRI Fw 5´GAATTCGCCCTTCGCCATGAAG3´ 
CHIP TPR BamHI Rev 5´TGGATCCTCAATCATCTTCATGACCCTCG3´ 
Cloning PCR reaction 
CHIP-TOPO…………………1 µl (100 µg) 
CHIP TPR EcoRI Fw……………...1.25 µl 
CHIP TPR BamHI Rev……………1.25 µl 
dNTPs…………………………....…0.5 µl 
5X buffer……………………………10 µl 
HerculaseII…………………………0.5 µl 
The reaction was performed in total volume of 50 µl by adding the H2O. Following PCR 
was performed: 
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Cloning PCR 
 
 
 
 
 
 
 
 
Digestion of PCR product and 1 µl pEGFP-C1 desired vector backbone was done for 2 h 
at 37°C. The vector backbone was additionally subjected to dephosphorylation for 30 min 
as described before. After gel purification and extraction of linearized vector form the 
agarose gel the ligation reaction was performed by using the Fast Link Ligation Kit  as 
described above. In the reaction the ratio of insert to vector 3:1 (150 ng : 50 ng) was used. 
      2.6.9.8. CHIP-WT-pET-16b 
CHIP-WT was subcloned to pET-16b backbone by using CHIP pET XhoI Fwd and CHIP 
U-box BamHI Rw primers and CHIP-WT-TOPO vector as a template. The Taq 
polymerase was used in the cloning PCR reaction. The primers were designed so that they 
create XhoI and BamHI restriction sites. After PCR the reaction was ran on an agarose 
gel and a product of the right size was extracted from the agarose gel as described above. 
Subsequently the extracted PCR product was subjected to digestion by these two enzymes 
allowing the formation of ``sticky ends´´ on the PCR product. 
PCR primers 
CHIP pET XhoI Fwd  5' CGCTCGAGTCCTTCGCCATGAAG3' 
CHIP U-box BamHI Rw 5' TGGATCCTCAATAGTCCTCTACCCAG3' 
 
Step Time (s) Temp.(˚C) 
1 120 95 
2 30 95 
3 30 55 
4 60 72 
5 600 72 
6 ∞ 4 
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Cloning PCR reaction 
CHIP-TOPO…………………1 µl (100 µg) 
CHIP pET XhoI Fwd  ……………...1.25 µl 
CHIP U-box BamHI Rw ………...…1.25 µl 
dNTPs…………………………....…0.6 µl 
5X buffer……………………………..3 µl 
MgCl2………………………………1.2 µl 
Taq……….…………………………...1 µl 
The reaction was performed in total volume of 50 µl by adding the H2O. Following PCR 
was performed: 
Cloning PCR 
 
 
 
 
 
 
 
 
The PCR product was first cloned back to the TOPO TA vector back bone. This step was 
necessary to create a XhoI digestion site. The new construct was termed CHIP pET XhoI 
TOPO. CHIP was than subcloned to a pET-16b backbone using XhoI and BamHI 
enzymes. Digestion of CHIP pET XhoI TOPO and pET-16b vector backbones was done 
for 2 h at 37 °C. The vector backbone was additionally subjected to dephosphorylation for 
30 min as described before. After gel purification and extraction of the linearized vector 
and insert of appropriate size form the agarose gel, a ligation reaction was performed 
Step Time (s) Temp.(˚C) 
1 120 95 
2 30 95 
3 45 63 
4 60 72 
5 600 72 
6 ∞ 4 
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using the Fast Link Ligation Kit as described above. The insert to vector ratios 3:1, 2:5 
and 1:5 were used. After DNA purification from bacteria the cloning products were 
checked by EcoRV digestion. The positive clones were sent for sequencing with T7 
forward primer and T7 terminator as reverse sequencing primer. 
      2.6.9.9. CHIP-H260Q-pET-16b 
The same mutagenesis primers and protocol as for CHIP H260Q pEGFP-C1 was used to 
create H260Q mutation in the CHIP-H260R-pET-16b. The positive clones were 
confirmed by sequencing with T7 forward primer and T7 terminator as reverse 
sequencing primer. 
      2.6.9.10. ILK-K341R-3XFlag-pCLMFG 
ILK K341R point mutation was generated by site directed mutagenesis as described 
above. The ILK-3XFlag-pCLMFG cloned by Carsten Grashoff was used as a template 
together with the following primers. 
ILK K341R A1022G Fw 
5´GAATCAGCATGGCTGATGTTAGGTTTTCTTTCCAGTGCCCTGGG3´ 
ILK K341R A1022G Rv 
5´CCCAGGGCACTGGAAAGAAAACCTAACATCAGCCATGCTGATTC3´ 
The constructs were confirmed by sequencing as described above using following 
primers: 
S_E fw 5´CATGCACTCAATAGCCGCAG3´ 
S_E rv 5´CTCCACATGTCTGCTGAGCG3´ 
 
      2.6.9.11. ILK-K341R-3xFlag-pCMV-14 
ILK K341R point mutation was generated by site directed mutagenesis as described 
above. The ILK-3XFlag-pCMV14 cloned by Carsten Grashoff was used as a template 
together with the following primers. 
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ILK K341R A1022G Fw 
5´GAATCAGCATGGCTGATGTTAGGTTTTCTTTCCAGTGCCCTGGG3´ 
ILK K341R A1022G Rv 
5´CCCAGGGCACTGGAAAGAAAACCTAACATCAGCCATGCTGATTC3´ 
The constructs were confirmed by sequencing as described above using following 
primers: 
S_E fw 5´CATGCACTCAATAGCCGCAG3´ 
S_E rv 5´CTCCACATGTCTGCTGAGCG3´ 
      2.6.9.12. ILK-K341R-pEGFP-C1 
ILK K341R point mutation was generated by site directed mutagenesis as described 
above. The ILK-pEGFP-C1 cloned by Dr. Sara Wickström was used as a template 
together with the following primers. 
ILK K341R A1022G Fw 
5´GAATCAGCATGGCTGATGTTAGGTTTTCTTTCCAGTGCCCTGGG3´ 
ILK K341R A1022G Rv 
5´CCCAGGGCACTGGAAAGAAAACCTAACATCAGCCATGCTGATTC3´ 
The constructs were confirmed by sequencing as described above using following 
primers: 
S_E fw 5´CATGCACTCAATAGCCGCAG3´ 
S_E rv 5´CTCCACATGTCTGCTGAGCG3´ 
      2.6.9.13. ILK -pHAGE2-CMV-eGFP-W-mU6 
ILK was subcloned in pHAGE-CMV_eGFP-W-mU6, a gift from Dr. Marc Schmidt-
Supprian, using ILK BsmBI Fwd and ILK NotI Rev primers and ILK-3XFlag-pCMV14 
as a template. Herculase II high fidelity polymerase was used for amplification. The 
primers were designed so that they create BsmBI and NotI restriction sites. After the PCR 
the reaction was ran on an agarose gel and PCR a product of the right size was extracted 
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from the agarose gel as described above. Subsequently the extracted PCR product was 
subjected to digestion by these two enzymes allowing the formation of ``sticky ends´´ on 
the PCR product 
PCR primers 
ILK BsmBI Fwd 5´ ATCGTCTCACTGACATGGACGACATTTTCAC 3´ 
ILK NotI Rev 5´ ATGCGGCCGCCTTGTCCTGCAT 3´ 
Cloning PCR reaction 
CHIP-TOPO…………………1 µl (100µg) 
ILK BsmBI Fwd ….……….……...1.25 µl 
ILK NotI Rev …………………..…1.25 µl 
dNTPs…………………………....…0.5 µl 
5X buffer……………………………10 µl 
HerculaseII…………………………0. 5µl 
The reaction was performed in total volume of 50 µl by adding the H2O. Following PCR 
was performed: 
Cloning PCR 
 
 
 
 
 
 
 
 
Step Time (s) Temp.(˚C) 
1 120 95 
2 30 95 
3 30 55 
4 120 72 
5 600 72 
6 ∞ 4 
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Digestion of PCR product and 1 µl pHAGE-CMV-eGFP-W-mU6 desired vector 
backbone was done for 2 h at 37 °C. The vector backbone was additionally subjected to 
dephosphorylation for 30 min as described before. After gel purification and extraction of 
the linearized vector form the agarose gel, a ligation reaction was performed by using the 
Fast Link Ligation Kit as described above. In the reaction a ratio of insert to vector 3:1 
(150 ng : 50 ng) was used. 
      2.6.9.14. ILK-K341R-pHAGE2-CMV-eGFP-W-mU6 
ILK K341R point mutation was generated by site directed mutagenesis as described 
above. The ILK -pHAGE2-CMV-eGFP-W-mU6 was used as a template together with the 
following primers. 
ILK K341R A1022G Fw 
5´GAATCAGCATGGCTGATGTTAGGTTTTCTTTCCAGTGCCCTGGG3´ 
ILK K341R A1022G Rv 
5´CCCAGGGCACTGGAAAGAAAACCTAACATCAGCCATGCTGATTC3´ 
The constructs were confirmed by sequencing as described above using following 
primers: 
S_E fw 5´CATGCACTCAATAGCCGCAG3´ 
S_E rv 5´CTCCACATGTCTGCTGAGCG3´ 
 
2.7. Microscopy 
    2.7.1.      Confocal microscopy 
Confocal images were collected by using a confocal microscope (Leica DMIRE2) with 
100x oil objectives at RT. Leica Confocal Software (version 2.5 Build 1227) was used for 
image acquisition and evaluation. 
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    2.7.2.      Live-cell microscopy 
Live cells were recorded using a Zeiss Axiovert 40C microscope equipped with a CCD 
camera (Prosilica, GC2450). The stage was supplied with 4,7% CO2 and heated at 37˚C. 
FireWire software (Molecular Devices, Downingtown, PA) was used for image 
acquisition as well as the microscope control. 
    2.7.3.     Fluorescence recovery after photobleaching (FRAP) in 1D 
Fluorescence recovery after the photobleaching is an optical technique used for 
quantifying the diffusiveness of proteins in the cell membrane or cytoplasm (Carman 
2012). Shortly, a defined region is photo-bleached and the movement of unbleached 
molecules from the surrounding environment is monitored over time (Fig. 2.1.). The 
movement of the molecules observed is defined by two major components: diffusion and 
interaction with other molecules. There are two important parameters that can be 
calculated by this method the diffusion coefficient and the mobile fraction of the 
molecule (Mf). Diffusion coefficient is the rate by which molecules move in and out of 
the monitored region and mobile fraction is the percentage of the molecules that undergo 
detectable movement (Carman 2012). 
 
Figure 2.1. Fluorescence recovery after photobleaching (FRAP). (a) Graphic 
representation of fluorescent area of the cell (green) and bleached region (white) and the 
recovery of the florescence over time. (b) Typical intensity profile measured by FRAP. 
The saturation point of the curve (plateau) allows the calculation of the mobile fraction of 
the fluorescent molecule. Diffusion coefficient is calculated from the recovery curve 
(Carman 2012) .  
Materials and Methods 
80 
 
 
In this particular setup cells were seeded and allowed to spread for 90 min on glass-
bottom dishes with 2,5 µm-line micropatterns functionalized with fibronectin. Bleaching 
was performed with a 405 nm laser for 3x100 ns. Images were captured with an Axiovert 
200 (Zeiss) microscope, a CSU10 spinning-disc confocal scanhead (Yokogawa), and a 
Cascade II EMCCD camera (Photometrics), with a 100× oil objective. Images were 
collected at 37°C, 5% CO2. Acquisition was controlled by Metamorph Software 
(Molecular Devices). Images were collected before, directly after and during recovery of 
bleaching with a rate of 1 frame/2 s in the first minute and 1 frame/20 s for the additional 
39 min. Recovery after bleaching was calculated as described previously (Tagawa, 
Mezzacasa et al. 2005). Briefly, fluorescent intensity (I) was measured from the three 
independent unbleached areas as well as the bleached area before bleaching (=I[0]) and 
during recovery (=I[t]). Relative fluorescent intensity (RI) was then calculated according 
to the following equation RI=(Itotal[0]/Ibleached[0]) x (Ibleached[t]/Itotal[t]). Unspecific bleaching 
during image acquisition is corrected in this equation. All measured intensities were first 
divided by the average intensity of the three background areas before their use in the RI 
equation. This allowed the additional correction for the background intensity fluctuation. 
The sampled data was analyzed by nonlinear regression fitting. The fitted curves allowed 
the extraction of the important parameters such as half time ( 1/2) and mobile and 
immobile fraction of the protein (Mf, If) 
2.8. Statistical Analysis 
Statistical analyses were performed using GraphPad Prism software (GraphPad, version 
5.0). Statistical significance was determined by the Mann-Whitney U-test, with the 
exception of Figs. 3.2.5. and 3.2.6., where analysis of variance (Two-way ANOVA) in 
combination with a post-hoc Bonferrony test was used, and Figs. 3.2.3., where analysis of 
variance (one-way ANOVA) followed by Tuckey´s posttest was usedand 3.2.4. where a 
paired t-test was used. Normal distribution of data was confirmed with the Kolomogorov-
Smirnov test (alpha=0.05). 
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3. Results 
3.1. ILK is posttranslationally modified by ubiquitin 
ILK is a central scaffolding element of 1 and 3 integrin containing focal adhesions 
(Hannigan, Leung-Hagesteijn et al. 1996). Taken that ILK regulates many cellular 
functions such as cell spreading, migration and proliferation (Sakai, Li et al. 2003) this 
study sought to investigate the mechanisms of ILK turnover and its effect on cellular 
behavior. As ubiquitination is one of the most common posttranslational modifications 
involved in regulation of a wide range of cellular processes like protein degradation, 
DNA repair, transcription, signal transduction, endocytosis and sorting (Welchman, 
Gordon et al. 2005), modification of ILK by ubiquitin was investigated. To this end, 
denaturing immunoprecipitation assays were performed followed by mass spectrometry 
using a cell line stably expressing ILK-Flag. This cell line was generated from ILK fl/fl 
fibroblasts that were isolated from the adult kidney of ILK fl-fl mice. The floxed ILK 
allele was deleted by infecting the cells with adenoviral Cre to yield ILK -/- cells. ILK-
Flag cells were then generated as a rescue cell line re-expressing a Flag-tagged ILK by 
stabile integrating pCLMFG retrovirus in ILK-/- fibroblasts as described in the Materials 
and Methods section. The parental ILK fl/fl cell line, expressing ILK but lacking the Flag 
tag, was used as a negative control in the immunoprecipitation assays. The principle of 
this assay is to denature the protein lysate abolishing all protein-protein interactions but 
retaining covalent modifications. In addition, enzymes that might remove these 
modifications are inactivated by denaturation as well. Subsequently an 
immunoprecipitation reaction is performed to isolate the protein of interest, after which 
the posttranslational modifications such as ubiquitination can be identified using western 
blot or mass spectrometry analysis. 
Taken that deubiqutinases are potent enzymes, all buffers used in the in vivo 
ubiquitination assay were supplemented with 25 mM N-Ethymaleimid (NEM), a 
deubiquitinase inhibitor, in order to prevent loss of this covalent modification during the 
course of the assay. Lysis of the adherent cells was performed in a denaturing buffer 
containing 1 % SDS and immediately boiled at 95 ˚C for 5 min for additional inhibition 
of deubiquitinase enzymes and denaturation of protein complexes. The lysates were 
Results 
82 
 
diluted in a 1:10 ratio in non-denaturing buffer containing Triton-X 100, leading to the 
sequestration of SDS in micelles. This allowed the immunoprecipitation assay to be 
performed without SDS negatively affecting the antibody-antigen interaction. Anti-FLAG 
M2 affinity gel from Sigma was used to perform the ILK-Flag immunoprecipitation. In 
this system a FLAG M2 antibody is covalently attached to agarose resin. Bound proteins 
are subsequently eluted using a competitive elution with excess of Flag peptide, 
circumventing the uncoupling of high amounts of IgGs. This is crucial, as ILK has similar 
molecular weight as the IgG heavy chain and it is difficult to resolve them in a SDS 
polyacrylamide gel, which can make consequent analysis of ILK immunoprecipitates 
difficult. Immunoprecipitates were resolved with SDS-PAGE after which silver stain was 
performed revealing a putative ILK band at approximately 50 kDa size as well as 
additional bands of higher molecular weights (Fig.3.1.1.). The indicated bands were 
analyzed by mass spectrometry, revealing that also the higher molecular weight bands 
contained ILK. This suggested that ILK is posttranslationally modified, leading to an 
increase in molecular weight.  
                                                 
Figure 3.1.1. Silver staining from immunoprecipitates of ILK-FLAG expressing 
fibroblasts. ILK fl/fl cells were used as a negative control. Arrows indicate bands 
analyzed by mass spectrometry. ILK and ubiquitin was identified from all bands 
analyzed. Gly-gly modification of K341 on ILK was detected in the band marked with an 
asterisk. 
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In addition, a glycine-glycine (Gly-Gly) modification on lysine 341 of ILK was identified 
(Fig 3.1.1, band marked by asterisk). Analysis by mass spectrometry requires the 
digestion of proteins into smaller peptides by trypsin. Trypsin is an endopeptidase able to 
cleave only the peptide bonds in which the carbonyl group is contributed either by an Arg 
or Lys residue. Although the ubiquitin is covalently attached to a target protein it is also 
cleaved into small peptides by trypsin leaving behind only a Gly-Gly dipeptide. However, 
other small protein modifiers such as SUMO leave the same signature mark therefore 
cannot be distinguished from ubiquitin only by mass spectrometry. Therefore this result 
demonstrated that ILK is modified posttranslationally and that this modification could be 
attachment of ubiquitins or ubiquitin-like molecules 
To confirm the result from mass spectrometry analysis and to determine if the 
posttranslational modification detected is ubiquitination, an in vivo ubiquitination assay 
was performed, followed by western blot analysis. This assay is based on the denaturing 
immunoprecipitation method described above. For this, CHO cells were transfected with 
ILK-Flag (ILK-3xFlag-pCMV14) and HA-ubiquitin, whereas the control cells were 
transfected by either HA-ubiquitin only or ILK-Flag only. 
                                           
Figure 3.1.2.Western blot analysis of Flag immunoprecipitates from CHO cells 
expressing HA-tagged ubiquitin, ILK-Flag or both. Ubiquitination of ILK is detected by 
both HA and ILK antibody. 
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Immunoprecipitation was performed as described above. After the elution with Flag 
peptide immunoprecipitates were analyzed by western blot. The immunoblot with HA 
antibody revealed a typical ladder band pattern derived from polyubiquitin chains of 
different length covalently attached to the target protein (Fig.3.1.2.). As the control 
transfected only with HA-ubiquitin gave no signal, one can conclude that the 
ubiquitination pattern arises from the specific modification of ILK. The immunoblot with 
ILK antibody revealed a ladder pattern of ILK-Flag both with and without HA-ubiquitin 
expression. This demonstrated that ILK can be ubiquitinated by endogenous ubiquitin and 
that this can be enhanced by over-expression of HA-ubiquitin. 
The ubiquitin molecule contains 7 lysine residues that can serve as ubiquitination sites for 
formation of polyubiquitin chains. Cells use various ubiquitin linkage patterns to 
differentially control signaling pathways (Behrends and Harper 2011). The most common 
polyubiquitin chains are the K48- K63-linked chains (Hochstrasser 2009; Behrends and 
Harper 2011). In order to determine the type of polyubiquitin chain attached to ILK, an in 
vivo ubiquitination assay was performed using ILK-Flag fibroblasts transiently 
transfected with wild type (wt) ubiquitin HA (pRK5-HA-Ubiquitin-Wt, Addgene), or 
alternatively with ubiquitin mutants containing a single lysine, either only K48 or only 
K63 (pRK5-HA-Ubiquitin-K48, pRK5-HA-Ubiquitin-K63). ILK fl/fl cells and ILK-Flag 
cells mock transfected with the empty vector were used as controls for the 
immunoprecipitation and transient transfection, respectively. The ubiquitin constructs 
were expressed for 24 h, after which an in vivo ubiquitination assay was performed as 
described above. The immunoprecipitates eluted with Flag peptide were resolved by 
SDS-PAGE and subsequently analyzed by western blot. Immunoblotting with antibodies 
against HA and Flag epitopes were then performed, detecting either ubiquitin or ILK, 
respectively.  
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Figure 3.1.3. Western blot analysis of Flag immunoprecipitates from ILK -/- fibroblasts 
expressing ILK-Flag and HA-tagged ubiquitin or ubiquitin mutants containing a single 
lysine K48 or K63. Both K48- and K63-linked ubiquitin chains are detected. 
The analysis of the Flag immunoblot revealed the typical ladder pattern of ILK bands 
indicative of posttranslational modifications (Fig3.1.3.). In addition, the HA immunoblot 
confirmed that this modification is indeed ubiquitination. Furthermore there was no 
significant difference in ILK ubiquitination between K48 and K63 HA-ubiquitin 
expressing cells leading to the conclusion that ILK is modified by both K48- and K63-
linked polyubiquitin chains. 
The mass spectrometry analysis had shown that the lysine K341 on ILK is ubiquitinated. 
In order to verify this and to assess whether this ubiquitin is indispensible for 
ubiquitination of ILK, fibroblasts expressing a mutant ILK containing a lysine 341 to 
arginine mutation were subjected to in vivo ubiquitination assays. By performing a site 
directed mutagenesis PCR using wt ILK-Flag as a template, lysine 341 was mutated to 
arginine as described in the Materials and Methods section. This amino acid change 
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abolished the possibility of a covalent isopeptide linkage of the ubiquitin C terminus to 
the -amino group of this lysine in the substrate (Kerscher, Felberbaum et al. 2006), but 
maintained the charge of the amino acid.  
In vivo ubiquitination assays were subsequently performed with ILK-/- fibroblasts 
transiently transfected with either ILK-Flag or ILK-K341R-Flag constructs. The parental 
ILK fl/fl cell line was used as a negative control. The immunoprecipitates eluted by Flag 
peptide were resolved by SDS-PAGE and analyzed by immunoblotting. Analysis of 
immunoblots using either an anti-ubiquitin antibody or an anti-Flag antibody showed 
absence of a ubiquitination ladder pattern in ILK-K341R-Flag expressing fibroblasts 
compared to the ILK-Flag expressing fibroblasts. This suggested that the K341 is a major 
ubiquitination site in ILK. In addition, both immunoprecipitates contained similar levels 
of ubiquitin confirming that overall ubiquitination in both cell types was unchanged 
(Fig.3.1.4.).  
 
Figure 3.1.4. Western blot analysis of Flag immunoprecipitates from ILK -/- fibroblasts 
expressing ILK-Flag or ILK-K341R. Ubiquitin and ILK-Flag immunoblots show major 
difference in detected ubiquitination. 
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3.2. K341R mutation leads to migration defects in fibroblasts  
Absence of ILK leads to a severe migration defect in fibroblast (Sakai, Li et al. 2003) It 
was therefore of interest to investigate if the ubiquitination of ILK a K341 is relevant in 
this process.  To investigate the influence of ubiquitination of ILK on migration, stable 
cell lines expressing ILK-GFP and ILK-K341R-GFP were generated by lentiviral 
transduction and subsequent FACS sorting for GFP expressing cells. The ILK-GFP, ILK-
K341R GFP and GFP only expressing ILK-/- control cells were sorted for comparable 
expression levels of GFP. Immunofluorescence staining for paxillin and actin could 
confirm that both ILK-GFP and ILK-K341R GFP localize to focal adhesions and rescue 
actin organization defect of ILK -/- cells (Fig. 3.2.1.).  
 
 
Figure 3.2.1. Immunofluorescence analysis of fibroblasts expressing either ILK-GFP or 
ILK-K341R GFP. Paxillin staining was used to confirm the localization of ILK to FAs. 
Phalloidin staining shows no difference in actin cytoskeleton between two cell lines. 
The ability of ILK-GFP, ILK-K341R GFP as well as GFP ILK-/- fibroblasts to migrate 
within a 3-dimensional (3D) collagen matrix was analyzed by embedding the fibroblasts 
in collagen gels as previously described (Lammermann, Bader et al. 2008). The gels were 
casted in self-made chambers and allowed to settle for 30 min at 37 ˚C and 4.5 % CO2. 
The migration process was imaged as described in Materials and Methods by Zeiss 
Axiovert 40C microscope equipped with a CCD camera (Prosilica, GC2450) and a heated 
stage (37˚C) supplied with 4,7 % CO2. Image acquisition was performed using FireWire 
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software (Molecular Devices, Downingtown, PA). Migrating cells were subsequently 
tracked using the Chemotaxis and Migration tool of ImageJ software (Fig.3.2.2.).  
 
 
Figure 3.2.2. Representative plots of migration tracks demonstrating reduced migration 
of ILK-K341R GFP and ILK-/- control fibroblast expressing only GFP compared to ILK-
GFP cells. 
The migration distance and velocity was quantified from the live cell imaging data using 
ImageJ software (Fig.3.2.3.).  The statistical significance was analyzed using the 
GraphPad Prism software by performing an ANOVA test followed by a Tucky post-hoc 
test. The quantifications demonstrate that the migration velocity and distance of ILK-
K341R fibroblasts was significantly decreased compared to ILK-GFP control. The 
migration velocity and distance of ILK-K341R fibroblasts were comparable to ILK-/- 
cells.  This led to the conclusion that mutation of K341 impairs fibroblast migration.  
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Figure 3.2.3. Quantitative representation of velocity and distance differences between 
ILK-GFP, ILK-K341R GFP and ILK-/- cells. The ANOVA followed by Tuckey´s post test 
was performed. Data is expressed as mean  SEM. n=6; ***p<0.0001; ns=not 
significant. 
3.2.1.      K341R mutation leads to the reduced mobile fraction of ILK protein 
measured by FRAP 
To further clarify potential mechanism of impaired migration of ILK-K341R expressing 
fibroblasts, the turnover of ILK-GFP and ILK-K314R-GFP protein in FAs was analyzed. 
For this, florescence recovery after photo bleaching (FRAP) was used. Usually, the cells 
investigated by this approach are seeded on a 2-dimentional (2D) glass bottom cell 
culture dishes. However, in this study it was observed that ILK-K341R-GFP cells display 
a defect in migration within 3D collagen matrix. As performing FRAP analysis in a 3D 
collagen matrix would be technically difficult, a 1D approach was used. This was chosen 
as it has been reported by Doyle et al. that 1D topography mimics  migration phenotypes 
observed in fibrillar 3D cell-derived matrices (Doyle, Wang et al. 2009). Firstly, behavior 
of ILK-GFP and ILK-K341R GFP fibroblasts on 1D micropatterns was investigated to 
confirm similar migratory behavior as in 3D collagen matrix. To this end cells were 
seeded on micropatterned 2,5 µm lines functionalized by fibronectin. The cells were kept 
in 1% FCS containing DMEM to prohibit serun-derived fibronectin from attaching to the 
coverslip. The migration of the cells was observed and recorded by a Zeiss Axiovert 40C 
microscope equipped with a CCD camera (Prosilica, GC2450) and heated stage (37˚C) 
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supplied with 4,7% CO2, as described in Materials and Methods. Quantification of cell 
migration on 1D fibronectin-coated micropatterns was the performed, and this assay 
could recapitulate the migration defect observed in 3D (Fig. 3.2.4.).  
                      
 
Figure 3.2.4. Quantitative representation of velocity and distance differences between 
ILK-GFP, ILK-K341R GFP. The paired T-tests were performed. Data is expressed as 
mean  SEM. n=3; **p=0.009  
The FRAP analysis of the ILK turnover in FAs was performed by seeding cells on 
fibronectin-functionalized micropatterned lines of 2.5 µm width in DMEM supplemented 
by 1% FCS. The cells were allowed to attach and spread for 90 min before starting the 
analysis. As this assay was performed in a 1D environment it was termed 1D FRAP 
analysis. Imaging was performed using an Axiovert 200 (Zeiss) microscope, a CSU10 
spinning-disc confocal scanhead (Yokogawa), and a Cascade II EMCCD camera 
(Photometrics), with a 100× oil objective. Images were collected at 37°C, 5% CO2, and 
controlled by Metamorph Software (Molecular Devices). Bleaching was performed with a 
405 nm laser for 3x100 ns. Images were collected before, directly after and during 
recovery from bleaching with a rate of 1 frame/2 s for the first minute after bleaching and 
1 frame/20 s for additional 39 min. Recovery after bleaching was calculated as described 
previously (Tagawa, Mezzacasa et al. 2005) according to the equation 
RI=(Itotal[0]/Ibleached[0]) x (Ibleached[t]/Itotal[t]) that allows the correction for unspecific bleaching 
of the cells during the course of imaging. The fluorescent intensity (I) was measured from 
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three separate unbleached control regions as well as the bleached area before bleaching 
(=I[0]) and during recovery (=I[t]) by use of Metamorph Software. Average intensity per 
area was used. All measured intensities were first divided by the average intensity of the 
three background areas before their use in the RI equation. This allowed the additional 
correction for background intensity fluctuation that can occur during imaging. The 
observation was made that overall dynamics of the FA turnover is changed in 1D 
comparing to 2D as seen by prolonged halftime when compared to previous studies of FA 
protein dynamics. The reported recovery rates of FA proteins are in the range of few 
minutes and depend on the proximity of the observed protein either to integrin (slower 
recovery) or actin (faster recovery) (Wehrle-Haller 2007; Lele, Thodeti et al. 2008; 
Wolfenson, Lubelski et al. 2009). Nonlinear regression analysis of the results gave the 
best fit for the sampled data. This allowed the calculation of the recovery rate and mobile 
and immobile fractions (Mf, If) of the protein. Comparison of these parameters for wt ILK 
and K341R ILK protein showed no difference in the overall recovery rates but 
interestingly a difference in the Mf and If of the proteins. The results showed that K341R 
mutant ILK has a reduced Mf (Mf=0,483) in FAs compared to the wt ILK protein 
(Mf=0,735) (Fig. 3.2.5.). 
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Figure 3.2.5. FRAP analysis of ILK-GFP and ILK-K341R GFP. (A) Stills showing 
morphology of fibroblasts and FAs on 1D micropattern at different points of the FRAP 
analysis. (B)The recovery curves calculated form recorded data. The solid smooth lines 
represent the best fit curves of a nonlinear regression analysis. The ANOVA with 
Bonferrony-post test was performed. Data is expressed as mean  SEM. n=9; 
***p<0.0001 
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   3.2.2.      K341R mutation leads to disturbed clathrin mediated internalization of 
ILK protein in FAs 
It has been demonstrated that integrin and ILK recycling within the myotendinous 
junction of D.melanogaster depends on clathrin-mediated endocytosis and the Rab5 
GTPase (Yuan, Fairchild et al. 2010). In order to address whether the altered turnover of 
K341R ILK observed in the FRAP analysis was due to altered endocytosis. Additional 
FRAP asssays were performed in the presence of the Chlorpromazine (CPZ), a inhibitor 
of clathrin-mediated endocytosis. The analysis was performed as described above, after 
which data was fitted using nonlinear regression and the Mf of ILK in cells treated with 
CPZ was calculated. The comparison of the results showed that Mf of K341R mutant ILK 
(Mf=0,552) was unchanged in CPZ treated cells as compared to untreated cells 
(Mf=0,483). However, the Mf of wt ILK was drastically reduced in CPZ treated cells 
(Mf=0,481) compared to the untreated cells (Mf=0,735). The results also showed that 
there was no significant difference between Mf of wt ILK protein in CPZ-treated cells 
compared to the K341R mutant ILK protein in untreated cells. This led to the conclusion 
that ubiquitination of ILK at K341 might be important for the clathrin-mediated 
endocytosis of the ILK protein. 
T  
Figure 3.2.6. FRAP analysis of ILK-GFP and ILK-K341R GFP in presence of CPZ. The 
recovery curves calculated form recorded data. The solid smooth lines represent the best 
fit curves of a nonlinear regression analysis. The ANOVA with Bonferrony-post test was 
performed. Data is expressed as mean  SEM. n=7; ***p<0.0001 
Results 
94 
 
The initial in vivo ubiquitination assays showing reduced ubiquitination of ILK in the 
K341R mutant was performed in ILK -/- cells that were transiently transfected with wt or 
K341R ILK. However, the migration and FRAP assays were preformed in stable cell 
lines where the expression levels of wt and mutant ILK were accurately adjusted. 
Therefore additional in vivo ubiquitination assays wete performed using a stable cell line 
generated by transduction of a pCLMFG retrovirus expressing either wt ILK-Flag or ILK-
K341R-Flag. Using these stable cell lines as well as the parental ILK fl/fl cell line as a 
negative control, an in vivo ubiquitination assay was performed. 
                                              
Figure 3.2.7. Western blot analysis of Flag immunoprecipitates from ILK -/- fibroblasts 
expressing ILK-Flag or ILK-K341R. Ubiquitin and ILK-Flag immunoblot show no major 
difference in detected ubiquitination. 
The immunoprecipitates eluted by Flag peptide were resolved by SDS-PAGE and 
analyzed by immunoblotting. Analysis of immunoblots using either an anti-ubiquitin 
antibody or an anti-Flag antibody unfortunately showed that the ubiquitination ladder 
pattern is unaffected by the K341R mutation. In addition, both immunoprecipitates 
contained similar levels of ubiquitin (Fig.3.1.4.). This allowed the conclusion that 
ubiquitination of the ILK-K341R-Flag mutant is comparable to wt ILK-Flag, implying 
that the K341 is dispensable for ubiquitination of ILK in stable cell lines. This finding 
opposes the previous experiments in this study performed using transient transfection. 
However, this finding is in line with numerous previous studies showing that lysine 
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residues are usually dispensable for ubiquitination and that ubiquitin chains can be 
assembled on various lysine residues within target proteins (Kundrat and Regan 2010). 
3.3. ILK interacts with the E3 ligase CHIP 
After confirming that ILK is modified by ubiquitination, further studies on the role of this 
posttranslational modification were performed. First, an experiment to identify novel 
interacting partners that might be involved in the ubiquitination of ILK was carried out. 
To this end co-immunoprecipitation experiments using the Flag affinity tag were 
performed. These experiments were performed using ILK-Flag cells that were compared 
to ILK fl/fl cells as a negative control and K341R-Flag cells to assess whether K341 is 
involved in specific protein-protein interactions. After in-solution tyrosine digestion the 
co-immunoprecipitates were analyzed by mass spectrometry. The immunoprecipitates 
were performed in biological triplicates and quantitative analysis of the precipitates was 
performed using a label-free method based on spectral comparison (Lee, Kwon et al. 
2011). As shown in Fig.3.3.1. the mass spectrometry analyses identified known major 
interacting partners of ILK such as PINCH-1, α and β parvin as well as RSU-1, 
confirming the validity of this assay. No specific binding partners involving K341 were 
identified. Interestingly, however, the analyses revealed significant binding to a 
chaperone complex consisting of Hsp70, Hsp90, Dnaja1 and Dnaja2, Bag2, as well as the 
E3 ligase CHIP (C terminus of Hsp70 interacting protein or Stub 1). CHIP is an E3 ligase 
involved in protein quality control. It contains a tetratricopeptide (TRP) motif important 
for the interaction with Hsp70 and Hsp90 and a U-box domain with ubiquitin ligase 
activity (Murata, Chiba et al. 2003). Through its interaction with molecular chaperones 
CHIP is involved in the decision of whether the misfolded proteins enter degradation or 
refolding pathway (McDonough and Patterson 2003).   
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Figure 3.3.1. Quantification of peptides co-precipitated with ILK-Flag. High ILK-Flag to 
ILK fl/fl ratio indicates specific binding. Identified components of the IPP complex and 
the novel interaction partners CHIP, Hsp90 and Hsp70 are highlighted in red. 
To further confirm the interaction between ILK and CHIP, Flag co-immunoprecipitation 
assays was carried out in wt ILK-Flag cells, using both ILK-/- and ILK fl/fl cells as 
negative controls. After the Flag peptide elution the immunoprecipitates were resolved 
with SDS-PAGE and analyzed by western blot. 
                                      
Figure 3.3.2. Flag pull-down from ILK -/- fibroblasts expressing ILK-FLAG. CHIP is 
detected in the ILK immunoprecipitate. 
Immunoblotting using an anti-ILK antibody confirmed the success of the IP. In addition 
immunoblotting using an anti-CHIP antibody showed that endogenous CHIP co-
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precipitated with ILK-FLAG (Fig.3.3.2.). This corroborated our previous mass 
spectrometry result showing that CHIP is a novel interaction partner of ILK. 
In order to characterize the interaction of ILK and CHIP in more detail, mapping of the 
interacting region within CHIP was carried out. To this end CHIP cDNA was cloned from 
fibroblast RNA using reverse transcription and subsequently subcloned into the pEGFP-
C1 vector allowing a N-terminal EGFP-CHIP fusion protein to be expressed. CHIP was 
cloned from mouse fibroblast cDNA generated from total RNA by PCR using CHIP-
specific primers. Next, CHIP cDNA was cloned into the TOPO vector from which it was 
consequently subcloned into the pEGFP-C1 backbone using restriction enzymes. The 
TPR and Ubox domains of CHIP were cloned into EGFP-C1 vector by performing PCR 
with specific primers followed by restriction enzyme cloning. There are two point 
mutations of CHIP that have been reported to be relevant for its function. Mutation of 
lysine 30 to alanine (K30A) abolishes the interaction of CHIP with its major interacting 
partner hsp70, whereas the mutation of histidine 260 to glutamine (H260Q) abolishes the 
E3 ligase activity (Dai, Zhang et al. 2003; Murata, Chiba et al. 2003; Zhou, Fernandes et 
al. 2003; Zhang, Windheim et al. 2005). These two mutants of CHIP were cloned by 
performing site directed mutagenesis using the CHIP-WT-pEGFP-C1 as a template.  
 
Figure 3.3.3. Schematic illustration of various EGFP-CHIP constructs.  
All EGFP-CHIP constructs (Fig. 3.3.3.) were transiently transfected into the ILK fl/fl cell 
line. After allowing the fusion proteins to be expressed for the 24 h, the cells were lysed 
and subjected to co-immunoprecipitation analysis. Here the µMACS GFP Isolation Kit 
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from Milteyi Biotec containing a GFP antibody covalently coupled to magnetic 
MicroBeads was used. This allows efficient immunoprecipitation without interference of 
the IgG heavy chain. The immunoprecipitates were resolved on an SDS-PAGE and 
analyzed by western blot. The immunoblotting was done using anti-ILK and anti-CHIP 
antibodies. The analysis revealed a strong ILK band in the immunoprecipitates from cells 
expressing the Ubox of CHIP (Fig. 3.3.4.). This indicated that ILK interacts with the 
Ubox domain of CHIP. Interestingly more ILK was co-precipitated with CHIP-Ubox than 
CHIP-WT. This can be explained by the asymmetric structure of the CHIP dimer in 
which only one of the Ubox domains is available for the interactions, while the other is 
masked by the TPR domain (Schulman and Chen 2005). Furthermore, the H260Q 
mutation did not affect the interaction of CHIP with ILK, indicating that the catalytic 
activity of CHIP is not a requirement for this interaction. Interestingly, although ILK did 
not co-precipitate with the TPR domain, the K30A point mutation that was generated in 
the TPR domain of full length CHIP abrogated ILK binding.  This is probably due to the 
loss of interaction of CHIP with hsp70, indicating that hsp70 might stabilize the 
interaction between ILK and CHIP (Pratt, Morishima et al. 2010). 
 
 Figure 3.3.4. GFP-pull down from fibroblasts expressing EGFP-CHIP or mutants. ILK 
is detected in immunoprecipitates of full length EGFP-CHIP and EGFP-Ubox. K30A 
mutation of CHIP abrogates ILK binding. 
To investigate whether the interaction between ILK and CHIP is direct, an in vitro 
binding assay was carried out using recombinant proteins. To this end CHIP-WT was 
subcloned into the pET-16b backbone vector allowing bacterial expression of His-tagged 
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CHIP-WT protein. BL21 E.coli strain was transformed with CHIP-WT-pET-16b 
construct and after IPTG induction bacterial cells were lysed and His-CHIP was purified 
using HisPur Cobalt NTA resin from Thermo Scientific. The success of induction and 
purity of the recombinant protein was confirmed by running the samples on an SDS-
PAGE and performing a Coomassie staining (Fig.3.3.5.). The purification of recombinant 
CHIP-WT protein was successful, giving a yield of 12 µg/µl, as measured by BCA assay. 
                                                 
Figure 3.3.5. Coomassie stained SDS polyacrylamide gel showing the bacterial lysate 
before and after the induction of CHIP-His expression by 1mM IPTG as well as the 
purified protein. 
Next, 5 µg of recombinant His-CHIP-WT and recombinant ILK-Myc/DDK (expressed in 
HEK293 cells, purchased from OriGene) were incubated in His pull down buffer 
containing 20 mM imidazole for blocking unspecific binding to the resin. After 
incubation at 25 ˚C for 2 h in an end-over shaker, the cobalt NTA resin was added and 
incubation was carried out for an additional 2 h. ILK without CHIP-WT protein was used 
as a control. After elution of the resin with 200 mM imidazole, the eluate was resolved by 
SDS-PAGE and analyzed by western blot. Immunoblotting with an anti-CHIP antibody 
revealed a strong band corresponding to CHIP in the reaction containing both CHIP and 
ILK, but no CHIP staining was detectable in the ILK only control reaction (Fig.3.3.6.). 
This indicated that that the pull down was successful and specific for His-tagged CHIP. 
The immunoblot with an anti-ILK antibody showed a band corresponding to ILK in the 
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reaction containing both ILK and CHIP, but no band was visible in the ILK only control 
pull down. This indicated that there is a direct interaction between ILK and CHIP. 
However, the levels of ILK pulled down in this reaction were relatively low, implicating 
that the presence of additional proteins could strengthen this interaction, as already seen 
in the GFP pull down experiment (Fig. 3.3.4.). 
                                            
Figure 3.3.6. Western blot of a His pull down with recombinant His-tagged CHIP and 
GST-tagged ILK. ILK co-precipitates with CHIP.                
3.4. ILK and CHIP partially co-localize in mature focal adhesions 
To visualize the cellular compartment in which the ILK-CHIP interaction might take 
place, immunofluorescence stainings of ILK and CHIP in adherent ILK fl/fl and ILK-/- 
fibroblasts were carried out. Cells were seeded on glass coverslips and allowed to adhere 
and spread over night. Next, cells were fixed in 100 % methanol and subsequently 
blocked with 3% BSA/5% goat serum in PBS. ILK and CHIP were detected with primary 
antibodies and fluorescent secondary antibodies diluted in 1 % BSA as described in 
Materials and Methods. The stainings were visualized by confocal microscopy. CHIP was 
found to localize in the cytoplasm into fiber-like structures as well as into focal 
adhesions, where it co-localized with ILK. The localization of CHIP to focal adhesions 
was independent of ILK since a similar staining of CHIP was observed in ILK-/- cells. 
(Fig.3.4.1.). 
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Figure 3.4.1. Immunofluorescence analysis of endogenous CHIP and ILK in ILK fl/fl and 
ILK-/- fibroblasts. Note co-localization in focal adhesions. CHIP localizes to focal 
adhesion also in the absence of ILK. 
To confirm the correct localization of EGFP-CHIP-WT fusion protein that had been used 
in the immunoprecipitation as well as to provide additional evidence for the localization 
of CHIP, immunofluorescence analysis of ILK fl/fl fibroblast expressing EGFP-CHIP-
WT was carried out. To this end adherent ILK fl/fl fibroblast seeded on glass cover slips 
were transiently transfected with EGFP-CHIP-WT using the Lipofectamine 2000 
transfection reagent. After 24 h of protein expression cells were fixed in 4 % PFA. 
Immunostaining of endogenous ILK was subsequently carried out as described above. 
ILK staining and EGFP-CHIP-WT were visualized by confocal microscopy (Fig.3.4.2). 
Localization of EGFP-CHIP fusion protein to fiber-like cytoplasmic structures and 
accumulation in focal adhesions, closely resembling the localization of endogenous 
CHIP, could be observed. This demonstrated that over-expressed EGFP-CHIP-WT 
protein localizes properly in the cell and supported our observation that CHIP localizes to 
focal adhesions as well as fiber-like structures resembling actin stress fibers in the 
cytoplasm. 
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Figure 3.4.2. Immunofluorescence analysis of transiently transfected EGFP-CHIP-WT 
and endogenous ILK in ILK fl/fl fibroblasts. Note co-localization in focal adhesions.  
In order to determine whether the localization of CHIP depends on the actin cytoskeleton 
and to assess the kinetics of CHIP localization to focal adhesions, ILK fl/fl cells were 
subjected to immunofluorescence analysis during the time course of cell spreading (Fig. 
3.4.3.). Cells were seeded on glass cover slips coated with 5 µl/ml fibronectin and 
allowed to adhere and spread. Cells were fixed at time points corresponding to the various 
stages of cell spreading. Cells were then immunostained using phalloidin to visualize 
polymerized F-actin as well as antibodies against the focal adhesion protein paxillin and 
CHIP. Inspection by confocal microscopy revealed that CHIP co-localized with actin 
stress fibers during both early and late stages of cell spreading. Co-localization of CHIP 
with paxillin was observed when actin stress fibers were already visible. This suggested 
that actin polymerization might drive the localization of CHIP. 
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Figure 3.4.3.  Immunofluorescence analysis of endogenous CHIP, paxillin, and actin in 
ILK fl/fl fibroblasts during cell spreading. CHIP localizes to focal adhesions during late 
stages of cell spreading. 
To address this potential interaction of CHIP with polymerized actin, actin co-
sedimentation assays were performed essentially as described previously (Riedl, 
Crevenna et al. 2008). In this assay 3 mM of recombinant His-tagged CHIP was 
incubated with increasing concentrations of polymerized actin. Actin was allowed to 
polymerize by incubating it in high salt buffer. The reactions were pelleted by 
ultracentrifugation at 60 000g. The supernatant and pellet were separated and resolved by 
SDS-PAGE. Coomassie blue staining of the gel revealed co- sedimentation of CHIP with 
actin. The co-sedimentation correlated with the amount of polymerized actin, indicative 
of a specific interaction. This demonstrated the interaction of CHIP and polymerized 
actin. 
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Figure 3.4.4. Coomassie staining of an actin co-sedimentation assay. Recombinant CHIP 
co-sediments with polymerized actin. 
3.5. CHIP ubiquitinates ILK 
The results so far had shown that CHIP both interacts and co-localizes with ILK. In order 
to address whether CHIP is capable of ubiquitinating ILK through its E3 ligase activity, 
an in vitro ubiquitination assay with recombinant CHIP-WT and ILK was performed 
essentially as previously described (Arndt, Daniel et al. 2005). Recombinant ubiquitin, E1 
ubiquitin activating enzyme, and UbcH5a E2 ubiquitin conjugating enzyme were all 
purchased from Boston Biolabs. In addition, the reactions were supplemented with 
recombinant hsp40 and hsp70 proteins that were gifts from Dr.Jörg Höhfeld. ILK-Flag 
fusion protein was purified from CHO cells that were transiently transfected with ILK-
p3XFlag CMV14. After 24 h of protein expression a large-scale Flag 
immunoprecipitation was performed. The immunoprecipitates were extensively washed 
in order to remove any co-immunoprecipitates before the elution by Flag peptide. The 
protein yield was 0.12µg/µl as measured by BCA assay. Expressing the protein in a 
mammalian system has the advantage that posttranslational modifications that might be 
important for protein-protein interaction will be present. This will not be the case for 
proteins expressed in E.coli. 
A series of ubiquitination reactions with constant concentrations of ILK, Ub, E1, E2 as 
well as Hsp40/Hsp70 but increasing concentrations of CHIP was carried out (Fig.3.5.1.).         
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Figure 3.5.1. Western blot analysis of an in vitro ubiquitination assay. CHIP 
ubiquitinates ILK in a dose-dependent manner. 
The reactions were carried out at 37 ˚C for 2 h after which they were terminated by heat 
inactivation at 95 ˚C in Laemmli buffer. Reactions were resolved by a 4-15% gradient 
SDS-PAGE and analyzed by western blot. The immunoblot for ILK revealed a typical 
ladder pattern. The intensity of the high molecular weight bands correlated with the 
concentration of CHIP indicating an increase in the efficiency of the reaction with 
increasing amounts of CHIP in the reaction. This shows that the reaction is specific. It 
should be noted that some background ubiquitination was observed also in the absence of 
CHIP. This probably arises from minor impurities of the ILK protein preparation since 
the same impurity was also observed in the reaction lacking ubiquitin. 
The specificity of the reaction was further confirmed by performing and in vitro 
ubiquitination assay comparing CHIP-WT and the CHIP-H260Q mutant that does not E3 
ligase activity (Fig.3.5.2.). Furthermore, to exclude that the ubiquitination arises from 
impurities of the ILK-Flag preparation, this in vitro ubiquitination assay was carried out 
with a commercially available recombinant ILK-Myc/DDK expressed in HEK293 
(purchased from OriGene). The recombinant CHIP-H260Q mutant was generated by 
performing site directed mutagenesis using a CHIP-WT-pET16b vector as a template. 
The His-tagged mutant protein was then expressed and purified as described earlier for 
the CHIP-WT protein. In vitro ubiquitination reactions were performed with a constant 
concentration of all recombinant proteins including ILK, CHIP-WT, CHIP-H260Q, 
ubiquitin, E1, E2 and Hsp40/Hsp70. 
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Figure 3.5.2. Western blot of an in vitro ubiquitination assay. CHIP-WT but not the 
ligase-dead H260Q-CHIP mutant ubiquitinates ILK. 
The reactions were incubated at 37 ˚C for 2 h, terminated by heat inactivation at 95˚C in 
Laemmli buffer and subsequently resolved by 4-15% gradient SDS-PAGE and analyzed 
by western blot. Immunoblot for CHIP revealed an equal intensity of both CHIP-WT and 
CHIP-H260Q confirming equal concentration of CHIP-WT and CHIP-H260Q in the 
reactions. Immunoblot for ILK showed a ladder pattern typical for ubiquitination only in 
the CHIP-WT sample indicating absence of ubiquitination in the reaction containing the 
E3 ligase dead CHIP mutant (CHIP H260Q).  
Since in vitro ubiquitination assays can give rise to unspecific ubiquitination reactions 
due to the high concentrations of enzymes, and in order to assess whether CHIP is 
capable of ubiquitinating ILK also in vivo, an in vivo ubiquitination assay was performed 
using CHO cells transiently transfected with ILK-3XFlag-pCMV14, Ub-HA-pcDNA3.1, 
CHIP-WT-pEGFP-C1 or CHIP-H260Q-pEGFP-C1 mutant (Fig.3.5.3.). After expressing 
the proteins for 24 h cells were lysed using the denaturating protocol followed by Flag 
immunoprecipitation. Immunoprecipitates were resolved using SDS-PAGE and analyzed 
by western blot. CHO cells transfected with CHIP-WT and ubiquitin-HA; ILK-Flag; ILK-
Flag and ubiquitin-HA or ILK-Flag and CHIP-WT without ubiquitin were used as 
controls. Band intensities of CHIP-WT and CHIP-H260Q in the input lanes were equal in 
indicating equal expression of CHIP-WT and CHIP-H260Q protein. Immunoblotting with 
antibodies against ILK and against ubiquitin revealed a stronger ladder pattern in the 
immunoprecipitates of cells transfected with CHIP-WT compared to cells transfected 
with CHIP-H260Q. This indicated that increased expression of CHIP-WT leads to a 
strong increase in ILK ubiquitination, whereas over-expression of CHIP-H260Q mutant 
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does not enhance the basal level of ILK ubiquitination. Taken together these experiments 
demonstrate that CHIP is capable of ubiquitinating ILK both in vitro and in vivo. 
                           
Figure 3.5.3.  Western blot analysis of Flag immunoprecipitates from CHO cells 
expressing ILK-Flag, CHIP, CHIP-H260Q and ubiquitin-HA. Expression of CHIP but 
not ligase-dead mutant enhances ubiquitination of ILK. 
3.6. ILK is degraded both by proteasome and lysosome 
A major consequence of ubiquitination, particularly through K48-linked chains, is 
proteasomal degradation of the target protein (Ciechanover 1994). As this study could 
demonstrate that ILK is modified by K48-linked polyubiquitin chains, further 
investigation of the consequences of ILK ubiquitination in fibroblasts was carried out. To 
this end ILK fl/fl fibroblast were treated with the proteasomal inhibitor MG132 or the 
DMSO solvent as control. After 6 h of treatment cells were lysed and analyzed by 
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western blot (Fig.3.6.1.). Immunoblotting with antibodies against ubiquitin was used as a 
positive control to confirm that the inhibition was successful, as this should lead to an 
accumulation of ubiquitinated proteins. This was found to be the case as the intensity of 
the ubiquitin signal in the inhibitor treated cells was significantly stronger compared to 
control. ILK levels were not found to be increased in response to inhibitor treatment. 
Actin was used as a loading control, demonstrating equal loading of the two samples. The 
result could either indicate that ILK is not degraded by proteasome, or that its half-life is 
significantly longer than 6 h. In addition, this experiment suggested that ILK might be 
degraded by the lysosome as blocking the proteasome has been shown to increase 
lysosomal degradation (Chen and Yin 2011). In agreement with this, ILK levels were 
found to be slightly decreased upon MG132 treatment (Fig.3.6.1.). 
                                                       
Figure 3.6.1. Inhibition of proteasome with MG132 results in decrease in ILK levels. 
Ubiquitin is used as a positive control for MG132 treatment and actin as loading control. 
In recent years it has been shown that ubiquitination does not only lead only to 
proteasomal degradation of target proteins but it can also act as a target signal for 
lysosomal degradation (Wong and Cuervo 2010). In particular, long-lived cytosolic 
proteins are often degraded via the lysosomal pathway (Wong and Cuervo 2010), and this 
can be induced by activation of autophagy by starvation or rapamycin (Klionsky, 
Abeliovich et al. 2008). In order to determine the half-life of the ILK protein and its 
degradation kinetics under starvation, ILK fl/fl fibroblasts were treated with 
cycloxeximide (CHX), an inhibitor of protein synthesis that acts by blocking translational 
elongation (Fig. 3.6.2.). In parallel, the cells were treated with CHX in serum-free 
medium to induce autophagy through starvation. Control cells were treated with DMSO. 
The cells were then lysed at different time points and analyzed by western blot. The 
immunoblot for ILK showed a moderate decrease in ILK levels after 12 h of treatment 
with CHX and after 24 h of treatment ILK levels were found significantly reduced. 
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Starvation was observed to enhance this effect. -catenin immunoblot was used as a 
positive control for the success of CHX treatment and immunoblot for GAPDH was used 
as a loading control. This indicated that ILK is a long lived protein with a half-life of 
approximately 12-24 h, and that starvation, possibly by activation of autophagy, reduces 
this half-life. 
                     
Figure 3.6.2. Western blot of fibroblasts treated with cycloheximide (CHX) to block 
protein synthesis for time points indicated. Majority of ILK is degraded in 24 h. Serum 
starvation enhances degradation. -catenin was used as a positive control for CHX 
treatment, and GAPDH as loading control. 
As ILK was found to have a relatively long half-life, we decided to combine inhibition of 
protein synthesis with inhibition of degradation to clarify whether ILK is degraded by the 
proteasome or by the lysosome. ILK fl/fl fibroblasts were treated with CHX for 12 h in 
order to block protein synthesis in combination with the proteasomal inhibitor MG132, 
the lysosomal inhibitor bafilomycin, the lysosomal activator rapamycin, or the vehicle 
DMSO (Fig.3.6.3.). After 12 h of incubation cells were lysed and analyzed by western 
blot. Immunoblot with antibodies against LC3, a marker for lysosome activation showed 
significantly stronger staining in the bafilomycin treated cells, indicating that lysosomal 
degradation was successfully blocked resulting in LC3 accumulation. The LC3 staining 
was reduced in rapamycin treated cells indicating that lysosomal degradation was 
induced, resulting in LC3 degradation. The immunoblot for ILK revealed a significant 
increase in ILK staining in bafilomycin treated cells compared to the DMSO control. In 
addition, bafilomycin could partially restore ILK levels in CHX treated cells, indicating 
that ILK can be degraded by the lysosome. However, also the MG132 treatment could 
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restore ILK levels in CHX-treated cells. Interestingly, MG132 blocked ILK degradation 
in CHX-treated cells more efficiently than bafilomycin. GAPDH immunostaining was 
used as a loading control. This indicated that ILK can be regulated both by proteasomal 
and lysosomal degradation pathways and suggested that majority of ILK is degraded via 
the proteasome.                      
                         
Figure 3.6.3. Western blot of fibroblasts treated with cycloheximide (CHX) to stop 
protein synthesis for time points indicated. Inhibition of proteasome with MG132 retards 
ILK degradation as well as inhibition of lysosome with bafilomycin. Induction of 
autophagy by rapamycin has no major effect. LC3 is a positive control for inhibition of 
lysosome and induction of autophagy. GAPDH is used as loading control. 
3.7. ILK is rapidly degraded by CHIP in the absence of Hsp90  
ILK has been shown to be a Hsp90 client protein in HT1800, COS-7 and NL-17 cells 
(Aoyagi, Fujita et al. 2005). As Hsp90 was identified in our interaction screen and it has 
been shown to act in co-operation with CHIP, it was of interest to test whether ILK is a 
Hsp90 client also in mouse fibroblasts. ILK fl/fl cells were therefore treated with 17AAG, 
an inhibitor of Hsp90 (Fig.3.7.1.). The control cells were treated with the vehicle DMSO. 
Cells were lysed after 12 h and 24 h of treatment and analyzed by western blot.  
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Figure 3.7.1. Western blot of fibroblasts treated with 17AAG to inhibit Hsp90 for time 
points indicated. Inhibition of Hsp90 with 17AAG leads to rapid degradation of ILK. 
Caveolin-1 was used as a loading control. 1 and paxillin were used as negative controls 
for the inhibitor treatment. Assay performed by Dr. Sara A. Wickström. 
Immunoblotting with antibodies against ILK revealed a significant decrease in ILK 
staining already after 12 h and a more pronounced effect after 24 h indicating that ILK 
protein levels were reduced. The immunoblots for the focal adhesion proteins paxillin and 
1 integrin showed no change in staining intensity, indicating that the effect is specific 
for ILK and not a general phenomenon for focal adhesion proteins. Caveolin-1 was used 
as a loading control.  
Based on this result we hypothesized that Hsp90 is a chaperone for ILK, and inhibition of 
chaperone activity leads to degradation of ILK. As previous experiments implicated that 
ILK can be degraded by both proteasomal and lysosomal pathway, it was of importance 
to analyze which of these pathways is involved in ILK degradation upon Hsp90 
inhibition. Inhibiting the degradation pathway should in this case maintain ILK levels 
also in the presence of the Hsp90 inhibitor. To test this, ILK fl/fl fibroblasts were treated 
with 2.5 µM 17AAG to inhibit Hsp90 and to induce ILK degradation in combination with 
either the proteasomal inhibitor MG132 or the lysosomal inhibitor bafilomycin 
(Fig.3.7.2.). Control cells were treated with DMSO or 17AAG alone. After 12 h of 
treatment cells were lysed and analyzed by western blot. The immunoblot for ILK 
revealed a decrease in ILK staining in samples treated with 17AAG as well as in samples 
treated with a combination of 17AAG and bafilomycin. However, in samples treated with 
a combination of MG132 and 17AAG, ILK staining was significantly stronger. This 
indicated that inhibition of Hsp90 leads to the degradation of ILK through the 
proteasome, whereas the lysosomal degradation pathway is not involved.  
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Figure 3.7.2. Western blot of fibroblasts treated with 17AAG to inhibit Hsp90 in 
combination with MG132 or bafilomycin. Inhibition of the proteasome with MG132 
rescues ILK from degradation induced by 17AAG treatment. 1 integrin was used as 
negative control for the inhibitor treatment. Assay performed by Dr. Sara A. Wickström. 
1 integrin was used as a negative control for the inhibtion treatment. Immunoblot for 
CHIP demonstrated that CHIP protein levels remained constant in all samples, excluding 
that variation in ILK levels could be a result of altered levels of CHIP.  
CHIP interacts with Hsp90 and Hsp70, and the complex is involved in the triage decision 
of protein refolding versus degradation (Pratt, Morishima et al. 2010). Therefore it was of 
importance to address whether the degradation of ILK that occurs when Hsp90 is 
inhibited by 17AAG involves CHIP. To this end, CHIP+/+ fibroblasts and two 
independent CHIP-/- cell lines were treated with 17AAG after which ILK levels were 
analyzed by western blot (Fig.3.7.3.). Two concentrations of the inhibitor, 1 and 5 µM, 
were used. Control cells were treated with the vehicle DMSO. 
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Figure 3.7.3. Western blot of CHIP +/+ and CHIP -/- fibroblasts treated with different 
concentrations of 17AAG to inhibit Hsp90. Inhibition of Hsp90 with 17AAG leads to 
rapid degradation of ILK in CHIP +/+ cells. This effect was attenuated in the CHIP-/- 
fibroblasts. CHIP was used to confirm the absence of the protein in CHIP-/- cells and 
caveolin-1 was used as a loading control.  Assay performed by Dr. Sara A. Wickström. 
The immunoblot for ILK revealed a significant decrease in ILK staining in 17AAG-
treated CHIP +/+ cells, whereas only a modest decrease was observed in both 
independent CHIP-/- cell lines. This indicates that CHIP is involved in the degradation of 
ILK when Hsp90 is inhibited. The CHIP immunoblot confirmed the absence of CHIP 
protein in CHIP-/- cells. Caveolin-1 was used as a loading control. 
To confirm the results from the mass spectrometry analyses that Hsp90 interacts with ILK 
and to assess whether the inhibition of Hsp90 activity leads to increased interaction of 
ILK with the E3 ligase CHIP, immunoprecipitation experiments in the presence of 
17AAG were performed. ILK-Flag cells were treated with 17AAG and lysed after 0, 30, 
60 and 120 min of treatment. These brief time points were selected to avoid degradation 
of ILK during the course of the experiment. The lysates were subsequently subjected to 
immunoprecipitation using the Flag affinity resin as described previously (Fig.3.7.4.). 
The immunoprecipitates were eluted by Flag peptide and analyzed by western blot. The 
immunoblot for Hsp90 confirmed the interaction between Hsp90 and ILK and showed 
that this interaction gradually decreases upon inhibition of Hsp90 activity. The 
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immunoblot with antibodies against CHIP revealed increased CHIP staining in 
immunoprecipitates of 17AAG-treated cells, indicating that the interaction between ILK 
and CHIP increases upon inhibition of Hsp90. Interestingly the parvin immunoblot 
showed decreased staining in of parvin in the immunoprecipitates of the inhibitor-
treated cells, indicating that ILK might be released from the IPP complex, or that the 
complex might be destabilized. The immunoblot for ILK-FLAG was used as a control for 
the succes of the immunoprecipitation. 
          
Figure 3.7.4. Western blot of Flag immunoprecipitation of fibroblasts treated with 
17AAG to inhibit Hsp90 for time points indicated. Inhibition of Hsp90 with 17AAG leads 
to increased interaction between ILK and CHIP and a decreased interaction between ILK 
and -parvin. Assay performed by Dr. Sara A. Wickström.  
The 17AAG inhibitor studies in this chapter were performed by Dr. Sara A. Wickström. 
3.8. Functional consequences of ILK-Hsp90 interaction 
In vitro studies conducted on fibroblasts, chondrocytes and keratinocytes have 
demonstrated the role of ILK in cell spreading, focal adhesion formation and migration 
(Grashoff, Aszodi et al. 2003; Sakai, Li et al. 2003; Lorenz, Grashoff et al. 2007). In 
order to analyze potential functional consequences of the interaction of ILK with Hsp90 
and subsequent stabilization of ILK protein levels, the ability of fibroblasts to migrate 
within a 3-dimensional (3D) collagen matrix was analyzed. Fibroblasts were embedded in 
collagen gels in the presence or absence of the Hsp90 inhibitor 17AAG. The gels were 
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casted in self-made chambers and allowed to settle for 30 min at 37 ˚C and 4.5 % CO2. 
The migration process was imaged by Zeiss Axiovert 40C microscope equipped with a 
CCD camera (Prosilica, GC2450) and a heated stage (37˚C) supplied with 4,7 % CO2. 
Image acquisition was performed using FireWire software (Molecular Devices, 
Downingtown, PA). Migrating cells were subsequently tracked using the Chemotaxis and 
Migration tool of ImageJ software (Fig.3.8.1.).  
 
Figure 3.8.1. Representative plots of migration tracks demonstrating reduced migration 
of ILK fl/fl fibroblasts treated with 17AAG or untreated ILK-/- fibroblasts compared to 
untreated ILK fl/fl cells. 
The migration distance and velocity was quantified from the live cell imaging data using 
ImageJ software (Fig.3.8.2.).  The statistical significance was analyzed using the 
GraphPad Prism software by performing an ANOVA test followed by a Tucky post-hoc 
test. The quantifications demonstrate that the migration velocity and distance of ILK fl/fl 
fibroblasts treated with 17AAG inhibitor was significantly decreased compared to non-
treated ILK fl/fl control. The migration velocity and distance of ILK fl/fl fibroblasts 
treated with 17AAG were comparable to ILK-/- cells.  This led to the conclusion that 
inhibition of Hsp90, which induces degradation of ILK, also impairs fibroblast migration. 
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Figure 3.8.2. Quantitative representation of velocity and distance differences between 
ILK fl/fl cells treated with 17AAG and untreated ILK-/- and ILK fl/fl fibroblasts. One way 
ANOVA test followed by Tucky´s post test was performed for statistical analysis. Data is 
expressed as mean  SEM. n=5; *p<0.005, **p=0.0037(velocity) and 0.0010(distance), 
***p=0.0004; ns=not significant. 
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4. Discussion 
Cell migration is a central process during development as well as during regenerative 
processes such as wound healing in adult organisms. Cell movement is achieved by 
coordinated assembly and disassembly of focal adhesions that couple to the actin 
cytoskeleton to generate the force and cell shape changes required for locomotion. To 
understand the detailed molecular mechanisms underlying focal adhesion dynamics, it is 
critical to study the regulation of individual focal adhesion proteins. As ILK is a major 
scaffold protein downstream of 1 integrins, alterations in levels of its function are likely 
to affect focal adhesions on a more global level. Therefore it was of interest to investigate 
how ILK might be regulated on the molecular level. The results of this study demonstrate 
that ILK is polyubiquitinated via K48- and K63-linked ubiquitin chains. The ubiquitin 
chains can be attached on K341 on ILK, but this lysine is dispensable for ubiquitination 
of ILK. ILK is further shown to interact with the chaperone-E3 ligase complex consisting 
of Hsp90, Hsp70 and CHIP. Hsp90 activity is required to stabilize ILK, and inhibition of 
Hsp90 activity leads to increased interactions between ILK and CHIP. CHIP is capable of 
ubiquitinating ILK, leading to its proteasomal degradation. 
4.1. ILK is posttranslationally modified by ubiquitin 
   4.1.1.      ILK is ubiquitinated at lysine 341 
Ubiquitination is one of the most abundant posttranslational modifications of the 
proteome. It targets proteins to proteasomal and lysosomal degradation, but can also 
regulate the subcellular localization and recycling of target protein. This study sought to 
unravel the molecular mechanisms by which ILK is regulated by identification of 
posttranslational modifications on ILK and subsequent investigation of their functional 
significance. To this end mass spectrometry analysis of ILK immunoprecipitates was 
performed. The results showed that ILK is modified by a glycine-glycine dipeptide side 
chain on lysine 341. It is likely that other modified sites remained undetected as the 
peptides identified in the mass spectrometer depend on the presence of trypsin cleavage 
sites within the protein, therefore generating a bias towards certain peptides. The glycine-
glycine modifications that remain covalently attached to the target protein after trypsin 
digestion are not specific for ubiquitin but can also be the consequence of modification by 
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other small proteins. Although abundant amounts of ubiquitin peptides were also detected 
in the mass spectrometry analysis, supporting the notion that ILK is ubiquitinated, further 
investigation of the nature of this modification by western blot analysis of the 
immunoprecipitates was carried out. In vivo ubiquitination assays performed in CHO 
cells expressing HA-ubiquitin together with ILK-Flag could confirm that ILK is indeed 
ubiquitinated in vivo. This does not, however, exclude that ILK could also be modified by 
other small proteins or molecules, and identification of additional posttranslational 
modifications of ILK might be important to fully understand how this protein is regulated.  
The results from the mass spectrometry analysis showed that lysine 341 contains an 
ubiquitin modification. To investigate the potential functional relevance of this lysine as a 
ubiquitination site, a point mutation in ILK cDNA leading to the exchange of the lysine 
341 to arginine was introduced. This particular amino acid was chosen because it keeps 
the positive charge of the lysine residue while abolishing the possibility of ubiquitin 
attachment. Initial experiments performed by transient transfection showed a reduction, 
but not complete absence, of ILK ubiquitination in mutants where lysine 341 was 
replaced by an arginine. This lead to the initial conclusion that K341 is a major 
ubiquitination site on ILK, but that other ubiquitination sites most likely exist. 
   4.1.2.      ILK is modified by both K48 and K63 polyubiquitin chain 
Ubiquitin can assemble into various polyubiquitin chains depending on the recipient 
lysine in the ubiquitin molecule. Taken that there are seven lysine residues in ubiquitin 
molecule (K6, K11, K27, K29, K31, K48, K63), there are seven different possibilities for 
chain formation. In addition, polyubiquitin chains can be assembled in a linear fashion by 
N-terminal conjugation or in a branching manner by alternating the acceptor lysine 
residue in ubiquitin. This gives the wide variety of different possibilities for polyubiquitin 
chain formation (Ikeda and Dikic 2008). Various chains serve as different signals and 
lead to different outcomes for the target protein (Ikeda, Crosetto et al. 2010). Therefore it 
was important to identify the type of chain(s) assembled on ILK. To this end in vivo 
ubiquitination assays were performed using HA-tagged ubiquitin mutants that can only 
assemble K48- or K63-linked chains, allowing unequivocal identification of the type of 
chain assembled.  Our results could demonstrate that ILK is modified by both K48 and 
K63 polyubiquitin chains. K48-linked chains target proteins to degradation, whereas K63-
linked chains often regulate protein function or localization. Therefore this result suggests 
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that ubiquitination of ILK might have several functional outcomes, depending on the type 
of chain assembled. 
4.2. Fibroblasts carrying a K341R mutation in ILK display reduced 
migration  
As a central scaffold linking integrin to actin cytoskeleton, ILK is important for migration 
of fibroblasts as well as several other cell types (Grashoff, Aszodi et al. 2003; Sakai, Li et 
al. 2003). Therefore, in order to elucidate the potential role of ubiquitination at K341 in 
processes regulated by ILK, migration assays were performed. These assays were 
performed in a 3D environment as this provides more physiological and in vivo relevant 
mode of cell migration compared to 2D (Rhee 2009; Harunaga and Yamada 2011). In 
addition a 1D environment was used as a simplified model for 3D topology (Doyle, Kutys 
et al. 2012). Both of these assays demonstrated a reduction in migration of ILK-K341R 
expressing fibroblasts as measured by velocity and distance compared to the ILK-wt 
expressing cells. This led to the initial conclusion that the ubiquitination of ILK at this 
particular lysine, or other potential functions of this lysine is important for fibroblast 
migration 
   4.2.1.      Fibroblasts carrying a K341R mutation show altered turnover of ILK in 
FAs 
This study employed new approach to investigate the turnover of proteins in FAs in a1D 
environment that can be used as a simplified model for cell behavior in 3D environment. 
In agreement with previous reports showing increased stability of FAs in 1D and 3D 
compared to a 2D environment ,this study could demonstrate a slow overall turnover rate 
of ILK protein in FAs of cells seeded in 1D fibronectin functionalized micropatterned 
lines (Doyle, Wang et al. 2009; Doyle, Kutys et al. 2012). Furthermore, this suggested 
that ubiquitination of ILK at K341 might be important for the stability of ILK in FAs. The 
mutation of lysine 341 to arginine that abolished the ubiquitination of ILK at this site led 
to the significant decrease in the mobile fraction (Mf) and a concomitant increase in the 
immobile fraction (If) of ILK. As the migration of cells depends on the tight regulation of 
FA turnover, the increased stability of the mutant ILK might explain the reduced 
migration of the fibroblast expressing mutated ILK. Further studies are necessary to 
investigate of the précised role of this lysine in the function of ILK. Furthermore the 
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overall turnover of FAs should be examined to determine if K341R mutation influences 
the global rates of FA turnover. 
In addition, this study could show K341 of ILK might be necessary for clathrin-mediated 
endocytosis. This is in agreement with studies performed on the myotendinous junction of 
D.melanogaster showing that integrins and ILK are endocytosed in clathrin and Rab5 
dependant manner and that this is important for the remodeling of the myotendinous 
junction and muscle function. One could speculate that ILK is regulated in a similar 
manned in mammals. It has been already demonstrated that mammalian muscles express 
high levels of ILK and that ILK is important for the maintenance of the murine 
myotendinous junction (Wang, Chang et al. 2008). Additional studies are required to 
determine K341 and the ubiquitination of ILK are involved in the maintenance of 
myotendinous junction in mammals. 
   4.2.2.      Lysine 431 is dispensable for ILK ubiquitination 
Using a retroviral construct a stable cell lines expressing either wt ILK-Flag or the 
K341R-Flag mutant were generated. The in vivo ubiquitination assay failed to show any 
difference in the ubiquitination pattern of wt and mutant ILK, indicating that lysine 341 is 
dispensable for ILK ubiquitination. This was not surprising as it is has been shown that 
ubiquitination is rarely specific for a particular lysine. Because of this known lack of 
specificity we decided not to attempt to identify additional lysines that might act as 
ubiquitin acceptors on ILK.  
This result is in stark contrast to the data obtained by transient transfection of the cells. It 
is possible that the variation in expression levels between wt and mutant ILK in the 
transient transfection experiments might explain the observed differences in the 
ubiquitination levels of the two proteins. Precise control of protein levels is not possible 
in transient transfection experiments. It is also possible that the unphysiological 
overexpression of ILK protein that is often a consequence of transient transfection led to 
the saturation of ILK in FAs and subsequent accumulation of excess ILK in the 
cytoplasm, leading to abnormal patterns of ubiquitination. Unfortunately this issue 
remains unresolved thereby fundamentally questioning the interpretation of the migration, 
turnover and endocytosis data shown in this study. It might be possible that ubiquitination 
of ILK at this particular lysine provides a docking site for a potential adaptor for 
endocytosis, regardless of compensatory ubiquitination at other lysine sites. However, we 
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can also not fully exclude that the observed defects in migration and turnover in cells 
expressing the K341R mutant ILK could be cell culture artifacts. It should, however, be 
noted that two independent pairs of cell lines were generated, one pair expressing Flag-
tagged mutant and wt ILK, and one pair expressing GFP-tagged mutant and wt ILK. In 
addition, both mixed populations and single cell clones were analyzed, and the defects 
were consistently observed. However, as no change in ubiquitination between wt and 
K341R ILK was observed, and no interaction partners that would fail to bind K341R 
mutant ILK were detected, it was beyond the scope of this study to resolve this 
controversy. 
4.3. CHIP is a novel interacting partner of ILK 
To further characterize this posttranslational modification we were prompted to identify 
the E3 ligase responsible for it. Therefore a mass spectrometry screen was performed 
where immunoprecipitates from wt ILK-Flag cells were compared to the ILK fl/fl 
negative control in order to identify specific binders as well as to immunoprecipitates 
from K341R-Flag cells in order to identify partners that would interact with lysine 341. 
This analysis was successful as all major known binding partners of ILK such as Pinch-1, 
-parvin, -parvin and RSU-1 were identified. There was, however, no significant 
difference in the interactome of wt versus K341R mutant ILK. Importantly the screen 
revealed significant binding of ILK to a chaperone complex consisting of Hsp70 and 
Hsp90. In addition, we could identify the E3 ligase CHIP as a major interaction. This was 
the only E3 ligase that was identified as a statistically significant interactor in this screen. 
The fact that it acts in co-operation with Hsp90 and Hsp70, also detected in the screen, 
further increased the probability that this hit was specific. Therefore further investigation 
of the ILK-CHIP interaction was carried out. As the detection of CHIP in the co-
immunoprecipitate from ILK-Flag cells also by western blotting was possible, conclusion 
could be made that CHIP is a new interacting partner of ILK. 
4.3.1.      Characterization of ILK-CHIP interaction  
In order to characterize this novel interaction in more detail the domains of CHIP 
mediating the interaction were investigated. To this end different truncation mutants of 
CHIP containing either the Ubox or the TPR domain as well as two full-length point 
mutants abolishing the interaction with Hsp70 (CHIP-K30A) or the ubiquitin ligase 
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function of CHIP (CHIP-H260Q) were cloned. The co-immunoprecipitation of ILK in 
cells expressing the various CHIP constructs showed that ILK binds very strongly to the 
Ubox domain and that this interaction is even stronger that the interaction with full-length 
CHIP. This can be explained by structural studies of CHIP showing that it is an 
asymmetrical dimer (Schulman and Chen 2005). The structure of CHIP reveals that only 
one of the Ubox domains is exposed at the protein surface while the other one is buried 
underneath the TPR domain. Therefore, the functional CHIP dimer has two TPR domains 
but only one Ubox domain exposed at the surface (Schulman and Chen 2005). The 
deletion of the TPR domain and expression of Ubox domain only gives rise to additional 
binding sites that are absent in the full length CHIP dimer. Furthermore, the reduction of 
ILK binding to the CHIP-K30A mutant was observed. As this mutation abolishes the 
interaction of CHIP with Hsp70 it is likely that the interaction of CHIP and ILK is 
stabilized by Hsp70. This further implies that the CHIP-ILK interaction is indeed part of a 
larger complex involving molecular chaperones. 
In vitro binding experiments with recombinant additionally showed that the interaction 
between ILK and CHIP is direct. The binding under our experimental conditions was, 
however, relatively weak. Therefore it does not exclude the possibility that Hsp70 could 
strengthen the interaction. The role of Hsp70 in this interaction should be addressed in 
more detail in future studies.  
4.4. CHIP and ILK co-localize in mature focal adhesions  
This study could demonstrate the partial co-localization of endogenous CHIP and ILK 
proteins in focal adhesions. The localization of CHIP to focal adhesions was, however, 
not dependent on ILK, as CHIP was found in adhesions also in ILK -/- cells. In addition 
to partially localizing to adhesions, CHIP was found to co-localize with actin stress fibers. 
This pattern of localization differs from previous studies where CHIP has been shown to 
have a diffuse cytoplasmic staining pattern (Dai, Zhang et al. 2003). These differences 
could arise from different cell fixation methods as well as different antibodies used in the 
stainings. Importantly, this study could demonstrate that the CHIP-GFP fusion protein 
also localizes to adhesions and stress fibers, providing additional support that CHIP 
indeed localizes to these structures. Interestingly, CHIP localization was found to be 
independent of ILK. This led to the hypothesis that CHIP could localize to adhesions and 
stress fibers by interacting directly with polymerized actin. This hypothesis was 
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confirmed by using co-sedimentation assays with recombinant CHIP and polymerized 
actin. This provides a putative mechanism for the localization of CHIP.  
The process of adhesion maturation from nascent adhesions to focal complexes and focal 
adhesions as well as fibrillar adhesions depends on actin polymerization (Vicente-
Manzanares and Horwitz 2011). Therefore co-localization of CHIP and ILK was 
investigated to determine the dependency of this co-localization on the maturation status 
of matrix adhesions and on stress fiber formation. Immunofluorescence analyses of CHIP 
during the various stages of cell spreading confirmed that CHIP localizes to mature focal 
adhesions. Taken together the conclusion could be made that ILK and CHIP co-localize 
only in mature focal adhesions that this co-localization depends on actin stress fiber 
formation. This data fits to the observation of others that CHIP is part of the chaperone 
machinery for cytoskeletal proteins such as myosin and filamin (Nyamsuren, Faggionato 
et al. 2007; Arndt, Dick et al. 2010). 
4.5. CHIP is an E3 ligase ubiquitinating ILK  
CHIP is a E3 ubiquitin ligase involved in ubiquitination of a wide range of proteins 
(Dickey, Patterson et al. 2007). As CHIP was the only E3 ligase present in the ILK 
interactome, it was a likely candidate for the E3 ligase responsible for ubiquitinating ILK. 
This study demonstrated that CHIP ubiquitinates ILK in vitro in a dose dependant 
manner. In addition, it could be observed that in vitro ubiquitination of ILK occurs only 
in presence of wt CHIP and not CHIP-H260Q ligase dead mutant. These observations 
lead to the conclusion that ILK can be ubiquitinated by CHIP in vitro. However, the in 
vitro ubiquitination studies have to be taken with some caution as they involve high 
concentrations of recombinant proteins and thus can give false positive results. Therefore 
it was necessary to address this question in an in vivo experiment as well. Despite a wide 
range of substrates, in most cases CHIP has been shown to be redundant and the 
ubiquitination is often compensated by other E3 ligases (Morishima, Wang et al. 2008; 
Taipale, Jarosz et al. 2010). Therefore, to avoid potential redundancy, overexpression 
studies were performed to address whether CHIP is capable of ubiquitinating ILK in vivo. 
Overexpression of CHIP in CHO cells led to a robust increase in ILK ubiquitination, 
whereas the ligase dead mutant did not display this effect. Taken together these results 
allow the conclusion that ILK is an in vivo target of CHIP ubiquitination.  
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4.6. ILK is degraded by both proteasome and lysosome 
K48-linked polyubiquitin chains target proteins for proteasomal degradation (Adhikari 
and Chen 2009), while the K63-linked polyubiquitin chain has been implicated in 
selective autophagy (Kirkin, Lamark et al. 2009; Clague and Urbe 2010). CHIP can 
catalyze the formation of several different polyubiquitin chains, depending on the E2 
ligase interaction. For example, when interacting with UbcH5a CHIP forms K48-linked 
polyubiquitin chains, while interaction with Ubc13/Uve1 leads to formation of K63-
linked polyubiquitin chains (Zhang, Windheim et al. 2005). This study revealed that ILK 
can contain both K48- and K63-linked polyubiquitin chains. Therefore the obvious 
question was which degradation pathway regulates ILK. There are several lines of 
evidence that suggest that ILK can be degraded both via the proteasome and via the 
lysosome. First, treatment of cells with MG132, a proteasomal inhibitor, lead to a 
reduction of ILK levels, which was contrary to the expected increase in ILK levels if ILK 
would have been targeted exclusively to the proteasome. The ubiquitin-proteasome 
system and the autophagy-lysosome system are synergistic, cooperative and 
complementary systems working to maintain cellular homeostasis (Chen and Yin 2011). 
It has been demonstrated that autophagy can be activated by proteasomal inhibition 
(Ding, Ni et al. 2007). Therefore it is possible that the reduction of the ILK protein levels 
after the proteasomal inhibition is due to the activation of autophagy-lysosome system. 
Second, it was observed that starvation of cells leads to faster turnover of ILK protein. As 
starvation has been shown to activate autophagy, it supports the conclusion that ILK is 
degraded by the autophagy-lysosome system. Third, however, blocking the proteasome in 
the presence of CHX that inhibits protein synthesis inhibited the degradation of ILK more 
efficiently than blocking the lysosome. Taken together the conclusion could be made that 
ILK can be degraded by both machineries and the pathway used might depend on the 
cellular context and the type of ubiquitin chain. 
Components of the IPP complex depend on the integrity of the complex for their stability. 
For example, in the absence of ILK, PINCH and parvin are degraded by the proteasome 
(ref). It would therefore be of interest to analyze whether this proteasomal degradation 
involves CHIP-mediated ubiquitination. 
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4.7. Hsp90 interaction protects ILK from CHIP ubiquitination 
CHIP is involved in the triage decision between refolding and degradation of misfolded 
proteins. This mechanism includes the interaction of CHIP with the chaperones Hsp70 
and Hsp90. Therefore, it was investigated whether ILK degradation is regulated by its 
interaction with Hsp90 and Hsp70, as these proteins were also detected in the interactome 
screen. Treatment of cells with the Hsp90 inhibitor 17AAG led to an almost complete 
depletion of ILK protein. Therefore, the conclusion could be made that ILK is Hsp90 
client protein in mouse fibroblasts. This is in line with the literature demonstrating ILK 
interaction with Hsp90 protein in HEK 293T, human fibrosarcoma HT1080 and COS-7 
cells (Aoyagi, Fujita et al. 2005). Here it would be interesting to note that may of the 
Hsp90 clients are kinases such as v-Src (Wayne, Mishra et al. 2011). It is possible that 
kinase-like domain of ILK, although lacking the structural flexibility essential for kinase 
activity (Fukuda, Gupta et al. 2009) allows the interaction with Hsp90 as a client protein. 
Interestingly, the depletion of ILK in response to Hsp90 inhibition was comparable to the 
effect of blocking protein synthesis by CHX treatment, suggesting that the entire cellular 
pool of ILK might require Hsp90 for its stability.  
   4.7.1.       Hsp90 inhibition leads to the proteasomal degradation of ILK  
As ILK degradation induced by Hsp90 inhibition could be successfully rescued by 
proteasomal inhibitor MG132 but not by the lysosomal inhibitor bafilomycin, the 
conclusion could be made that inhibition of Hsp90 leads to proteasomal and not 
lysosomal degradation of ILK. In addition, the ILK protein levels could be partially 
rescued by deletion of CHIP as demonstrated by Hsp90 inhibition in CHIP-/- cells. This 
suggests that Hsp90 promotes folding of ILK and thereby protects it from ubiquitination 
by CHIP and subsequent proteasomal degradation. This hypothesis is further supported 
by co-immunoprecipitation experiments in 17AAG-treated cells. The interaction between 
ILK and CHIP is increased upon inhibition of Hsp90. Interestingly, the interaction of ILK 
with its key binding partner -parvin is reduced, implying that Hsp90 might promote the 
formation of the IPP complex, or alternatively stabilize it after it has formed. In fact, 
Hsp90 has been shown to stabilize several multiprotein complexes, for example by 
folding and thereby stabilizing a core component of a protein complex (Taipale, Jarosz et 
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al. 2010). Whether Hsp90 indeed has this function for the IPP complex as well, remains a 
task for future studies. 
4.8. Ubiquitination and degradation of ILK impairs fibroblast 
migration  
ILK is a central scaffold linking integrins with the actin cytoskeleton. It has been shown 
to be essential for cell migration in fibroblasts as well as several other cell types 
(Grashoff, Aszodi et al. 2003; Sakai, Li et al. 2003). In recent years also E3 ligases and 
ubiquitination have been implicated in the regulation of cell adhesion dynamics and 
migration. It has been demonstrated that various E3 ligases, via ubiquitination of 
numerous components of focal adhesions and the actin cytoskeleton, can tune the cell 
migration machinery through regulation of actin polymerization, adhesion dynamics and 
cell polarization (Huang 2010). Therefore, one of the aims of this study was to investigate 
the influence of ILK ubiquitination and subsequent degradation on fibroblast migration. 
To this end migration assays in 3D collagen gels were performed, as these provide more 
in vivo-like conditions than migration assays performed in 2D (Hakkinen, Harunaga et al. 
2011; Harunaga and Yamada 2011). These assays revealed a dramatically reduced 
migration velocity and distance of ILK -/- fibroblasts compared to ILK fl/fl cells. 
Interestingly, ILK fl/fl fibroblasts treated with the Hsp90 inhibitor 17AAG displayed a 
similar migratory defect as the ILK -/- cells. These data clearly demonstrate that 
inhibition of Hsp90 leads to impaired fibroblast migration. This might occur through 
destabilization of ILK and subsequent ubiquitination and proteasomal degradation of the 
protein. At this point it cannot, however, be excluded that destabilization of other Hsp90 
clients could also play a role in the observed migration defect.  
Interestingly, many adhesion molecules including ILK, are overexpressed in different 
hematological and solid malignancies (Schmidmaier and Baumann 2008). It has been 
proposed that this overexpression of adhesion molecules mediates drug resistance (CAM-
DR) in certain malignancies such as multiple myelomas, lymphomas, acute and chronic 
leukemia as well as pancreatic cancer, breast cancer, colorectal carcinoma, 
neuroblastoma, small cell and non-small cell lung cancer among the solid tumors 
(Schmidmaier and Baumann 2008). Therefore, destabilizing ILK and the IPP complex by 
17AAG would be a very interesting potential anti-adhesion therapy in different 
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hematopoietic and solid malignancies. ILK plays a role also in fibrosis of the kidney, liver 
and lung through a process highly resembling the epithelial-mesenchymal transition 
(EMT) that leads to accumulation of fibroblasts and myofibroblasts in the tissue (Li, 
Yang et al. 2003; Zhang, Ikegami et al. 2006; Kavvadas, Kypreou et al. 2010). Therefore 
it might be of interest to explore the antifibrotic effect of 17AAG in these tissues. 
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